Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRP,Agouti-related protein,40058,0.287879645011495,0.00460703995636391,0.278849846697022,0.296909443325968,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL27,C-C motif chemokine 27,39868,0.263323276285979,0.00562763848372513,0.252293104857878,0.274353447714081,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN1,CCN family member 1,39758,0.380347896043658,0.00668335939690563,0.367248511625723,0.393447280461593,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F7,Coagulation factor VII,39899,0.128626975825231,0.00268760149032006,0.123359276904203,0.133894674746258,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FURIN,Furin,39913,0.123572459282781,0.00310422817236144,0.117488172064953,0.12965674650061,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCG,Pro-glucagon,39477,0.472907547512715,0.0111681173007913,0.451018037603164,0.494797057422266,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHR,Growth hormone receptor,37124,0.107243814371112,0.00261008242963434,0.102128052809028,0.112359575933195,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.289511187490809,0.00694403870634591,0.275900871626371,0.303121503355247,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0945160978678686,0.00194014384144791,0.0907134159386307,0.0983187797971065,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLR,Low-density lipoprotein receptor,39882,0.422593425281401,0.00378223107255941,0.415180252379185,0.430006598183618,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPL,Lipoprotein lipase,39868,-0.170873021531294,0.00433277575361274,-0.179365262008374,-0.162380781054213,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFGE8,Lactadherin,39858,0.238445351801956,0.00375893222972082,0.231077844631703,0.245812858972209,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPY,Pro-neuropeptide Y,40030,0.379363699458855,0.00562017568339632,0.368348155119398,0.390379243798312,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.126223783607609,0.00275215542569965,0.120829558973237,0.13161800824198,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAP1,Proline-rich acidic protein 1,37437,0.147381347882642,0.00366271455570189,0.140202427353466,0.154560268411817,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROC,Vitamin K-dependent protein C,39908,0.105216865356443,0.00232956947885794,0.100650909177881,0.109782821535004,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH,Parathyroid hormone,37039,0.293395282713989,0.0072349847591261,0.279214712586102,0.307575852841876,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,39949,0.193029657690536,0.00426674922314307,0.184666829213175,0.201392486167896,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.130983895400995,0.00296573136397841,0.125171061927597,0.136796728874392,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.155926723061307,0.0038919293752589,0.1482985414858,0.163554904636815,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBC,Inhibin beta C chain,39858,0.147810790686793,0.00380808296051752,0.140346948084179,0.155274633289407,1.11253716760264e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES1,Liver carboxylesterase 1,39854,0.281931541474147,0.00732103869611272,0.267582305629766,0.296280777318527,1.12431139761089e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF9,Protein turtle homolog A,37437,0.290623127847497,0.00752527625916253,0.275873586379538,0.305372669315455,1.1690376722336e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTR,Transthyretin,37309,0.0884639661263659,0.00229845653502937,0.0839589913177083,0.0929689409350234,1.5119169065153e-307
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APCS,Serum amyloid P-component,37333,0.122126633015412,0.0031793103394157,0.115895184750157,0.128358081280667,1.94431517045566e-306
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A5,Zinc transporter ZIP5,39866,0.184858346631022,0.00485833898615016,0.175336002218167,0.194380691043876,2.36501665169962e-303
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL23,C-C motif chemokine 23,39931,0.141765826995898,0.00379076225892972,0.134335932968396,0.149195721023401,1.38724554366839e-293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD4,T-cell surface glycoprotein CD4,39839,0.0981107890612722,0.0026607408401289,0.0928957370146195,0.103325841107925,9.97168443598485e-286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI,Tissue factor pathway inhibitor,39843,0.105179292515954,0.00290120158298135,0.0994929374133104,0.110865647618597,1.21565141309585e-276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.273417164119086,0.00763366112761686,0.258455188308957,0.288379139929215,4.39009426490002e-270
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0631114029338151,0.00178463318957062,0.0596135218822567,0.0666092839853736,8.44737909769869e-264
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR37,Prosaposin receptor GPR37,39585,0.210141435374077,0.00595066679627028,0.198478128453387,0.221804742294767,5.93616886148292e-263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCHE,Cholinesterase,37208,0.0887295730833153,0.00253915520955896,0.0837528288725798,0.0937063172940509,4.47675682532088e-256
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.462501098828812,0.0134070902085891,0.436223202019978,0.488778995637647,1.90445537952712e-251
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS15,Enteropeptidase,39788,0.284222032556223,0.0082549784644516,0.268042274765898,0.300401790346548,1.23532541070154e-250
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.269238122679585,0.00783675549270923,0.253878081913875,0.284598163445295,1.74156426996449e-249
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.275476690254536,0.00804693581857225,0.259704696050134,0.291248684458937,6.66853415094462e-248
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPM,Carboxypeptidase M,39955,0.109294489400605,0.00319538709245894,0.103031530699386,0.115557448101825,1.41288623543815e-247
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP1,Neuropilin-1,39949,-0.0877009994335801,0.00256702701236919,-0.0927323723778238,-0.0826696264893365,5.00234836786136e-247
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.249086748899234,0.00736811727742412,0.234645239035482,0.263528258762985,5.25230564309041e-242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCS1,Neuronal calcium sensor 1,40030,0.0879427758590629,0.00261027727209941,0.082826632405748,0.0930589193123777,1.49735029405198e-240
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.207362570272634,0.00617272513461538,0.195264029008788,0.21946111153648,4.24845050248048e-239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA4,Kallistatin,37241,0.0726626087707652,0.00216125079545215,0.068426557211679,0.0768986603298514,5.73933836067792e-238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.330422628570465,0.00988984121756842,0.311038539784031,0.349806717356899,1.3136147021873e-236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADIPOQ,Adiponectin,37453,-0.202694912755485,0.00611546814626915,-0.214681230322173,-0.190708595188797,9.93597905349244e-232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG2,Desmoglein-2,39858,-0.0815120628159894,0.00248193334901929,-0.0863766521800672,-0.0766474734519116,5.49945859062843e-229
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,37283,0.0968779528529511,0.00294472146282315,0.0911062987858177,0.102649606920084,2.34558749733766e-228
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL6,C-X-C motif chemokine 6,40058,0.233624649866821,0.00713746190192622,0.219635224539046,0.247614075194597,1.32075899699295e-227
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,39749,0.0883368881852825,0.0027064651084749,0.0830322165726717,0.0936415597978933,3.13306420380087e-226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPIND1,Heparin cofactor 2,37424,0.0851757512464212,0.00260880005888694,0.0800625031310028,0.0902889993618396,3.75297269110637e-225
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F9,Coagulation factor IX,39908,0.0549383543254204,0.00169037038195815,0.0516252283767824,0.0582514802740584,1.83569082849446e-224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN3,Contactin-3,39858,0.0979697017000424,0.0030407298948384,0.0920098711061591,0.103929532293926,1.00916942912809e-220
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.336455475354678,0.0105570686847956,0.315763620732479,0.357147329976878,3.77561990846931e-216
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFM,Afamin,37453,0.0560715465204752,0.00176085593978043,0.0526202688785056,0.0595228241624449,1.12948182515886e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFI,Complement factor I,37453,0.0589765106899608,0.0018527377571692,0.0553451446859091,0.0626078766940124,1.57724488253801e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.362724078800098,0.0114499437173847,-0.385165968486173,-0.340282189114024,9.8237003536725e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.100054314814922,0.00315850551280302,0.0938636440098284,0.106244985620016,1.01175399782566e-213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFH,Complement factor H,36763,0.06919174601141,0.00218048353211132,0.0649179982884718,0.0734654937343482,7.49469645545927e-213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA1,Glutathione S-transferase A1,39841,0.249410691508806,0.00790913558284209,0.233908785766436,0.264912597251177,8.535211131523e-212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F10,Coagulation factor X,37445,0.0775754094886152,0.00246101568057022,0.0727518187546975,0.0823990002225328,1.5223501772154e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAT,Tissue-type plasminogen activator,40002,0.145243035769295,0.00462578682212424,0.136176493597931,0.154309577940658,4.18295999828749e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,37254,0.0747031636728819,0.00237365631139377,0.0700507973025501,0.0793555300432137,8.34908508430607e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAMR1,Inactive serine protease PAMR1,39858,0.0810523436595349,0.00258464933536219,0.075986430962225,0.0861182563568448,1.52287388235005e-209
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0561195341575585,0.00179557871255968,0.0526001998809416,0.0596388684341755,5.13320225013134e-208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROS1,Vitamin K-dependent protein S,37453,0.0711810324402311,0.00227585769798505,0.0667203513521804,0.0756417135282817,1.98651762943228e-207
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP6,Charged multivesicular body protein 6,37437,0.164274656472192,0.00526869648296823,0.153948011365575,0.17460130157881,3.44733963741499e-206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRP,Gastrin-releasing peptide,37043,0.149250942539133,0.00483929200702838,0.139765930205358,0.158735954872909,9.75385175409146e-202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,39868,0.086382334900735,0.00281712526919659,0.0808607693731097,0.0919039004283603,1.06752207724638e-200
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA3,Glutathione S-transferase A3,39477,0.217722847753437,0.00713840222038746,0.203731579401478,0.231714116105397,1.6340708629354e-198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.168100990406337,0.00551409794578117,-0.178908622380068,-0.157293358432605,1.99466458993199e-198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.175831864001077,0.00580392567933998,-0.187207558332584,-0.164456169669571,3.88530779943645e-196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBP,Protein AMBP,40003,0.0545384879764078,0.00180566746642337,0.050999379742218,0.0580775962105976,5.35016635537948e-195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFP,Properdin,37453,0.0651532460362629,0.00215550022634455,0.0609284655926276,0.0693780264798982,2.65089286075708e-194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY1,Aminoacylase-1,39868,0.172749798595547,0.0057656590215792,0.161449106913252,0.184050490277843,5.89865020735586e-192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.07697676889477,0.00258661961887182,0.0719069944417813,0.0820465433477588,1.73178998805208e-189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0941985832136976,0.00317709330255479,-0.100425686086705,-0.0879714803406903,3.5687045537262e-188
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,39477,0.304543778565883,0.0102999647746072,0.284355847607653,0.324731709524113,5.3458527728503e-187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.163632695876853,0.00553608822502823,0.152781962955798,0.174483428797908,7.07524767562755e-187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9,Complement component C9,37445,-0.146007073749169,0.00494373581661896,-0.155696795949742,-0.136317351548596,7.44235835266567e-186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,P4HB,Protein disulfide-isomerase,39776,0.106162318833987,0.00364217161148832,0.0990236624754699,0.113300975192504,5.16553106689709e-182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIP2,Cysteine-rich protein 2,39749,0.0978112909611355,0.00336145313041176,0.0912228428255284,0.104399739096743,2.10844607188303e-181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUSB,Beta-glucuronidase,39919,0.159706023944672,0.00549460015336258,0.148936607644081,0.170475440245262,4.55956934255839e-181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPB1,Beta-ureidopropionase,37437,0.249907708755783,0.00858957000391302,0.233072151548114,0.266743265963453,1.38829260474006e-180
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL16,C-C motif chemokine 16,40052,0.141417289082573,0.00488196249781564,0.131848642586854,0.150985935578291,6.38902540791892e-180
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYNU,Kynureninase,40058,0.122959903364667,0.00425681627044257,0.1146165434746,0.131303263254735,6.06964507938292e-179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCA,Alpha-synuclein,37124,0.313353370981486,0.0108372519322323,0.292112357194311,0.334594384768662,2.51363021897565e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0572188862862617,0.00198473916694291,0.0533287975190536,0.0611089750534698,2.92701740030274e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0837672616072409,0.00290779080591404,0.0780679916276494,0.0894665315868324,5.46841058516474e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP5,Retinol-binding protein 5,39788,0.150828065349167,0.00524017500772263,0.14055732233403,0.161098808364303,1.19496416163386e-177
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.140008887879378,0.00490223118054929,0.130400514765501,0.149617260993255,4.57355419522268e-175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,37224,0.0359296265022633,0.00125960034662611,0.0334608098228761,0.0383984431816505,8.8313198301653e-174
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR3,Anterior gradient protein 3,39464,0.157228300144737,0.00552669536859718,0.146395977222286,0.168060623067187,1.31413723815913e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOST,Sclerostin,39846,0.101794402002594,0.00358422756573075,0.0947693159737622,0.108819488031427,3.83648500963973e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLKB1,Plasma kallikrein,37187,0.0663841120337993,0.00233359815085885,0.0618102596581159,0.0709579644094826,7.32715422900211e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRN,"Attractin, Isoform 2",37453,0.0430707244598113,0.00152262582112218,0.0400863778504118,0.0460550710692108,4.27611661137193e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.180383386273463,0.00648444688417157,0.167673870380487,0.193092902166439,1.17578261120377e-165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLTP,Phospholipid transfer protein,39976,-0.0930945782506764,0.00337072493955418,-0.0997011991322026,-0.0864879573691502,4.30484477490694e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELN,Elastin,37437,0.0867750874788433,0.00314323839411501,0.0806143402263778,0.0929358347313087,2.84161569666346e-163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0777651122026266,0.00282494739713636,0.0722282153042393,0.0833020091010139,5.17780902560943e-163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,37056,0.222056085578087,0.00805667149417564,0.206265009449502,0.237847161706671,1.23143806579112e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0647057061771756,0.00235432730686948,0.0600912246557114,0.0693201876986398,1.55204720449287e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,39913,0.0658734071171378,0.00239708856818351,0.0611751135234981,0.0705717007107775,1.6857734585062e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.173589160317862,0.00634659673031526,0.161149830726444,0.18602848990928,6.25538545769452e-161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.190207442985402,0.00695847209775586,0.176568837673801,0.203846048297004,8.41700573023077e-161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,37124,-0.076975788095005,0.00281767577351167,-0.0824984326110879,-0.0714531435789221,6.46001624044313e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.21556401574361,0.007907335056588,0.200065639032697,0.231062392454522,2.40738159982309e-159
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORT1,Sortilin,39846,0.0947514857592687,0.00350162089095099,0.0878883088130047,0.101614662705533,1.03706651438858e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHBG,Sex hormone-binding globulin,37445,-0.130827994313302,0.00482895711297538,-0.140292750254734,-0.12136323837187,1.78274133582749e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO3,Beta-enolase,37043,0.153150679990202,0.00565155290369039,0.142073636298968,0.164227723681435,2.00171093977909e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUMB,Protein numb homolog,37056,0.214632878311225,0.00792467020735452,0.19910052470481,0.23016523191764,2.89524145044695e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,37411,0.146873610693847,0.00542878466493803,0.136233192750568,0.157514028637125,4.82250274996171e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",39489,0.129392238565183,0.00479691466315801,0.119990285825393,0.138794191304972,1.12573494605803e-156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYAP1,Synapse-associated protein 1,37124,0.145721475292196,0.00539155177643703,0.13515403381038,0.156288916774013,1.17323435144288e-156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR2,Cadherin-related family member 2,39788,0.184463586761769,0.00685143440154514,0.171034775334741,0.197892398188798,3.58551854542793e-156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.354618619962054,0.0132036301585636,0.328739504851269,0.380497735072839,7.63619469118832e-155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,39788,0.313176823902894,0.0116956476333551,0.290253354541518,0.33610029326427,1.53873720376326e-154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS1,Protein MTSS 1,37382,0.27719454114991,0.010344491734472,0.256919337350345,0.297469744949475,3.64859495613581e-154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,39913,0.0536455374911375,0.00202817262526384,0.0496703191456204,0.0576207558366546,6.11739679778136e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0534554989664039,0.00202837706863775,0.0494798799118739,0.0574311180209338,3.11406051909658e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,37039,0.298163405143636,0.0113241578723176,0.275968055713894,0.320358754573379,5.99943481589497e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.159271145549439,0.00605482562464427,0.147403687325136,0.171138603773741,8.74638918780212e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MME,Neprilysin,39788,0.193825606979328,0.00739780459169075,0.179325909979614,0.208325303979042,3.56075326075415e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLN,Promotilin,39866,0.219070287256681,0.00837246633427031,0.202660253241512,0.235480321271851,8.26755301881583e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAB2,Stabilin-2,37437,0.0688875539796114,0.00263059343816864,0.0637315908408008,0.0740435171184219,1.66357745682889e-147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLA,Alpha-galactosidase A,37088,0.0926252241055485,0.00354803011908653,0.0856710850721389,0.0995793631389581,1.54797837315765e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,39913,0.223792216017378,0.00859155514785451,0.206952767927584,0.240631664107173,1.54820156767505e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEG1,Protein HEG homolog 1,37124,0.0662866490813987,0.00254497251425508,0.0612985029534588,0.0712747952093387,6.71689868382358e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EEF1D,Elongation factor 1-delta,37437,0.222981647093446,0.00856568933117031,0.206192896004352,0.23977039818254,7.91321039374567e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LG,CMRF35-like molecule 9,39858,-0.0893574816571711,0.00344884560367392,-0.096117219040372,-0.0825977442739702,5.03490555855098e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,39587,0.207359902060658,0.00802515908964769,0.191630590244949,0.223089213876368,3.27138554878093e-144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YES1,Tyrosine-protein kinase Yes,39788,0.276716546006196,0.0107264469688573,0.255692709947236,0.297740382065157,8.34079217783755e-144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11R,Junctional adhesion molecule A,39858,0.137376252061304,0.00532702161575403,0.126935289694426,0.147817214428182,1.01370812280042e-143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPC,C-type natriuretic peptide,39866,0.11061109132801,0.00429839020497463,0.10218624652626,0.11903593612976,3.98806219369478e-143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FN1,Fibronectin,37453,0.0644714039864577,0.00250153936338744,0.0595683868342184,0.0693744211386971,4.76158928620441e-143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0629261267157032,0.00244687663311949,0.058130248514789,0.0677220049166174,6.22652613286051e-143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH9,Myosin-9,37437,0.269037508134698,0.0104637213306455,0.248528614326633,0.289546401942763,2.16463557727235e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0945274465330431,0.0036836906332199,0.0873074128919321,0.101747480174154,2.44390654268498e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKB,Creatine kinase B-type,37437,-0.140285003550333,0.00546353600765024,-0.150993534125327,-0.129576472975338,5.09220379556396e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.150315581274523,0.00587797488296063,0.13879475050392,0.161836412045126,2.44973512390304e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.119620088832894,0.00468146664417055,0.11044441421032,0.128795763455469,3.54795760508783e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0937389382618071,0.00367772785439892,-0.100947284856429,-0.0865305916671853,1.662465334897e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.191477661487847,0.00750899061645983,0.176760039879586,0.206195283096108,3.98541853397411e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTYMK,Thymidylate kinase,37437,0.164390232749184,0.00645033863189515,0.151747569030669,0.177032896467698,5.43468015352077e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA1,Ephrin type-A receptor 1,39904,0.0798932512892743,0.00314468355379116,0.0737296715238436,0.0860568310547049,1.23575718977658e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL22,C-C motif chemokine 22,39686,0.119871729410874,0.00474751993243251,0.110566590343306,0.129176868478442,6.1039473556906e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTD,Biotinidase,37453,0.0487810150937695,0.00192982969877161,0.0449985488841771,0.0525634813033618,8.42289097210522e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0694828929701509,0.00275152894684824,0.0640898962343284,0.0748758897059734,1.5504263118674e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN2,Ficolin-2,39810,0.0959573124532732,0.00381403163049119,0.0884818104575104,0.103432814449036,5.21403053747117e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCLY,Selenocysteine lyase,39984,0.116317554429746,0.00463500597728077,0.107232942714276,0.125402166145217,2.27938592804275e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,37124,0.179118971487058,0.00712807763917474,0.165147939314275,0.19309000365984,3.61037252225543e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR5,Cadherin-related family member 5,39868,0.0915924856122511,0.00365297138453465,0.0844326616985632,0.0987523095259391,4.05071880742423e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0532976431657693,0.00212864751333991,0.049125494039623,0.0574697922919155,9.38098402756847e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH1,Somatotropin,39846,-0.425139710386191,0.0170021097373655,-0.458463845471428,-0.391815575300955,2.12288946074041e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM20A,Pseudokinase FAM20A,37437,0.0665002243839403,0.00265559393179233,0.0612952602776273,0.0717051884902533,2.48157904863311e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FYB1,FYN-binding protein 1,39836,0.216144262363047,0.00864975396910398,0.199190744583603,0.23309778014249,3.18061251868588e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.109388491733789,0.0043816867677693,0.100800385668961,0.117976597798617,5.93173042997856e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL13,C-X-C motif chemokine 13,40009,0.138073478256333,0.00554630313114836,0.127202724119283,0.148944232393384,2.85343737831662e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOMO1,Nodal modulator 1,39858,0.0556789569826618,0.00223686905205406,0.0512946936406358,0.0600632203246877,3.25204941023795e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,39788,0.159965336770667,0.00644255050364799,0.147337937783517,0.172592735757817,1.47279240097959e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,37368,0.129802988536336,0.00524247204234226,0.119527743333345,0.140078233739327,2.12354531666855e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.167886582128308,0.00679257808463833,0.154573129082417,0.1812000351742,2.26736996242837e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SARG,Specifically androgen-regulated gene protein,37390,0.254584340175529,0.0103036155484089,0.234389253700647,0.27477942665041,7.14298663023868e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL17,C-X-C motif chemokine 17,40058,0.0997543375020857,0.00404496135247201,0.0918262132512406,0.107682461752931,7.42570901315611e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHK,Ketohexokinase,37043,0.150278382767961,0.00608798183199481,0.138345938377251,0.162210827158671,1.48889999338637e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF21,Fibroblast growth factor 21,40011,0.276045713954739,0.0112400723661197,0.254015172117144,0.298076255792333,8.57763747704766e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,39931,-0.0649195133264896,0.00265622730828465,-0.0701257188507275,-0.0597133078022517,1.45620388242044e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORD,Sorbitol dehydrogenase,39963,0.157726183307431,0.00646010512656444,0.145064377259365,0.170387989355497,2.60370767665054e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.166395160317623,0.00683235010302151,0.153003754115701,0.179786566519546,1.09855205313096e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK1,Dickkopf-related protein 1,40009,0.136953281123946,0.00563458989138954,0.125909484936823,0.14799707731107,3.38430303506745e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB2,Carboxypeptidase B2,37424,0.0517165533013108,0.00212550043901662,0.0475505724408382,0.0558825341617833,4.95607920208428e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0893546790628162,0.00369979016851033,0.0821030903325359,0.0966062677930964,1.24534051939593e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.124299194327429,0.00515192649438673,0.114201418398431,0.134396970256427,2.56217679362539e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0872103328859516,0.00362494718754197,-0.0943152293735338,-0.0801054363983693,1.12727311653033e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0630090055084823,0.00262302556315859,0.0578678754046914,0.0681501356122731,2.71041669306097e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL17,C-C motif chemokine 17,39836,0.204461881814687,0.0085161954184436,0.187770138794537,0.221153624834836,3.69163280784477e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0451033669706859,0.00187887611706028,0.0414207697812478,0.0487859641601241,3.99103239399004e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0670268435991863,0.00278892596402132,0.0615605487097045,0.0724931384886681,5.14131535462965e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPY30,Protein dpy-30 homolog,39979,0.134000130719375,0.00559041222783635,0.123042922752816,0.144957338685935,8.72245920264641e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18R1,Interleukin-18 receptor 1,40058,0.0735845453527329,0.00307067834053676,0.0675660158052809,0.079603074900185,9.79220233793467e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEP,Leptin,39868,0.15313996004305,0.00639266683652499,0.140610333043461,0.165669587042639,1.25014543088622e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0931223678114578,0.003881333871537,0.0855149534232453,0.10072978219967,1.31590830576827e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.0984883187132429,0.00411715982742353,0.0904186854514928,0.106557951974993,2.82456308586812e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,39858,-0.088438243493507,0.00370472051761772,-0.0956994957080377,-0.0811769912789762,8.70939450999297e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL16,Pro-interleukin-16,40058,0.0926912378731523,0.00388585803553423,0.0850749561235052,0.100307519622799,1.25131390079427e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.117610011860884,0.0049306847666658,0.107945869718219,0.127274154003549,3.29372552769219e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.201201591742035,0.00845491568662686,0.184629956996246,0.217773226487824,5.09232432907935e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0581833074096624,0.00244223113684811,0.0533965343814401,0.0629700804378847,6.34108070752314e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHBP1,EH domain-binding protein 1,37437,0.168068962498181,0.00707381053600151,0.154204293847618,0.181933631148744,2.71140738618505e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MVK,Mevalonate kinase,39587,0.176889205021178,0.00747142428419632,0.162245213424154,0.191533196618203,8.64213018344318e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,39877,0.0879730052588925,0.00371954972697956,0.0806826877940126,0.0952633227237725,1.37045085317606e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP20,Centrosomal protein 20,39477,0.165018125956592,0.00697676294505345,0.151343670584287,0.178692581328897,1.50952523136093e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJAP1,Tight junction-associated protein 1,39913,0.18489286343132,0.00784433957832063,0.169517957857812,0.200267769004829,8.69667722298739e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,39585,0.110654589433468,0.00471399142128318,0.101415166247753,0.119894012619183,8.62666083701799e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.151368172294925,0.00644413632208755,0.138737665103634,0.163998679486217,1.48687820153424e-119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE4,Ribonuclease 4,37051,0.0574190197624912,0.00244861535915697,0.0526197336585435,0.0622183058664388,3.59735498285131e-119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4R,Reticulon-4 receptor,40030,0.0729483507389708,0.00313063779815481,0.0668123006545874,0.0790844008233542,3.76335183340938e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0450714077075613,0.00193659000792986,0.0412756912920188,0.0488671241231038,7.53796853606896e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.186494779872628,0.00800079074418788,0.170813230014019,0.202176329731236,8.41874523909951e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPY,Pancreatic prohormone,39826,0.219436814053641,0.00946303446834867,0.200889266495678,0.237984361611605,5.02712264966591e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXLNA,Alpha-taxilin,39749,0.195249956296037,0.00843123531157055,0.178724735085359,0.211775177506715,1.02792541677455e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,40009,0.210743430810772,0.00910362943925312,0.192900317109835,0.228586544511708,1.16111663621568e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.179245416538276,0.00773412795336562,0.164086525749679,0.194404307326872,1.47704362094206e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.213281132387515,0.00921602087717923,0.195217731468244,0.231344533306787,3.06557883012716e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3F,Semaphorin-3F,39868,0.0554546187458241,0.00241108644672479,0.0507288893102435,0.0601803481814047,3.42174921700244e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRN,Agrin,39931,0.0703805497904727,0.0030845032594759,0.0643349234018999,0.0764261761790455,1.93896533325471e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,39489,0.171809222118381,0.00752900994370958,0.157052362628711,0.186566081608052,2.07288173556129e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.210192751005659,0.00922706693127233,0.192107699820366,0.228277802190953,4.60410729833301e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS8,Prostasin,39805,0.0863747889015492,0.00379248626614587,0.0789415158199033,0.0938080619831951,5.09467549079957e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL5,C-X-C motif chemokine 5,39805,0.245023342827286,0.0107652491893488,0.223923454416162,0.266123231238409,7.0431260583286e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD63,CD63 antigen,39720,0.110787168169407,0.00486741206414623,0.101247040523681,0.120327295815134,7.13144526626104e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.110945957579718,0.00487730755224152,0.101386434777324,0.120505480382111,1.0229146681693e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0748130272875814,0.003293570752002,0.0683576286136575,0.0812684259615053,1.87980635720944e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.210518326358136,0.00926925586447094,0.192350584863773,0.228686067852499,2.05043608663154e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F13B,Coagulation factor XIII B chain,37380,0.0546596173324256,0.00240671583743453,0.0499424542910539,0.0593767803737973,4.28147129814205e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0600087962717487,0.0026518383720796,0.0548111930624726,0.0652063994810247,1.25647580138974e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.227261001885579,0.010044977181361,0.207572846610111,0.246949157161047,1.3944650186439e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.242033847362831,0.010687457999365,0.221086429684075,0.262981265041586,1.90196568131765e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS2,Protein MTSS 2,37368,0.21218518412943,0.00941315669530192,0.193735397006638,0.230634971252222,1.76006899098534e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNA4,Plexin-A4,39866,0.172648456547389,0.00767405784045017,0.157607303180107,0.187689609914672,2.23673448276554e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,37388,0.100020741137493,0.00444434978024148,0.09130981556822,0.108731666706767,3.84174295582773e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCXR,L-xylulose reductase,39913,0.114197725249563,0.00509734830465964,0.10420692257243,0.124188527926696,1.73009417620127e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARF6,ADP-ribosylation factor 6,37382,0.225109563482505,0.0100436726589757,0.205423965070913,0.244795161894098,2.83718996591036e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.121148067295555,0.00541598990268764,0.110532727086288,0.131763407504823,8.32157735325109e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HJV,Hemojuvelin,37411,0.0935281571561238,0.00418912544451385,0.0853174712848767,0.101738843027371,1.82914962545865e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL5,C-C motif chemokine 5,39931,0.212484049999384,0.00954502167526618,0.193775807515862,0.231192292482905,3.76501123258417e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELP,P-selectin,39931,0.12070933708778,0.00542400215849131,0.110078292857137,0.131340381318423,4.34112314400981e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.173305926608559,0.00778838280929688,0.158040696302337,0.188571156914781,4.53218958792217e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUCB2,Nucleobindin-2,39995,0.0788172726512915,0.0035467428406291,0.0718656566836585,0.0857688886189246,8.58702772669231e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5E,5'-nucleotidase,39913,0.116165445167935,0.00523302147805953,0.105908723070938,0.126422167264932,1.46557285588678e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.227828061032947,0.0102514958067874,0.207735129251643,0.24792099281425,1.6757100934032e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXIN1,Axin-1,39866,0.200236099375833,0.00902267082423968,0.182551664560323,0.217920534191343,1.68568125384925e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.173559048790039,0.00781380145862277,0.158243997931139,0.18887409964894,2.36367266987103e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAB2,Disabled homolog 2,40030,0.233908253259807,0.0105537335334692,0.213222935534207,0.254593570985406,3.03589104956251e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZN,Kazrin,37382,0.21826056954736,0.00983853528832654,0.19897704038224,0.23754409871248,3.93089152019493e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,39866,0.0904584847923311,0.00410756791448243,0.0824076516799455,0.0985093179047166,6.53591013558461e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFC,Vascular endothelial growth factor C,39913,0.115728682544781,0.00526024951693774,0.105418593491583,0.126038771597979,1.03132841394033e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTBS,Di-N-acetylchitobiase,37296,0.057442208520699,0.00260927559090518,0.0523280283625248,0.0625563886788731,1.51567180728171e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FETUB,Fetuin-B,39908,0.0698749005834886,0.0031831932406957,0.063635841831725,0.0761139593352522,2.96903072894389e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.147452744205489,0.00671759791015979,0.134286252301576,0.160619236109402,3.33811437905667e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSO,Cathepsin O,40058,0.0620897161343362,0.00283232970333192,0.0565383499158057,0.0676410823528668,5.38607174067504e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0539031007929112,0.00245480003418496,0.0490916927259087,0.0587145088599138,5.44250644496712e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.0981396428052208,0.00448493237408621,0.0893491753520119,0.10693011025843,2.67395054569537e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN1,Perilipin-1,39489,0.0716366895377582,0.00327823097037619,0.0652113568358208,0.0780620222396955,2.681440879048e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.101243774107333,0.00463259672926264,0.0921638845179781,0.110323663696688,4.76173727239744e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUOM,Fucose mutarotase,37124,0.131050517357224,0.00600613084438893,0.119278500902222,0.142822533812227,1.00137848842592e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.0656775544205277,0.0030265360178266,0.0597455438255875,0.0716095650154678,6.08357654750021e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,39931,0.259446306849569,0.0119620212643771,0.23600074517139,0.282891868527748,7.71095611362768e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.14905821801951,0.00687152123671148,0.135590036395555,0.162526399643464,1.49599476139811e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,36838,0.0653866058210212,0.00301667614494049,0.0594739205769379,0.0712992910651046,2.28273038512244e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.109311420994777,0.00506181714680811,0.0993902593870331,0.119232582602521,5.7885545243585e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.137492238266296,0.00636853808591712,0.125009903617899,0.149974572914694,6.9552409942434e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2AP,CD2-associated protein,39868,0.129406973268886,0.00599595134634573,0.117654908630049,0.141159037907724,7.40753189435018e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN2,CCN family member 2,39880,0.119299179676962,0.00553806772301379,0.108444566939855,0.130153792414069,1.73803522874177e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANG,Angiogenin,39843,0.0688131032868353,0.00319680928114225,0.0625473570957964,0.0750788494778741,2.45466182717848e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,39868,0.177017623521457,0.00823404303694267,0.16087889916905,0.193156347873865,4.32673424207414e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES3,Carboxylesterase 3,39788,0.140009631647461,0.00651723603684469,0.127235849015245,0.152783414279676,6.05540867225255e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLUL1,Clusterin-like protein 1,39840,-0.0918978165150017,0.00427860591116887,-0.100283884100893,-0.0835117489291107,6.58756143456989e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0745795851553675,0.00348108171960964,0.0677566649849326,0.0814025053258024,2.03364994511165e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYY,Peptide YY,37021,0.187442716074765,0.00873792039418851,0.170316392102156,0.204569040047375,2.28555315194801e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0586920023381514,0.00274234001352557,0.0533170159116413,0.0640669887646615,3.10916989664025e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,39477,0.129537182626754,0.0060513810328966,0.117676475802277,0.141397889451231,3.20639229881998e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.217963688386595,0.0101850812276045,0.19800092918049,0.237926447592699,5.89925873121329e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0525130610957622,0.00245985516683965,0.0476917449687565,0.0573343772227679,9.59235025658659e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,37382,0.173554294947471,0.00813344472772871,0.157612743281123,0.18949584661382,2.16080990936777e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN1,Dynactin subunit 1,40030,0.131187438824236,0.00615960627928143,0.119114610516845,0.143260267131628,2.72684885876248e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BECN1,Beclin-1,37043,0.122071830974037,0.00572379365188791,0.110853195416336,0.133290466531737,2.9980894439824e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPL,N-acetylneuraminate lyase,37437,0.088535320865003,0.00416217946719143,0.0803774491093078,0.0966931926206983,8.49206470830703e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBIN,Erbin,39788,0.20625882228592,0.00973138681490916,0.187185304128699,0.225332340443142,2.40170677080526e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.149511131811298,0.00705085813180615,0.135691449872958,0.163330813749639,3.73521568315583e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.218898346734184,0.0103257694999639,0.198659838514255,0.239136854954114,3.83341762077752e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMIP,C-Maf-inducing protein,37368,0.16615519700926,0.00784615747298487,0.150776728362209,0.18153366565631,6.08285506849747e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOC1,Apolipoprotein C-I,37424,0.074941995339351,0.00354338044714355,0.0679969696629497,0.0818870210157524,1.03857604446091e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCR,Breakpoint cluster region protein,39866,0.183827882242458,0.00870311337672114,0.166769780024084,0.200885984460831,1.06955739992475e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOM,Apolipoprotein M,39908,0.0532300064417101,0.00252103758438389,0.0482887727763177,0.0581712401071026,1.24499117817851e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",39788,0.16261872007211,0.00770323514788656,0.147520379182252,0.177717060961968,1.37930669785375e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL10,C-X-C motif chemokine 10,39931,0.131587021308851,0.00624654691855862,0.119343789348476,0.143830253269226,3.37969714655915e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,39786,-0.125747516166685,0.00599964892587245,-0.137506828061395,-0.113988204271975,3.07361868830666e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTBDN,Retbindin,39788,0.0581804941618157,0.00277755890843766,0.0527364787012778,0.0636245096223535,3.96817373533212e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINC1,Antithrombin-III,37424,0.0288525070405241,0.00137822211434074,0.0261511916964162,0.0315538223846319,8.42983536458404e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.205695579529298,0.00983952931069707,0.186410102080332,0.224981056978264,9.14696495054731e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THOP1,Thimet oligopeptidase,39798,0.0602133893182052,0.00288280053904511,0.0545631002616768,0.0658636783747336,1.33401562664351e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINH1,Serpin H1,37169,0.253379174554007,0.0121485504243377,0.229568015722305,0.277190333385708,4.36219047332752e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,37388,0.173995065496934,0.00834987607468801,0.157629308390545,0.190360822603322,6.02637990634449e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,37411,0.126385329039463,0.00607082944091833,0.114486503335263,0.138284154743663,8.9042280053941e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.14716088505773,0.00708888742295721,0.133266665708734,0.161055104406726,3.23748976819307e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFC,Platelet-derived growth factor C,39477,0.0571966153230843,0.00276559223528137,0.0517760545419328,0.0626171761042357,9.14351961645337e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.185499492477538,0.00897573942154711,0.167907043211305,0.20309194174377,1.13986891815698e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPD52L2,Tumor protein D54,37124,0.213996344733096,0.010345299440712,0.1937195578293,0.234273131636892,1.39765348828984e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0648673177061565,0.00314493465033816,0.0587032457914937,0.0710313896208193,2.59177230959663e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.178180635653946,0.0086449843520566,0.161236466323915,0.195124804983977,3.72179519895203e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0458759292675872,0.00222716771591711,0.0415106805443896,0.0502411779907847,4.56783411622449e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.120247445044042,0.00583695340919398,0.108807016362022,0.131687873726062,4.61107030012435e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.104477877857313,0.0050757236843008,0.0945294594360832,0.114426296278542,6.15233502368053e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.106348097172735,0.00517341613921462,0.0962082015398744,0.116487992805596,1.13918461480091e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLA2,Src-like-adapter 2,37411,0.205257169435323,0.00997692565400157,0.18570239515348,0.224811943717167,1.23466902956909e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.044082108020476,0.00214553026254948,0.039876868705879,0.048287347335073,1.36624037082204e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.164332429149289,0.00800292542705286,0.148646695312266,0.180018162986313,2.69893440878667e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R9B,Neurabin-2,40058,0.184024401979193,0.00897678081355341,0.166429911584629,0.201618892373758,3.17627532427705e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.200059297789956,0.00975643106581293,0.180936692900962,0.219181902678949,5.2200697756762e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINK1,Misshapen-like kinase 1,37388,0.180229298522952,0.00880152975643362,0.162978300200342,0.197480296845561,8.45321354447317e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLSCR3,Phospholipid scramblase 3,37373,0.115371925424481,0.00563741495990467,0.104322592103068,0.126421258745894,1.06956321354079e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,39862,-0.0658989561458894,0.00323228144419772,-0.072234227776517,-0.0595636845152619,3.08976066383293e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKBKG,NF-kappa-B essential modulator,39866,0.17725537129007,0.00873281547682457,0.160139052955494,0.194371689624646,1.85241104433976e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0740307884588688,0.00364915476111176,0.0668784451270898,0.0811831317906479,2.21966928227494e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK2,Docking protein 2,39868,0.235863357168407,0.0116323498162556,0.213063951528546,0.258662762808268,2.81475333312558e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AAMDC,Mth938 domain-containing protein,37043,0.102749679107807,0.00506400529055159,0.0928242287383255,0.112675129477288,3.71495296719974e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD6,T-cell differentiation antigen CD6,40040,0.100710879791678,0.00497087362786697,0.0909679674810587,0.110453792102297,3.78356279185601e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCK2,Cytoplasmic protein NCK2,39931,0.20405760544803,0.0100779704956837,0.18430478327649,0.223810427619569,4.91132332315396e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCTN3,Tectonic-3,37437,0.0565566802619556,0.0027943276010029,0.0510797981639899,0.0620335623599213,9.16853328642026e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.200008384805279,0.00990030640484412,0.180603784251785,0.219412985358774,1.2435905115098e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFX1,Transcriptional repressor NF-X1,37021,0.128929503620934,0.00638124839298401,0.116422256770685,0.141436750471182,2.02009747389199e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,39931,0.163957367410805,0.00812977896913492,0.148023000631301,0.17989173419031,2.40337857813001e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BACH1,Transcription regulator protein BACH1,39866,0.141569845108005,0.00702783570063834,0.127795287134754,0.155344403081256,3.84615715724258e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,39788,0.262894095089346,0.0130540177984042,0.237308220204473,0.288479969974218,4.31487369579397e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.158263278478902,0.00787740378583606,0.142823567058664,0.173702989899141,1.16860687911555e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST3,Cystatin-C,39897,0.0505541960413356,0.00251862479726463,0.045617691438697,0.0554907006439743,1.57720097601465e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.135166254438021,0.00673495037696491,0.12196575169917,0.148366757176872,2.59646956224805e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.133914341292568,0.00668072580950621,0.120820118705935,0.1470085638792,2.82546237072466e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,37411,0.21780124865637,0.0108554500416058,0.196524566574823,0.239077930737917,2.9131220763582e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0707562889151617,0.00352971512258355,0.0638380472748979,0.0776745305554254,4.3953957744974e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT,Linker for activation of T-cells family member 1,40058,0.144002939327339,0.00719476014594048,0.129901209441296,0.158104669213383,4.72131652783908e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,40052,0.128174428697742,0.00642051388318546,0.115590221486699,0.140758635908786,1.29902237596287e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0759290619766528,0.00380485077185175,0.0684715544638233,0.0833865694894822,2.39944828544471e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EZR,Ezrin,40009,0.0453643925170868,0.00228065845854037,0.0408943019383477,0.0498344830958259,5.35786123155115e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,37021,0.115759764456626,0.00581678919709668,0.104358857630317,0.127160671282936,7.51840760403341e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEC31A,Protein transport protein Sec31A,37043,0.145196944655387,0.00730174112690521,0.130885532046652,0.159508357264121,1.01450400177901e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO1,Forkhead box protein O1,39866,0.161763526037694,0.00815369932116627,0.145782275368208,0.17774477670718,1.49286108317911e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0928131582698281,0.00468127122360706,0.0836378666715583,0.101988449868098,2.02882724637216e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A4,Protein S100-A4,39913,0.106772810486431,0.00539683818906857,0.0961950076358564,0.117350613337005,4.30267300339375e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP5,Fatty acid-binding protein 5,39972,0.127991732803615,0.00647378646907543,0.115303111324227,0.140680354283002,5.54665196611581e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.214730604569831,0.0108510323218627,0.19346258121898,0.235998627920681,6.08749141013423e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0610425734278272,0.00308992351822107,0.054986323332114,0.0670988235235405,7.64055507105377e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.20292732994658,0.0102633133059354,0.182811235866947,0.223043424026214,8.39914636142394e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0909618068652433,0.00460639884742159,0.0819332651242969,0.0999903486061896,8.71191265300036e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.186259291783488,0.00945170788971064,0.167733944319655,0.20478463924732,1.90009429044528e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0685078717822387,0.00347461672155493,0.0616976230079911,0.0753181205564864,2.43746109595466e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP10,Stromelysin-2,39857,-0.109677677217968,0.00557305902172467,-0.120600872900549,-0.0987544815353879,3.2544527726431e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THPO,Thrombopoietin,39585,0.0712179070260714,0.0036203345911993,0.0641220512273208,0.0783137628248221,3.97519972151685e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL13,C-C motif chemokine 13,40024,0.128353172599097,0.00652854845379891,0.115557217629651,0.141149127568543,4.64396883796329e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.2105964507477,0.0107402148188635,0.189545629702727,0.231647271792672,1.29202862093781e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB3,Plexin-B3,39812,0.0884770907188235,0.00452134997749968,0.0796152447629241,0.0973389366747228,2.77603853433566e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.156954130510081,0.00802191697591345,0.141231173237291,0.172677087782872,2.95410786735277e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.107847050959979,0.00551235860940225,0.0970428280855505,0.118651273834407,3.03196609342609e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,40052,0.0398768199551275,0.00203907708960688,0.035880228859498,0.043873411050757,3.4072618164732e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USO1,General vesicular transport factor p115,39788,0.166542057162257,0.00851701034465272,0.149848716886738,0.183235397437777,3.68984443326251e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.131445515183796,0.00672560349837972,0.118263332326972,0.144627698040621,4.59772331254567e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPK2,SRSF protein kinase 2,39866,0.155696052584677,0.00797755949093518,0.140060035982444,0.171332069186909,7.45011514513178e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAXX,Protein PAXX,37124,0.0849147944611988,0.00436310240775257,0.0763631137420037,0.0934664751803938,3.32098352296664e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,37411,0.133817490943351,0.00687722792118538,0.120338124217828,0.147296857668875,3.38735530519327e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA5,Integrin alpha-5,39858,0.0457352633284228,0.00235513965377673,0.0411191896070204,0.0503513370498252,4.77838957142518e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGF,Hepatocyte growth factor,40058,0.0624170213234359,0.00322434320129138,0.0560973086489049,0.068736733997967,1.49052199259231e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.173843797974241,0.0089866750146717,0.156229914945484,0.191457681002997,2.00364960438523e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSD,Cathepsin D,38721,0.0720414081521163,0.00372366387167057,0.064743026963642,0.0793397893405906,2.22533361193988e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.166475043438833,0.00860692974701474,0.149605461134684,0.183344625742982,3.06053705785165e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFA,Vascular endothelial growth factor A,39993,0.104529659380493,0.00541123232099771,0.093923644031338,0.115135674729649,3.26276929583572e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.141997252193589,0.00734713031191492,0.127596876782235,0.156397627604942,4.05027246779419e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0822324611110682,0.00426132379905155,-0.0905846557572093,-0.0738802664649272,7.06214166074052e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.127042684265523,0.00658517453027343,0.114135742186187,0.139949626344859,7.81713999807873e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.177223167463175,0.00921671204345855,0.159158411857996,0.195287923068354,1.83891384950959e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEXIM1,Protein HEXIM1,39866,0.148859580849626,0.00774733350983524,0.133674807170349,0.164044354528903,2.31341252781096e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.204178968992588,0.0106423119752747,0.183320037521049,0.225037900464126,4.05118446714894e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2,Prothrombin,37453,0.0267614554366812,0.00139377729264296,0.024029651943101,0.0294932589302614,4.31418199057421e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.116554271184811,0.00607104169475127,0.104655029463099,0.128453512906524,4.51464718730949e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.13900883263981,0.00724361886979178,0.124811339655018,0.153206325624601,5.23245800791709e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0487653833578381,0.00254373528739958,0.0437796621945349,0.0537511045211412,5.2872228675899e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.097420168092156,0.00508556434930196,0.0874524619675242,0.107387874216788,1.04383260837252e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.117814030932333,0.00615959495566513,0.105741224819229,0.129886837045437,1.25735080101573e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,37437,0.164520029436378,0.0085999867387606,0.147664055428408,0.181376003444349,1.61526166522056e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL3,C-X-C motif chemokine 3,39859,0.171950716193883,0.00900254666343542,0.15430572473355,0.189595707654217,1.97204113483534e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN1,Pantetheinase,37445,0.1314322345448,0.0068761811046286,0.117954919579728,0.144909549509872,2.17999504677779e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0915954267945001,0.00479969219429485,0.0821880300936822,0.101002823495318,2.82392569992701e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGF,Placenta growth factor,40058,0.0465501510748576,0.00244230042113761,0.0417632422494279,0.0513370599002874,4.0863086138435e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.185395096080613,0.00971883478281496,0.166346179906295,0.20444401225493,4.49990542238774e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,39477,0.111023789950127,0.00582767902292502,0.0996015390651937,0.12244604083506,5.1900554604625e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAO1,Hydroxyacid oxidase 1,40030,0.233165763309661,0.012248352936464,0.209158991554192,0.257172535065131,6.35587428383272e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PENK,Proenkephalin-A,37124,0.0527362896481609,0.00276694877034424,0.0473130700582862,0.0581595092380356,6.40534781313999e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNST,Consortin,39868,0.194988859521629,0.0102575224193226,0.174884115579757,0.215093603463501,1.07598432637486e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC1,Stanniocalcin-1,40009,0.0757105803775572,0.00398328549077482,0.0679033408156386,0.0835178199394759,1.10344336296016e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD5,Programmed cell death protein 5,40009,0.104645346849444,0.00550931715090138,0.0938470852336774,0.115443608465211,1.40119896103452e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.187634392940521,0.00989037913971537,0.168249249826679,0.207019536054363,2.16449853795612e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH2,Neutral ceramidase,39749,0.0943156459960878,0.00497820671851282,0.0845583608278027,0.104072931164373,3.56964442279449e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC4,Syndecan-4,39868,0.0813281821231831,0.00430889024009211,0.0728827572526026,0.0897736069937636,1.31758437679344e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP43,Centrosomal protein 43,39476,0.125329203125508,0.0066493129733307,0.11229654969778,0.138361856553236,2.23974572241445e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0788134613513047,0.00418341832328102,0.0706139614376739,0.0870129612649354,2.54279579315005e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD1,Sushi domain-containing protein 1,39585,0.0869461258600413,0.00462292240402491,0.0778851979481525,0.0960070537719301,4.69575088828657e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,37382,0.171857321969395,0.00915283384949608,0.153917767624382,0.189796876314407,1.14202654423445e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.161859259899302,0.0086311527047933,0.144942200597907,0.178776319200697,1.75708105838819e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAG1,Dystroglycan,39931,0.0864122018966878,0.00461346955738982,0.0773698015642038,0.0954546022291718,1.8664782702897e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,37382,0.136551924640199,0.00728590167426867,0.122271557358633,0.150832291921766,2.14846249824506e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,37056,0.141626100086162,0.00755715844214297,0.126814069539562,0.156438130632762,2.32333643521235e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH2,Cadherin-2,39868,0.0623242517918976,0.00333321756804391,0.0557911453585316,0.0688573582252637,3.41481303322071e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0903325709095632,0.00482822988145517,0.080869240341911,0.0997959014772153,4.16991151194536e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES2,Cocaine esterase,39788,0.0959295029852597,0.00514319154171696,0.0858488475634944,0.106010158407025,8.03494226119998e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,A1BG,Alpha-1B-glycoprotein,37453,0.0302405370478681,0.00162269967003588,0.0270600456945978,0.0334210284011385,1.47318520629028e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,39830,0.0347052452976198,0.00186406164995766,0.0310516844637028,0.0383588061315368,1.48014537337773e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BID,BH3-interacting domain death agonist,39866,0.116904373024734,0.00628071444018237,0.104594172721977,0.129214573327491,1.61062654679848e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.123789305912237,0.00664551293615055,0.110764100557381,0.136814511267092,1.83701646799468e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99L2,CD99 antigen-like protein 2,39858,0.0425780504386631,0.00229064257349113,0.0380883909946205,0.0470677098827057,2.56379095732605e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.182102465853279,0.00979755371023882,0.162899260581211,0.201305671125347,2.59001527678058e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.135497337068575,0.00729292730242009,0.121203199555832,0.149791474581318,3.02005657485978e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.151225034628213,0.00813175924981982,0.135286786498566,0.16716328275786,3.22463774367666e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2B3,SH2B adapter protein 3,39477,0.17401929550368,0.00936943956738043,0.155655193951614,0.192383397055746,3.50706964065477e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,37445,0.0470325868717783,0.00253160473660295,0.0420706415880365,0.0519945321555201,4.22041468277453e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.18724348064339,0.0100853916707775,0.167476112968666,0.207010848318114,5.52087091612855e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.11585277940259,0.00624355838947027,0.103615404959229,0.128090153845952,6.39621962739338e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLG,Plasminogen,37162,0.0398600344849548,0.00214890062946038,0.0356481892512124,0.0440718797186971,7.4933249525034e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,39585,0.128896672206107,0.00697112906580324,0.115233259237133,0.142560085175082,1.56685798295102e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNMBP,Dynamin-binding protein,39749,0.10902787359975,0.00589733093302615,0.0974691049710184,0.120586642228481,1.60642998527747e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0914379016030724,0.00494790627728528,0.0817400052995932,0.101135797906552,1.80966563590249e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLK1,Protein delta homolog 1,40052,0.0978637267980357,0.00529986338738623,0.0874759945587587,0.108251459037313,2.32957788300628e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.177840110971809,0.00963831539144293,0.158949012804581,0.196731209139037,3.06227903836884e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,39866,0.151268216339754,0.00819865663539524,0.135198849334379,0.167337583345128,3.11841921180619e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXT,Oxytocin-neurophysin 1,40009,0.243095662677097,0.0131779166033841,0.217266946134464,0.26892437921973,3.25118990758875e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.0980074435048353,0.0053241321367878,0.0875721445167312,0.108442742492939,6.55699795229249e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,37437,0.126484578650079,0.00686436848769642,0.113030416414194,0.139938740885964,6.608088857157e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,40009,0.116513197375559,0.00635046824190359,0.104066279621428,0.12896011512969,1.98179635075385e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EREG,Proepiregulin,39713,0.139314980283218,0.00759311921427949,0.124432466623231,0.154197493943206,2.03355714305163e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBPL,FK506-binding protein-like,37382,0.103752710304864,0.00565639868409322,0.0926661688840418,0.114839251725687,3.00419004800702e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM1,Isthmin-1,39866,0.0693900737185647,0.00378767243001873,0.061966235755728,0.0768139116814015,3.28472722720507e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,37124,0.135733636539616,0.00740993103197358,0.121210171716948,0.150257101362284,4.87045055761221e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD36,Platelet glycoprotein 4,37056,0.0795215432495292,0.00434456500943665,0.0710061958310334,0.0880368906680251,6.33857943485133e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,37411,0.13310139232749,0.00727683110506798,0.118838803361557,0.147363981293423,7.51901316634554e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRAP,BRCA1-associated protein,37249,0.191430493279186,0.0104709632730748,0.17090740526396,0.211953581294413,9.06456237757088e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,37056,0.16962694818214,0.00928100140832369,0.151436185421825,0.187817710942454,1.02547610176281e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,39788,0.146732339197746,0.00804676432636016,0.13096068111808,0.162503997277412,1.52475355834242e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC5,Glypican-5,39749,0.09689802569101,0.0053187311876567,0.0864733125632029,0.107322738818817,2.06443849443707e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA1,GDNF family receptor alpha-1,40011,0.0465632963993671,0.00255686498215626,0.0415518410343409,0.0515747517643934,2.28346707611063e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,37411,0.207283390862108,0.0113725206870165,0.184993250315556,0.22957353140866,2.37851933010204e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC13,Mucin-13,39489,0.0875999221586176,0.00481818653105074,0.0781562765577581,0.097043567759477,4.12617282585628e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0483784191819919,0.00266271176761793,0.0431595041174608,0.0535973342465231,4.97252657304772e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.106213577393526,0.00584876601104437,0.0947499960118793,0.117677158775173,5.77679331309856e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.110142332672095,0.00606565694278654,0.0982536450642336,0.122031020279957,6.20044654819948e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,39713,0.0406413654772719,0.00224008784458277,0.0362507933018896,0.0450319376526541,7.98389028010292e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMN,Protein amnionless,39587,0.0822411304820267,0.00453303135781692,0.0733563890207056,0.0911258719433479,8.10903403227893e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D23,TBC1 domain family member 23,39788,0.155181180072969,0.00855961170306171,0.138404341134968,0.17195801901097,1.00384369340219e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.0942010113021829,0.00520571051082181,0.0839978187009721,0.104404203903394,1.8697708436602e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,39866,0.108656537079157,0.0060060800470364,0.0968846201869654,0.120428453971348,1.97156539939756e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.137876889273513,0.00763451182577624,0.122913246094991,0.152840532452034,4.62240468509864e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZI2,5-azacytidine-induced protein 2,37411,0.0951241360296696,0.00526731992194518,0.0848001889826571,0.105448083076682,4.65370914314878e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREG1,Protein CREG1,39660,0.0645452560835255,0.00357897646499669,0.0575304622121319,0.071560049954919,5.49436043566059e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1S,Complement C1s subcomponent,37453,0.0359105351361908,0.00199007492641492,0.0320099882804176,0.039811081991964,5.97730051887087e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT2,Omega-amidase NIT2,37377,0.129352733821835,0.007168613322397,0.115302251709937,0.143403215933733,6.09496564751232e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.115452005483067,0.00640557817364557,0.102897072262722,0.128006938703413,6.78414776437074e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.200405331199758,0.0111233068391623,0.178603649795,0.222207012604516,7.44014577775735e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLM2,Protein GOLM2,40009,0.0379272451772229,0.00210590048718981,0.0337996802223308,0.0420548101321149,8.19612394218376e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS1,Galectin-1,39868,0.0573612172221328,0.00318698741805794,0.0511147218827392,0.0636077125615264,1.01740819431288e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0715774687384409,0.00397904221342141,0.0637785460001349,0.0793763914767469,1.24851023795636e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MITD1,MIT domain-containing protein 1,39749,0.166294474512915,0.00924658567900555,0.148171166582065,0.184417782443766,1.32255079766757e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,39585,0.129846155218366,0.007223864707536,0.115687380391595,0.144004930045136,1.59953077560197e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.160732560381177,0.00895984189896144,0.143171270259212,0.178293850503141,2.98737440933585e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,37124,0.141266884424687,0.00787562944903765,0.125830650704574,0.156703118144801,4.17032190479946e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.104589730591782,0.00583722884094869,0.0931487620635229,0.116030699120042,4.25402028204378e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGCC,Regulator of cell cycle RGCC,37411,0.128863706481253,0.00719798833180605,0.114755649350913,0.142971763611593,7.33853472922994e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.123632522869466,0.00691571570985134,0.110077720078157,0.137187325660774,1.15829938229369e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.181180080934617,0.0101369137882964,0.161311729909556,0.201048431959678,1.22954523205123e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD1,COMM domain-containing protein 1,37043,0.104880897337567,0.00589287889449246,0.093330854704362,0.116430939970772,4.83070273266539e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP2,Methionine aminopeptidase 2,40011,0.0974163444223902,0.00549275813115849,0.0866505384853195,0.108182150359461,1.02314758630157e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYDGF,Myeloid-derived growth factor,37437,0.170851717904536,0.00963066386742078,0.151975616724391,0.18972781908468,1.24667108745397e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,37056,0.149195800000583,0.00841421923398121,0.13270393030198,0.165687669699186,1.53454097585085e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.105512649655879,0.00595661546148385,0.0938376833513704,0.117187615960387,2.00133300276764e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCC,Tubulin-specific chaperone C,39749,0.13692081064864,0.00773794388041454,0.121754440643027,0.152087180654252,2.13123066886578e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0847940345266836,0.00479561164140488,0.07539463570953,0.0941934333438371,2.65107537652167e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB27B,Ras-related protein Rab-27B,37437,0.137985807750293,0.00779857961401086,0.122700591706831,0.153271023793754,2.80484431139929e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX2,Heme oxygenase 2,39489,0.079456387159249,0.00450045825365093,0.0706354889820932,0.0882772853364048,4.34659861704151e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAX1BP1,Tax1-binding protein 1,37388,0.105918389825117,0.00599993164891318,0.094158523793247,0.117678255856987,5.68942546271862e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDHD2,Phospholipase DDHD2,37411,0.111968817178988,0.00634306552734827,0.0995364087453857,0.124401225612591,5.78203697478572e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPHN1,Oligophrenin-1,37388,0.181212034344598,0.0102684167510655,0.16108593751251,0.201338131176687,6.28494211828595e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.184662111443662,0.0104759151415052,0.164129317766312,0.205194905121012,6.76282022813307e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GASK1A,Golgi-associated kinase 1A,37021,0.0718156525985702,0.0040707119132181,0.0638370572486628,0.0797942479484777,7.25466516673739e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSP1,Lymphocyte-specific protein 1,39866,0.067676544044706,0.00384362596575278,0.0601430371518306,0.0752100509375815,9.5944046566548e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.100438618276742,0.00570700400243625,0.0892528904319672,0.111624346121517,1.09386967704651e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.149262556890182,0.00847371229968123,0.132654080782807,0.165871032997557,1.10779599563369e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIAE,Sialate O-acetylesterase,39875,0.0789000790686341,0.00449172053001595,0.0700963068298029,0.0877038513074654,1.97654189313672e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTPBP2,GTP-binding protein 2,37039,0.134957750794506,0.00769126362998776,0.11988287407973,0.150032627509282,3.73415314878999e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0331257602667178,0.00189007804846213,0.029421207291732,0.0368303132417035,5.09948791205997e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0453595215004584,0.00259063762907115,0.0402818717474789,0.0504371712534378,5.44578576676567e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,39931,0.215842798453244,0.0123339983068607,0.191668161771797,0.240017435134691,6.12707752017884e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COCH,Cochlin,37437,0.0761347092896449,0.00434837630403324,0.0676118917337398,0.0846575268455501,6.8316650592725e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,39489,0.141973640560836,0.00812004214889758,0.126058357948996,0.157888923172675,8.32760020423019e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.120109007736362,0.00686813095489564,0.106647471064766,0.133570544407957,1.01752940823422e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS6,Growth arrest-specific protein 6,39947,-0.0424358084702496,0.00243013780555791,-0.0471988785691431,-0.0376727383713561,1.16700228544896e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTDH,Protein LYRIC,37056,0.15385519778968,0.00880535564355936,0.136596700728304,0.171113694851056,1.32672080272067e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS8,Galectin-8,40009,0.101458835652356,0.00582248080055936,0.0900467732832594,0.112870898021452,2.18928052716539e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,37382,0.07864232370187,0.00450978174847151,0.0698031514748659,0.0874814959288742,2.30756322552637e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.203889573691511,0.0117022946758286,0.180953076126887,0.226826071256135,2.41254720396975e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEFTY2,Left-right determination factor 2,40011,0.0884095639935356,0.00507672265633586,0.0784591875871173,0.0983599403999539,2.62854822619206e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRKL,Crk-like protein,39881,0.177404856065277,0.0101882467473346,0.157435892440501,0.197373819690053,2.75105683546491e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,39892,0.0583347644806148,0.00335033173750081,0.0517681142751132,0.0649014146861164,2.79875305630004e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.143611864851471,0.00827436826959877,0.127394103043057,0.159829626659885,7.21553555274758e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.138164340579101,0.007969987129541,0.122543165805201,0.153785515353001,1.33069262393229e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOT,Angiomotin,37124,0.0680543453626102,0.00393371036731779,0.0603442730426673,0.075764417682553,2.49747716305927e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM13A,Protein FAM13A,37382,0.111395074480776,0.0064463163798288,0.0987602943763117,0.124029854585241,3.39074670981089e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBNL,Drebrin-like protein,39931,0.152950958049223,0.00885946804377281,0.135586400683429,0.170315515415018,3.46284017012293e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C3,Complement C3,36816,0.0757777029014112,0.00438615214379976,0.0671808446995637,0.0843745611032588,3.88286737288638e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QDPR,Dihydropteridine reductase,39790,0.0713796731263221,0.00413702113720512,0.0632711116974001,0.0794882345552442,4.17125097459606e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELE,E-selectin,40052,0.0816898425306597,0.00473863116774658,0.0724021254418764,0.090977559619443,5.24301826594111e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.136854948889781,0.00793959874117185,0.121293335357084,0.152416562422478,5.51875873885231e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0622855300715974,0.00361357239658055,0.0552029281742996,0.0693681319688953,5.53242500578484e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS1BP3,HCLS1-binding protein 3,37043,0.150088745027712,0.00871322913499016,0.133010815923132,0.167166674132293,8.9723744264502e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.151741188185203,0.00882106386006684,-0.169030473350934,-0.134451903019472,9.9706220097459e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0471791525957848,0.00274434003686101,0.0418002461235372,0.0525580590680324,1.17663822616633e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.118673783626242,0.00692052100142826,0.105109562463443,0.132238004789042,2.47883013602256e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.148751099068634,0.00867245215553998,0.131753092843776,0.165749105293493,3.08200751112869e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGA,Protein O-GlcNAcase,37382,0.116146035456288,0.00677310899663313,0.102870741822887,0.129421329089689,3.17313642385853e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGFR,Opioid growth factor receptor,39788,0.053200241053784,0.0031107647764436,0.0471031420919545,0.0592973400156135,5.45371658381981e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAMBP,STAM-binding protein,39713,0.104881795669743,0.00613329122902298,0.0928605448608584,0.116903046478628,5.63507552936521e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.127053455085475,0.00742505449026114,0.112500348284563,0.141606561886387,5.86000278599429e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASHC3,WASH complex subunit 3,37388,0.123391659922023,0.00721352682917841,0.109253147336833,0.137530172507213,6.48309171282785e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0433874956983259,0.00254087512350568,0.0384073804562548,0.048367610940397,8.40706349160338e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILPL2,RILP-like protein 2,37437,0.160560820838612,0.00939601215537396,0.142144637014079,0.178977004663145,8.63579116342158e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXN,Paxillin,39489,0.0838685849432957,0.00492421371160571,0.0742171260685485,0.0935200438180429,1.81772746549818e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK1,Docking protein 1,37388,0.222604178313405,0.0130608113678004,0.197004988032516,0.248203368594294,1.83149704437383e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0533989760001217,0.00313384458836932,0.0472566406069179,0.0595413113933256,2.09483105220353e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCG,Gamma-synuclein,39749,0.105204667967856,0.00618803338134038,0.0930761225404287,0.117333213395283,2.96977813664611e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIP,Gastric inhibitory polypeptide,37043,0.0705561372347091,0.0041483457715914,0.06242537952239,0.0786868949470282,3.4454378856925e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0860015362438047,0.0050674351119889,0.0760693634243064,0.0959337090633029,6.12963746331114e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD69,Early activation antigen CD69,39785,0.141793090833489,0.00836598858998163,0.125395753197125,0.158190428469853,7.13375425211189e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.137314321383283,0.00810582688736943,0.121426900684039,0.153201742082527,8.43848284331423e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RB,Interleukin-17 receptor B,39644,-0.0866406774426498,0.00512781712803622,-0.0966911990136008,-0.0765901558716988,1.73324726841575e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAX,Protein max,39489,0.169600212582206,0.0100453177105267,0.149911389869574,0.189289035294838,2.16841309422193e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.110135142147594,0.00652738112218082,0.0973414751481199,0.122928809147069,2.48733027937833e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.100434268668733,0.00595062089961686,0.0887710517054841,0.112097485631982,3.0200475474658e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,39866,0.0532089946743603,0.00315813571905086,0.0470190486650206,0.0593989406837,3.78318845429002e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.120457333105091,0.00714968993599375,0.106443940830543,0.134470725379639,3.8033027304465e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,37056,0.126404657061805,0.00750073594300099,0.111703214613523,0.141106099510086,4.60049892003188e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0444745123363548,0.00264177555363377,0.0392966322512326,0.049652392421477,6.07034121996552e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.236325708930617,0.0140397217429203,0.208807854314493,0.263843563546741,6.14357592127266e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,39477,0.148065252886217,0.00881964300701107,0.130778752592476,0.165351753179959,1.05674148818693e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.138088514893448,0.00823069187986505,0.121956358808913,0.154220670977984,1.58339485010914e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRL,Appetite-regulating hormone,39868,0.122307307339152,0.00730381892858916,0.107991822239117,0.136622792439187,2.06826249087718e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA11,Annexin A11,39829,0.106315079698004,0.00636107548823983,0.0938473717410544,0.118782787654954,3.53367262533157e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGLN1,Egl nine homolog 1,39866,0.0847849170947572,0.00507680288771946,0.074834383434827,0.0947354507546873,4.360440926766e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR,GMP reductase 1,40058,0.0788830449765506,0.00472401660038583,0.0696239724397943,0.0881421175133068,4.45444296314333e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,40052,0.0639653073117796,0.00383098346696743,0.0564565797165234,0.0714740349070357,4.56506097752845e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0487304562007937,0.00291663924652253,0.0430138432776096,0.0544470691239779,4.81374157157571e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,39585,0.0546340330116657,0.00327882434867236,0.0482075372882679,0.0610605287350635,8.29100908036556e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F12,Coagulation factor XII,37453,0.0657616653549744,0.00394807233838368,0.0580234435717424,0.0734998871382064,1.10552602832505e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSNL1,Visinin-like protein 1,37388,0.0598606301236516,0.00359605213925992,0.0528123679307022,0.0669088923166011,1.32050757183533e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPP,Lipoma-preferred partner,37021,0.106393955306336,0.00639462341319708,0.0938604934164699,0.118927417196202,1.56910899752552e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C19orf12,Protein C19orf12,39489,0.102748995986146,0.00618734354913094,0.0906218026298489,0.114876189342442,2.10580744046666e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IST1,IST1 homolog,37287,0.157959690907944,0.00950571895642315,0.139328481753355,0.176590900062534,2.13981470757862e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSB,Arylsulfatase B,39788,0.0873713284836572,0.00526225869296209,0.0770573014454515,0.0976853555218629,2.16021035128888e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11,Coagulation factor XI,37249,0.04944887220583,0.00297617105058254,0.0436155769466882,0.0552821674649718,2.23430142454706e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKA,Diacylglycerol kinase alpha,37056,0.0866196632421751,0.00521801337683134,0.0763923570235857,0.0968469694607645,2.90391071148081e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY4,Protein canopy homolog 4,39788,0.119254367286015,0.00720438691340353,0.105133768935744,0.133374965636286,4.9235036469513e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,39749,0.125572381098363,0.00758990217558677,0.110696172834212,0.140448589362513,5.65938696506269e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX15,Sorting nexin-15,37124,0.0849911449012352,0.00513550348830683,0.0749255580641538,0.0950567317383165,6.5552043707593e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TWF2,Twinfilin-2,37437,0.133228097819933,0.00805248669885607,0.117445223890175,0.149010971749691,6.86015645281736e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FIS1,Mitochondrial fission 1 protein,39855,0.123256342259659,0.00745585698395529,0.108642862571107,0.137869821948212,6.96425472604021e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS9,Galectin-9,39859,0.0495781712525267,0.00300092669610108,0.0436963549281686,0.0554599875768848,8.26595552478902e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK10,Kallikrein-10,39856,0.0619913333342153,0.00375343628996413,0.0546345982058856,0.069348068462545,8.97941890408043e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGF,Pro-epidermal growth factor,39808,0.162993605609286,0.00987756327348938,0.143633581593247,0.182353629625325,1.14092580891624e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.114244377595301,0.00691815039688773,0.100684802817401,0.127803952373201,1.18747693554139e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,39858,0.0811168766966599,0.00491764333777761,0.0714782957546158,0.090755457638704,1.26020810673916e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0794005832543557,0.00481022609468277,0.0699725401087774,0.0888286263999339,1.28657996462201e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,39868,0.126777711072698,0.00768888439360299,0.111707497661236,0.14184792448416,1.40282106000581e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLGA3,Golgin subfamily A member 3,37411,0.121900475314991,0.00739380943765168,0.107408608817194,0.136392341812789,1.76889546420948e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,40052,0.112656425197753,0.00684175623536644,0.0992465829764343,0.126066267419071,1.99449180618811e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1A,Meprin A subunit alpha,37382,0.112209533734761,0.00681533599720705,0.0988514751802349,0.125567592289286,2.55720970258819e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGLL,Monoglyceride lipase,39908,0.136759821906131,0.00832284491677709,0.120447045869248,0.153072597943014,3.50736526063427e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.10663232118159,0.00648688867753083,0.0939180193736298,0.119346622989551,4.00608990146964e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPART,Spartin,37124,0.122225124070508,0.00743938254259017,0.107643934287031,0.136806313853984,4.60795442412479e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",39585,0.145915796288626,0.0088944876713697,0.128482600452742,0.163348992124511,5.52821219001533e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.105834687188557,0.00645332561655801,0.0931861689801028,0.11848320539701,7.49146786876292e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL16,C-X-C motif chemokine 16,40034,0.0362595522725837,0.00221375672998112,0.0319205890818207,0.0405985154633467,8.15916757684749e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG2,Secretogranin-2,39949,0.0485242094500113,0.00296395339131631,0.0427148608030313,0.0543335580969912,9.30141443040127e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0487954753374139,0.00297859638533643,0.0429574264221545,0.0546335242526733,9.9892097975137e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL11,Eotaxin,40058,0.0594815871464137,0.00363476176000042,0.0523574540968129,0.0666057201960145,1.03057995129619e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,39866,0.0880915009983559,0.00538534287991015,0.077536228953732,0.0986467730429798,1.16923924696291e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,37056,0.0778205648461559,0.00475588868865939,0.0684990230163835,0.0871421066759283,1.35573912644104e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDUA,Alpha-L-iduronidase,40030,0.0714438595145519,0.00437123184940606,0.062876245089716,0.0800114739393877,1.43870458258227e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD207,C-type lectin domain family 4 member K,39496,0.0585520540262894,0.00358331740939403,0.0515287519038771,0.0655753561487017,1.59059968678319e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0907091073831939,0.00556117873716325,0.079809197058354,0.101609017708034,3.09924457641841e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD226,CD226 antigen,37056,0.0650887358792654,0.00399421723392878,0.057260070100765,0.0729174016577658,3.99374970540462e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.115866288583632,0.00712780581755772,0.101895789181218,0.129836787986045,6.09559750243384e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2,Microtubule-associated protein 2,37388,0.071173385040643,0.00438603827814188,0.0625767500154849,0.0797700200658011,1.1575886739231e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPBP,Platelet basic protein,37371,0.131368438874725,0.00809959906248562,0.115493224712253,0.147243653037197,1.32023854738618e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICA1,Islet cell autoantigen 1,39587,0.12347180096284,0.00764602623166924,0.108485589548769,0.138458012376912,3.41781456512478e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM17,Splicing factor 45,37411,0.117723559236337,0.00729478160540436,0.103425787289744,0.132021331182929,4.78669585317822e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.120268636345317,0.00745930481172984,0.105648398914326,0.134888873776307,5.14393433751534e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0452851423300197,0.00280984818501665,0.0397778398873871,0.0507924447726524,5.57798768671386e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0450549190970131,0.00279566535746557,0.0395754149963806,0.0505344231976456,5.62426637982641e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASC3,Protein CASC3,37039,0.0643876863074366,0.0039940538899317,0.0565593406831705,0.0722160319317027,6.50827988743862e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.118017054890206,0.0073299062993442,0.103650438543491,0.13238367123692,7.36312408007382e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.160552212773938,0.00997973694668495,0.140991928358436,0.180112497189441,8.81463326639461e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YJU2,Splicing factor YJU2,37368,0.0497486552071919,0.0030936880649081,0.043685026599972,0.0558122838144118,1.19385319659151e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.120340786069045,0.0074972446987711,0.105646186459454,0.135035385678636,1.58497478253951e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0855956526116271,0.00533450467374623,0.0751400234510845,0.0960512817721697,1.70566720509003e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0692433551964056,0.00432096851692619,0.0607742569032303,0.0777124534895809,2.4503672033891e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0878289233109306,0.00548150539567856,0.0770851727354006,0.0985726738864606,3.07764095460756e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GLB2,Endophilin-B2,37388,0.101004413974446,0.00630537522523377,0.0886458785329878,0.113362949415904,3.1718409062535e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0427633759029188,0.00267485548741683,0.0375206591475818,0.0480060926582558,4.34245624377025e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0480080146494531,0.00300742482082709,0.042113462000632,0.0539025672982742,6.37547983704229e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0707611328978473,0.00443920537996082,0.0620602903531241,0.0794619754425705,9.13837464004952e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0735042223729789,0.00460927502360294,0.0644700433267171,0.0825384014192406,9.83567375784725e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0754793907844716,0.00474256868833444,0.0661839561553361,0.0847748254136071,1.6470001325785e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRAP2,GRB2-related adapter protein 2,39868,0.194572316222348,0.0122386841966699,0.170584495196875,0.218560137247821,1.76568022429999e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.058981899224826,0.00370906373363288,0.0517121343069056,0.0662516641427465,2.03361803321754e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2,Complement C2,39908,0.0357622773132793,0.00225125943963895,0.031349808811587,0.0401747458149717,2.1497453780457e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NSFL1C,NSFL1 cofactor p47,40009,0.0982645568326733,0.00619544331047334,0.0861214879441455,0.110407625721201,3.14680954549952e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APPL2,DCC-interacting protein 13-beta,37124,0.171014260836994,0.0107822625193259,0.149881026299116,0.192147495374873,3.88653816278892e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.102331348210685,0.0064575848398024,0.0896744819246722,0.114988214496698,4.71920840747714e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD2,Polycystin-2,37021,0.0899691046681471,0.00568122353274258,0.0788339065439717,0.101104302792323,5.74855515374352e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT1,Angiopoietin-1,39794,0.126980063247565,0.0080428606055532,0.111216056460681,0.14274407003445,9.96419421624953e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK24,Serine/threonine-protein kinase 24,39489,0.0936777256643416,0.00593527935367657,0.0820445781311355,0.105310873197548,1.0928663697723e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.115438740715021,0.00731826159644221,0.101094947985995,0.129782533444048,1.22846897032063e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARC,SPARC,39913,0.105899645167529,0.00672423344408648,0.0927201476171193,0.119079142717938,1.81628552173623e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0673793701380783,0.00427602849242858,0.0589983542929183,0.0757603859832383,1.90608378604708e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.109809140424421,0.00697585085607435,0.0961364727465155,0.123481808102327,2.0509977436799e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PF4,Platelet factor 4,37385,0.145012418206148,0.00920641191202667,0.126967850858576,0.16305698555372,2.09134561364221e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN3,Centrin-3,37382,0.118528940183209,0.00752777935971599,0.103774492638166,0.133283387728252,2.28554549183086e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0673018121706172,0.00428199691716263,0.0589090982129784,0.0756945261282559,2.98977348958851e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRY2,Protein sprouty homolog 2,39587,0.138752621058495,0.00883356423592716,0.121438835156077,0.156066406960912,3.5321937576512e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL4,C-C motif chemokine 4,39882,0.0933483328719308,0.00594543230474016,0.08169528555464,0.105001380189221,3.84422407859362e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.102657739028404,0.00653422796012238,0.0898506522265637,0.115464825830243,4.03356899174161e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.144088218023853,0.00918717626249152,0.12608135254937,0.162095083498336,5.02677548620807e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.109984062610281,0.00700800908466261,0.0962483648043419,0.123719760416219,5.22260542777433e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,37124,0.189401076613045,0.012074555951748,0.165734946947619,0.213067206278472,5.87761010793199e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0876195681305451,0.00558604620507184,0.0766709175686043,0.0985682186924859,5.96039904492405e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0817349282924851,0.0052151391814382,0.0715132554968662,0.091956601088104,5.9612304457189e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME1,Proteasome activator complex subunit 1,39738,0.0552222340336444,0.00352443717932895,0.0483143371621597,0.0621301309051291,6.41423198422849e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRAS,Ras-related protein R-Ras,37039,0.196658125495089,0.0125504523814802,0.172059238827388,0.221257012162791,7.64690188504619e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0850843195096919,0.00543626798145162,0.0744292342660467,0.0957394047533371,9.84999287820518e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL7,C-C motif chemokine 7,39866,0.0868372083826586,0.00555248422205335,0.075954339307434,0.0977200774578831,9.9798786038123e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT1,Deaminated glutathione amidase,37043,0.0702175050372952,0.00449169571099669,0.0614137814437416,0.0790212286308487,1.34589604432982e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDC,Nuclear migration protein nudC,40058,0.0957951810562006,0.00613418711317227,0.083772174314383,0.107818187798018,1.40288762233282e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0888589100690625,0.00568656167983612,0.0777132491765837,0.100004570961541,1.44932709985301e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RWDD1,RWD domain-containing protein 1,40009,0.0950479991534283,0.00608753544844809,0.0831164296744701,0.106979568632387,1.47488833206682e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS2,Trypsin-2,39931,0.076276736450185,0.00489147150280665,0.066689452304684,0.0858640205956861,2.00844910149623e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNLR1,Interferon lambda receptor 1,39866,0.0555490945693205,0.00356345655667652,0.0485647197182345,0.0625334694204065,2.18685917671477e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARA5,Scavenger receptor class A member 5,40009,0.0433833921150318,0.00278341067419297,0.0379279071936136,0.04883887703645,2.2416484011888e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHD3,EH domain-containing protein 3,37043,0.174777128725052,0.0112049006500834,0.152815523450889,0.196738733999216,2.28780510516089e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT2A1,Bile salt sulfotransferase,39866,0.0829070648184043,0.00532091121951318,0.0724780788281585,0.0933360508086502,2.44267394520001e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.126955355051851,0.00814249340273965,0.110996067982481,0.142914642121221,2.46471439256552e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TALDO1,Transaldolase,37415,0.0663921819666618,0.00426432336511187,0.0580341081710426,0.0747502557622811,3.46923858026377e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5,T-cell surface glycoprotein CD5,40003,0.048712402926477,0.00313404881933088,0.0425696672405885,0.0548551386123656,4.37799963345905e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF2,TNF receptor-associated factor 2,39866,0.105152070568871,0.00676899445681727,0.0918848414335095,0.118419299704233,5.03440379612362e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATOX1,Copper transport protein ATOX1,39913,0.107850203191884,0.00694297315158841,0.0942419758147702,0.121458430568997,5.07162021260113e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,39587,0.058806463916869,0.00378935277054696,0.0513793324865969,0.066233595347141,6.49021609510935e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",39818,0.162470926816681,0.0104764658647632,0.141937053721745,0.183004799911616,7.54666667693852e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4D,Semaphorin-4D,40009,0.044247133428135,0.00285594698383637,0.0386494773398157,0.0498447895164543,9.42735586364701e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.126004977706425,0.00813757838102539,0.110055324079615,0.141954631333235,1.10907249149641e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL18,C-C motif chemokine 18,39715,0.104160865907734,0.00673291048900555,0.0909643613492831,0.117357370466185,1.35403447231661e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0629452476669843,0.00407030609017979,0.0549674477302319,0.0709230476037367,1.45810005090886e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLG4,Disks large homolog 4,37388,0.10577396309889,0.00683549957384426,0.0923763839341553,0.119171542263625,1.48931721231932e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.116378901658199,0.00752818659157374,0.101623655938714,0.131134147377683,1.62927101956305e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0749165891401802,0.00484884067279976,0.0654128614214927,0.0844203168588677,1.86342660898741e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,39788,0.0878067360390738,0.00568730520758857,0.0766596178322002,0.0989538542459474,2.17720213118197e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.113179212501508,0.00733310139754014,0.0988063337623292,0.127552091240687,2.82431711268793e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.086432080452791,0.00562317059789473,0.0754106660809174,0.0974534948246647,6.28335839516344e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.143698819952182,0.0093455647679463,0.125381513007007,0.162016126897356,6.62568889677337e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,39931,0.0666429770341154,0.00434056177711398,0.058135475950972,0.0751504781172588,7.95227424691937e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP7,Caspase-7,37388,0.123584379814506,0.00804461666650178,0.107816931148162,0.139351828480849,8.16617927304746e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED8,Protein TMED8,37382,0.151401917465551,0.00986985212781366,0.132057007295036,0.170746827636066,1.1494575912934e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIFBP,KIF-binding protein,39788,0.121251315041215,0.00791540502590537,0.10573712119044,0.136765508891989,1.36596168330227e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMVK,Phosphomevalonate kinase,39480,0.162292306383343,0.0105968509974773,0.141522478428288,0.183062134338399,1.4593518190726e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0898022295481448,0.00586681537405943,0.0783032714149883,0.101301187681301,1.61738115589783e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0826254803049514,0.00540155855501196,0.072038425537128,0.0932125350727748,1.89415386858889e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,39931,-0.0476261089054397,0.00311532017446385,-0.0537321364473889,-0.0415200813634906,2.15778248129503e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.129076446309897,0.0084601260407895,0.112494599269949,0.145658293349844,3.45659553490717e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN2,Centrin-2,39489,0.0985789478073359,0.0064641398595142,0.085909233682688,0.111248661931984,3.89881460002785e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF2,Growth/differentiation factor 2,39868,0.0512796781007172,0.00336419064232897,0.0446858644417525,0.057873491759682,4.26742190796086e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUS,RNA-binding protein FUS,39455,0.0570880659404331,0.00374572113741677,0.0497464525110963,0.06442967936977,4.49112679240669e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRG1,Scrapie-responsive protein 1,37437,0.0384389038764763,0.00252157984036614,0.0334966073893587,0.0433812003635939,4.86649371661426e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIN2,Bridging integrator 2,39858,0.130368783106294,0.00855883064020052,0.113593475051501,0.147144091161087,5.01891319362382e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0505021247705729,0.00331873559500518,0.0439974030043627,0.0570068465367831,6.26985651600057e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPSE,Heparanase,37306,0.136663273922691,0.00897519363214876,0.11907189440368,0.154254653441703,6.36374003799738e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRADD,Death domain-containing protein CRADD,39713,0.11077241269883,0.00728557620999543,0.0964926833272392,0.125052142070421,7.67979024391972e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.125008619436691,0.00821659552097479,0.108904092215581,0.141113146657802,7.79629761278806e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.135815541801549,0.00892948626147357,0.118313748729061,0.153317334874037,8.15276100184702e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.106411364332659,0.00699818533917423,0.0926949210678779,0.120127807597441,8.84066282296185e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.0831859342013321,0.00548636687723961,0.0724326551219424,0.0939392132807217,1.42525029425925e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE2,Glia-derived nexin,37437,0.0933247657433174,0.00615830386384185,0.0812544901701873,0.105395041316447,1.86971673646674e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7,Interleukin-7,39866,0.0940899786881235,0.00621585735804342,0.0819068982663584,0.106273059109889,2.09225389201929e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.141930331597787,0.00938690248905071,0.123532002719248,0.160328660476326,2.75592901434249e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0805143524520525,0.00533012896141219,0.0700672996876846,0.0909614052164204,3.40495756833045e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEXN,Nexilin,37445,0.0991456100057094,0.00656417986065916,0.0862798174788175,0.112011402532601,3.96008815021601e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,39788,0.0509870494271764,0.00337850829810799,0.0443651731628848,0.0576089256914681,4.15021567532087e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RFC4,Replication factor C subunit 4,37368,0.0307517655974135,0.00203804065971193,0.0267572059043781,0.0347463252904488,4.99048014793066e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0488982621199881,0.00324473935838558,0.0425385729775524,0.0552579512624238,5.69215993330658e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON2,Spondin-2,39775,-0.0481879044214474,0.0031980194920387,-0.0544560226258432,-0.0419197862170515,5.90221807735201e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.132893591945387,0.00882874816010178,0.115589245551588,0.150197938339187,7.42280959518624e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSTN,Growth/differentiation factor 8,39585,0.0744503774553475,0.00494874645048219,0.0647508344124024,0.0841499204982926,8.49214952247055e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.142734459771523,0.0094880162113491,0.124137947997278,0.161330971545767,1.00492238362032e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX8,Syntaxin-8,39866,0.0697790698992419,0.00464990667576199,0.0606652528147484,0.0788928869837354,1.46813260745758e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.122372968797163,0.0081510862083495,0.106396839828798,0.138349097765528,1.53565710310528e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUB1,NEDD8 ultimate buster 1,39866,0.120458065557529,0.0080324516180257,0.104714460386199,0.13620167072886,1.70653109100689e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,37445,0.104453973864228,0.00696120153089034,0.0908100188636827,0.118097928864773,1.72311364016879e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0825488744475446,0.00551051496740142,0.0717482651114378,0.0933494837836514,2.21235542054194e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53,Cellular tumor antigen p53,39477,0.0631395395767494,0.00421498549560818,0.0548781680053573,0.0714009111481414,2.22785277622604e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.137497831639908,0.00918490193943956,0.119495423838607,0.15550023944121,2.53022426461201e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP7,Matrilysin,39563,0.0704827973464427,0.00471964450866288,0.0612322941094635,0.079733300583422,4.37489794870904e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0726528898911966,0.00486690410195528,0.0631137578513642,0.0821920219310289,5.42614630939999e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,39826,0.092150740673997,0.00617983338194493,0.0800382672453849,0.104263214102609,6.01369691224698e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,40030,0.0529564392174816,0.00355409727227768,0.0459904085638174,0.0599224698711459,7.04954043884021e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0803181585883058,0.0053966549676574,0.0697407148516973,0.0908956023249143,9.18480367857278e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFB,Complement factor B,37220,0.046846688652428,0.00314717647737405,0.0406782227567749,0.0530151545480812,1.02706964613101e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST13,Hsc70-interacting protein,37124,0.0785340332436968,0.00527822781807306,0.0681887067202736,0.08887935976712,1.13656431789663e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESYT2,Extended synaptotagmin-2,37388,0.116828905642857,0.00785717685912696,0.101428838998968,0.132228972286746,1.28942786804845e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2L,Ataxin-2-like protein,37411,0.0680667148212276,0.00458169319125472,0.0590865961663684,0.0770468334760869,1.55457580011824e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.159758685663458,0.010762619966015,0.138663950530069,0.180853420796848,1.65742062990351e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6AP2,Renin receptor,39477,0.0577148016625064,0.00388871694453442,0.050092916451219,0.0653366868737939,1.71397412561194e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGLAP,Osteocalcin,37437,0.122501546028102,0.00824963102935,0.106332269210576,0.138670822845628,1.71737126254854e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB6,Serpin B6,39970,0.0852356438710933,0.00574539175364455,0.07397467603395,0.0964966117082367,1.83186604038876e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM2,Paralemmin-2,37388,0.0535805968161555,0.00360985881006173,0.0465052735484345,0.0606559200838765,1.89488976671266e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCB,Tubulin-folding cofactor B,39749,0.143433144843898,0.00967364938756746,0.124472792044265,0.16239349764353,2.09038860972308e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.142092198342672,0.00960380425458305,0.123268742003689,0.160915654681654,3.31506409606129e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0728786967265341,0.0049281963542332,0.063219431872237,0.0825379615808312,3.69016675150271e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APP,Amyloid-beta precursor protein,39829,0.0939367790295078,0.00635427955193013,0.0814823911077247,0.106391166951291,3.96957284665171e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM106A,Transmembrane protein 106A,37368,0.100495576624332,0.00679617415062054,0.0871750752891156,0.113816077959548,4.29377790044059e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.122335295763995,0.00828100213652516,0.106104531576406,0.138566059951584,4.69911384588535e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0884166906515434,0.00598403962006316,0.0766879729962196,0.100145408306867,5.07745032341258e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.064900975090409,0.0043926991241846,0.0562912848070072,0.0735106653738108,5.13582218409294e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0592320578689505,0.00400928921781424,0.0513738510020346,0.0670902647358664,5.22052032438505e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM3,Junctional adhesion molecule C,37124,0.0713556402733014,0.00483215373099298,0.0618846189605552,0.0808266615860476,5.86401363310308e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.147500388239263,0.00999260791309805,0.12791487672959,0.167085899748935,6.39023356618072e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACYBP,Calcyclin-binding protein,37088,0.146092706657406,0.0099104707533246,0.12666818398089,0.165517229333923,8.53695777788403e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXJ3,Forkhead box protein J3,37056,0.0630978424120822,0.00428275650791039,0.0547036396565778,0.0714920451675865,9.64752742655133e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0869103985336888,0.00590101548262461,0.0753444081877446,0.0984763888796331,1.03784554604955e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0502600236985042,0.00341886360544078,0.0435590510318403,0.0569609963651681,1.51026826355406e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0757393635753327,0.00515881656118029,0.0656280831154193,0.085850644035246,1.75861834260387e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0765779421117922,0.00521935695894667,0.0663480024722567,0.0868078817513277,2.0194097828779e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0900194542914407,0.006135968713096,0.0779929556137726,0.102045952969109,2.37206054104697e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMT,Catechol O-methyltransferase,39403,0.119058321070265,0.00812029084835145,0.103142551007496,0.134974091133034,2.38019155258189e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,37124,0.167091328714279,0.0114071384110769,0.144733337428568,0.18944931999999,3.30177361106494e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR2,GMP reductase 2,37124,0.0936683033389978,0.0064021036126611,0.081120180258182,0.106216426419814,4.22885169536653e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.122575953674066,0.00838352101943381,0.106144252475975,0.139007654872156,4.77829734689726e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.108321520292647,0.00741419468357158,0.0937896987128465,0.122853341872447,4.94300639071003e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF19,Fibroblast growth factor 19,39931,0.106679320830066,0.00730404134529311,0.0923633997932912,0.12099524186684,5.25888620923989e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,37411,0.0841158863042996,0.00575788190340633,0.0728304377736232,0.095401334834976,5.7117493538801e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0650875100726057,0.00445662311020391,0.0563525287766061,0.0738224913686054,6.05543539895386e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0933397257938366,0.00640349467535146,0.0807888762301478,0.105890575357525,9.2617438786734e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.107227227966741,0.00736402572954778,-0.121660718396655,-0.0927937375368272,1.00276967267172e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTF1,Cardiotrophin-1,39585,0.117525805892333,0.00810155927844257,0.101646749706586,0.133404862078081,2.22698402233406e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTNB,Dystrobrevin beta,37348,0.0608554699597814,0.00419614088165621,0.0526310338317353,0.0690799060878276,2.64172166520902e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2R,Proteinase-activated receptor 1,39908,0.0807978272302743,0.00557642677293638,0.069868030755319,0.0917276237052296,2.81969900678516e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TADA3,Transcriptional adapter 3,37368,0.0547403128427327,0.00378067721587966,0.0473301854996086,0.0621504401858568,3.70899840899607e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP2B1,AP-2 complex subunit beta,37039,0.067770005530453,0.00468150656969455,0.0585942526538517,0.0769457584070543,3.94239545617538e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPI,Mannose-6-phosphate isomerase,39788,0.119163560647631,0.00823834786223779,0.103016398837645,0.135310722457617,4.03922774480508e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP5,Platelet glycoprotein V,37124,0.0499679341822572,0.00345607305054247,0.0431940310031939,0.0567418373613204,5.0811638316311e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0877021598718274,0.00607499619802401,0.0757951673237003,0.0996091524199545,5.9657652889595e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.148899842337414,0.0103084573857979,0.12869526586125,0.169104418813577,6.07945486761196e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBXN1,UBX domain-containing protein 1,37124,0.0957803748623865,0.00663107922855676,0.0827834595744153,0.108777290150358,6.1934322139482e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OCLN,Occludin,37411,0.0591110013949936,0.00409499269647835,0.051084815709896,0.0671371870800911,6.94455791323099e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.154613997177183,0.0107224161751382,0.133598061473912,0.175629932880453,7.62699600982322e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0817691742220135,0.00568753288934641,0.0706216097588945,0.0929167386851325,1.42566684981052e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB33A,Ras-related protein Rab-33A,37021,0.0922631679703227,0.00641412847689169,0.0796914761556149,0.10483485978503,1.46200488146614e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0788509644550388,0.00548828300936232,0.0680939297566887,0.089607999153389,1.62746202585173e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D5,TBC1 domain family member 5,39866,0.106746768294133,0.00743287336667476,0.0921783364954507,0.121315200092816,1.75674459359816e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.129834045554916,0.0090375307136671,0.112120485356129,0.147547605753704,1.85713691712133e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,37382,0.0798248635777139,0.00556764117550465,0.0689122868737248,0.090737440281703,2.79400051651714e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO9B,Unconventional myosin-IXb,39587,0.0900717618390915,0.00631113432207157,0.0777019385678313,0.102441585110352,6.34054292675324e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLB1,Beta-galactosidase,39749,0.0574276530422729,0.00402633383474188,0.0495360387261788,0.065319267358367,7.14079705244745e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,37382,0.114081810003599,0.00799514777014364,0.0984113203741175,0.129752299633081,7.35928992665106e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MESD,LRP chaperone MESD,39858,0.166173059666344,0.0116610971087797,0.143317309333136,0.189028809999552,8.52128406878823e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB1,Heat shock protein beta-1,39617,0.0945760935826915,0.00664952634418705,0.0815430219480849,0.107609165217298,1.26405016330123e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,37411,0.0846612946683625,0.00595169100644331,0.0729959802957336,0.0963266090409914,1.36926345986056e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC22D1,TSC22 domain family protein 1,37411,0.0919475354820504,0.00646842520393091,0.0792694220823458,0.104625648881755,1.57452157904666e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEMIP2,Cell surface hyaluronidase,37056,0.04342230872386,0.00305724931633366,0.0374301000638461,0.049414517383874,1.89536903690344e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOA,Elongin-A,39788,0.069188908552296,0.00487741169055996,0.0596291816387985,0.0787486354657936,2.1267872370815e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF1,Scavenger receptor class F member 1,40052,0.0578928762040205,0.00408344308025961,0.0498893277667117,0.0658964246413294,2.35966172971102e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L1,Bcl-2-like protein 1,37388,0.135512804828676,0.00955623597302175,0.116782582321553,0.154243027335799,2.55201312141442e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK13,Kallikrein-13,39490,0.0571186590834355,0.00403016438282657,0.0492195368930954,0.0650177812737755,2.57696283621292e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0881434445852819,0.0062184700844747,0.0759552432197115,0.100331645950852,2.81978450855196e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0402452791958796,0.00284210678824251,0.0346747498909242,0.0458158085008349,3.04265933277519e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0635899670029412,0.0044920303127903,0.0547855875898722,0.0723943464160102,3.58873081206098e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID1,Nidogen-1,39892,0.0506893079157519,0.00358400570064532,0.0436646567424871,0.0577139590890167,3.84318625892948e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0877403717429313,0.00620207622676546,0.075584302338471,0.0998964411473916,4.09126841789988e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.128091194869099,0.00906098883564323,0.110331656751238,0.14585073298696,4.23572284953259e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPACT,Protein IMPACT,37388,0.0746824477558236,0.00528732322486231,0.0643192942350935,0.0850456012765538,5.57468025764073e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0618451016317402,0.00437828656809977,0.0532636599582646,0.0704265433052157,5.63451493237728e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.0962827825412853,0.00682137562618973,0.0829128863139535,0.109652678768617,5.71587413341557e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,37405,0.0828127832656921,0.00586602592315691,0.0713153724563045,0.0943101940750796,6.1816269427679e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP10,Caspase-10,39489,0.0963071606920215,0.00682621914078789,0.0829277711760773,0.109686550207966,6.35852934889527e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB1,Carboxypeptidase B,40052,0.0773321670399891,0.00548227750206371,0.0665869031359443,0.088077430944034,6.44903409617481e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.137755044493752,0.00977595202156184,0.118594178531491,0.156915910456013,9.08438588992223e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,40058,0.0910859369090997,0.0064690633382236,0.0784065727661814,0.103765301052018,9.2262202416866e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA1,Carboxypeptidase A1,40052,0.0794625364590127,0.00564580822350508,0.0683967523409427,0.0905283205770826,9.98349292284846e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0408145226908063,0.00290266582748039,0.0351252976689448,0.0465037477126679,1.3635010891721e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTX3,Pentraxin-related protein PTX3,39866,-0.0664831787384938,0.00474249367063693,-0.0757784663329421,-0.0571878911440454,2.19507526397609e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,39913,0.048401834184683,0.00345275915107587,0.0416344262485743,0.0551692421207917,2.20057971758158e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0427041431334141,0.00304708641837182,0.0367318537534053,0.0486764325134229,2.30473871542767e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,39858,0.0702933254466252,0.0050203230815643,0.0604534922067591,0.0801331586864912,2.77603388759413e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.133022233637854,0.0095025660012432,0.114397204275417,0.151647263000291,3.23157701505496e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSZ,Cathepsin Z,39865,0.041388396627888,0.00295918765315484,0.0355883888277045,0.0471884044280715,3.43503091296464e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.106667071665663,0.00762148895687485,0.0917289533101879,0.121605190021137,3.43820977300599e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THTPA,Thiamine-triphosphatase,37345,0.118013486159296,0.00843326744127341,0.1014842819744,0.134542690344192,3.46374362601333e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB9,Serpin B9,39749,0.0446439417653528,0.0031939000949337,0.0383838975792827,0.0509039859514228,3.88356065061946e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACTB2,Endoribonuclease LACTB2,39868,0.0888487920292788,0.00635844473172329,0.0763862403551012,0.101311343703456,4.11686573397807e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164,Sialomucin core protein 24,39858,0.034853963803344,0.00250378785008763,0.0299465396171723,0.0397613879895158,8.56368842434333e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,37437,0.0817468206098136,0.0058714210997613,0.0702388352542815,0.0932548059653457,9.19938860555955e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNMT,Histamine N-methyltransferase,39669,0.061442687058923,0.00441588095986916,0.0527875603775795,0.0700978137402666,9.42978268222418e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0633460250379421,0.00455384582599192,0.054420487218998,0.0722715628568863,1.09276308662517e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM3,Dynamin-3,37411,0.0728481282252484,0.0052399716578584,0.0625777837758459,0.0831184726746508,1.22107034122076e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0378682437612519,0.00272666623960136,0.0325239779316332,0.0432125095908705,1.48445095777092e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YWHAQ,14-3-3 protein theta,37124,0.0985301500386105,0.00709730925565012,0.0846194238975363,0.112440876179685,1.62394861357948e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD22,B-cell receptor CD22,40058,0.0531047583752723,0.00382854833633332,0.045600803636059,0.0606087131144856,1.68979442265922e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADD1,Alpha-adducin,37124,0.0915130831364807,0.00659381445015558,0.0785892068141758,0.104436959458786,1.71865009016635e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0825832622954118,0.00595155117153067,0.0709182219992117,0.0942483025916119,1.75547206562368e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3,Galectin-3,39901,0.0390582801200003,0.0028168914227933,0.0335371729313254,0.0445793873086752,1.82014308402498e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP2,Caspase-2,39866,0.0903787915431644,0.00652120400155018,0.077597231700126,0.103160351386203,1.99359467675921e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0810936640348515,0.00584805450194107,0.069631477211047,0.092555850858656,2.03167264615436e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0431816459837966,0.00311744860686688,0.0370714467143376,0.0492918452532557,2.21385564509424e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0374616977189626,0.00270660312386739,0.0321567555961826,0.0427666398417427,2.57617783362193e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.117748028063887,0.00850898064543007,0.101070425998844,0.13442563012893,2.95162102445595e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSS,Cathepsin S,36543,0.0323855173933148,0.00234036234577998,0.027798407195586,0.0369726275910435,3.10551668709093e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C4BPB,C4b-binding protein beta chain,39913,0.0523405925118171,0.00378774518307293,0.0449166119529941,0.05976457307064,3.4879512302115e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18,Interleukin-18,39795,0.060099016272174,0.00434913402021998,0.0515747135925428,0.0686233189518051,3.49234676733456e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,36991,0.0623695506838475,0.00451249158923877,0.0535250671689395,0.0712140341987555,3.78837026707111e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0622413262434332,0.00450580707969063,0.0534099443672396,0.0710727081196269,4.21269129919393e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.158919520672833,0.0115246791277853,0.136331149582374,0.181507891763293,5.18148492466242e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CERT,Ceramide transfer protein,39489,0.0811509283337264,0.00588812279636093,0.069610207652859,0.0926916490145938,5.82197171699342e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL8,C-C motif chemokine 8,40003,0.0794031740457038,0.00576320512295749,0.0681072920047072,0.0906990560867005,6.08248700431245e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0265213089736332,0.00192495433639892,-0.0302942194729751,-0.0227483984742914,6.09568189765802e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX6,Peroxiredoxin-6,40030,-0.0777071247212122,0.00564559080344493,-0.0887724826959643,-0.0666417667464602,7.29886932712183e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.107692093146284,0.00782408295663039,0.0923568905512881,0.123027295741279,7.34368362394788e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN3,Ataxin-3,37388,0.0806346743100874,0.0058559882964042,0.0691569372491351,0.0921124113710396,7.55161552315291e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0574935760930758,0.00417929916949487,0.0493021497208658,0.0656850024652857,9.09948658373255e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGT1,Protein SGT1 homolog,39477,0.106386455627535,0.00774613850093601,0.0912040241657002,0.121568887089369,1.12248546772968e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0348176629919392,0.00254089473055464,0.0298375093200521,0.0397978166638263,1.69468923931193e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP6,Platelet glycoprotein VI,39836,0.115959551120653,0.0084741114308251,0.0993502927162363,0.132568809525071,2.19439959041262e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,39811,0.117037977132655,0.00855293530668011,0.100274223931562,0.133801730333748,2.19697011536251e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMFG,Glia maturation factor gamma,37437,0.0940656101102363,0.00688115255108709,0.0805785511101056,0.107552669110367,2.91923587974294e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL1,Growth-regulated alpha protein,39839,0.123837974854272,0.00906818110050995,0.106064339897272,0.141611609811271,3.19475350278212e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.104864382464606,0.00767609485542276,0.0898192365479776,0.119909528381235,3.35332796509463e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRGN,Neurogranin,37445,0.119585470596446,0.00875988756329886,0.102416090972381,0.136754850220512,3.7519540350826e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0846997572905315,0.00620570424876273,0.0725365769629565,0.0968629376181064,3.97677399337348e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.120462900887514,0.00883476062972191,0.103146770053259,0.137779031721769,4.77373962697744e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,37039,0.103931496402051,0.00762482546268756,0.0889868384951838,0.118876154308919,5.06956296717642e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LARP1,La-related protein 1,37368,0.0834057274320705,0.00612280002562509,0.0714050393818453,0.0954064154822957,5.59868254360598e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP4,Dipeptidyl peptidase 4,39575,0.0389592433502886,0.00286202873844489,0.0333496670229367,0.0445688196776406,5.84036070866664e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIAPIN1,Anamorsin,39913,0.0820908665140673,0.00603242002872821,0.07026732325776,0.0939144097703746,6.10944706405716e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.128290693186027,0.00943283249094561,0.109802341503774,0.146779044868281,7.48144763061111e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0966757417916472,0.00711214310112884,0.0827359413134346,0.11061554226986,7.61432794142455e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP3,Caspase-3,40052,0.115391800528514,0.00849657580030511,0.0987385119599165,0.132045089097113,8.79545175819736e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0882417599574145,0.0065010483654824,0.075499705161069,0.10098381475376,9.79235618257193e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG6,Large proline-rich protein BAG6,39585,0.0479359943053844,0.00353227354766709,0.0410127381519569,0.0548592504588118,1.02392753989787e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0884715765027044,0.00652039972391302,0.0756915930438349,0.101251559961574,1.06200813124513e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0521945998008898,0.00384746803486419,0.0446535624525559,0.0597356371492236,1.08966051748864e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,37382,0.114377141856931,0.00843438254271767,0.0978457520732041,0.130908531640657,1.27901362258988e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,37368,0.0712475915688366,0.00525524661932026,0.0609473081949689,0.0815478749427043,1.33969429581075e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3C,Protein FAM3C,39846,0.0374526684220139,0.00276407133715623,0.0320350886011877,0.0428702482428401,1.34781544428012e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.164469822824823,0.0121393963166737,0.140676606044143,0.188263039605504,1.50874375533825e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,37043,0.0737366982969135,0.0054464281269594,0.063061699168073,0.0844116974257539,1.75305105094929e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1R,Complement C1r subcomponent,37453,0.0250112397924085,0.00184779138494896,0.0213895686779085,0.0286329109069084,1.78567761845965e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,37124,0.0897456286326186,0.00663440519190337,0.076742194456488,0.102749062808749,2.03053263331347e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,37424,0.0242991335017373,0.00179713167775401,0.0207767554133394,0.0278215115901352,2.17749611362247e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPI,Glucose-6-phosphate isomerase,37445,0.0612609795870862,0.00453549326795495,0.0523714127818945,0.0701505463922779,2.62631349061475e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP1,Syntaxin-binding protein 1,37411,0.100789471506675,0.00746773292290027,0.0861527149777902,0.115426228035559,3.02160702256986e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX4,Syntaxin-4,39788,0.07627385645006,0.00566029065240252,0.065179686771351,0.0873680261287689,3.67642608593663e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0460707247243585,0.00342111308072555,0.0393653430861365,0.0527761063625806,4.12293870259568e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.122120806716309,0.00907041250920805,0.104342798198261,0.139898815234357,4.30022140188636e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL3,C-C motif chemokine 3,39866,0.0806635189559675,0.00599294013681383,0.0689173562878124,0.0924096816241226,4.51283421783171e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMTN,Smoothelin,37342,0.123939510750584,0.00920667488797284,0.105894427970157,0.141984593531011,4.82354231324325e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0385627749246201,0.0028700014433239,-0.0441879777535349,-0.0329375720957053,6.1494894608412e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.144133584409781,0.0107396618196921,0.123083847243184,0.165183321576377,7.6760675424594e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTD,Deoxycytidylate deaminase,37124,0.122784786666235,0.0091572857425366,0.104836506610863,0.140733066721606,9.93807283465966e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRB1,Chymotrypsinogen B,39858,0.0684101120952117,0.00510731970853957,0.0583997654664741,0.0784204587239492,1.07841525808532e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0687945957056062,0.00513607942871749,0.0587278800253199,0.0788613113858924,1.1838584817221e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0854311516773648,0.00637818384832675,0.0729299113346443,0.0979323920200852,1.20518570324495e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,39868,0.0995382884527393,0.007436467375502,0.0849628123967553,0.114113764508723,1.22125236585011e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0511113920938079,0.00381754081142363,0.0436290121034176,0.0585937720841982,1.27624256863513e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICALL2,MICAL-like protein 2,37039,0.0869238929977855,0.00649790318966015,0.0741880027460516,0.0996597832495194,1.51022777458015e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.112622809110286,0.00843734458019131,0.0960856137331107,0.129160004487461,2.21232244355225e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREH,Trehalase,37437,0.0961147910612554,0.00720128822217669,0.0820002661457891,0.110229315976722,2.21852334184204e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,36874,0.068189603602353,0.00511701728572903,0.0581602497223241,0.0782189574823819,2.99728775061259e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0390776415929974,0.00294478190840594,-0.044849414133473,-0.0333058690525217,5.57918995113033e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.115700837911595,0.00871456762958305,0.0986202853576122,0.132781390465578,5.70016471925313e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,37021,0.0891285216607829,0.006725324933426,0.0759468847912679,0.102310158530298,7.83462345996147e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.123083944270657,0.00929068039989396,0.104874210686865,0.141293677854449,8.3110003797812e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,37043,0.09763461760519,0.00737269177812922,0.0831841417200568,0.112085093490323,8.91908518627223e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0713581888042217,0.00539989167580951,0.0607744011196351,0.0819419764888084,1.17753616135399e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.154614985056456,0.0117014101616737,0.131680221139576,0.177549748973337,1.18501247284773e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFP,Alpha-fetoprotein,39699,0.0853303082043061,0.00645789847572687,0.0726728271918815,0.0979877892167308,1.19156666662062e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLMH,Bleomycin hydrolase,40052,0.0403058711123768,0.0030567135746216,0.0343147125061185,0.0462970297186351,1.68788208492041e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERMAP,Erythroid membrane-associated protein,37056,0.0561528736622426,0.00425944211403516,0.0478043671187337,0.0645013802057515,1.94730738944987e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0437026503466729,0.00331788689665087,-0.0502057086641087,-0.0371995920292372,2.0438594466179e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0473842393625937,0.00360081724377722,0.0403266375647904,0.0544418411603971,2.62540559986224e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB1,Beta-crystallin B1,37437,0.0836461425863589,0.00636155134173446,0.0711775019565594,0.0961147832161585,3.00683274492647e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0592141036832581,0.00451277052924717,0.0503690734459336,0.0680591339205825,3.93437565178018e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0483412181789996,0.00368352860632464,0.0411215021106033,0.0555609342473959,4.17527406232098e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIF,Macrophage migration inhibitory factor,39826,0.0854547992878664,0.00651883956263084,0.0726778737451099,0.0982317248306229,4.65918109643746e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,39749,0.0520229873917664,0.00396971051874419,0.0442423547750277,0.059803620008505,4.9141996454139e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO3,Forkhead box protein O3,39477,0.12224304139495,0.00933560287031462,0.103945259769133,0.140540823020767,5.69508446267618e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1,Allograft inflammatory factor 1,39477,0.0660198150453772,0.00504337018037309,0.0561348094918459,0.0759048205989084,5.98938520433883e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBI,Acyl-CoA-binding protein,39793,0.100057780338628,0.00764499134283653,0.085073597306668,0.115041963370587,6.12228549518432e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0513710285364344,0.00392728564560375,0.043673548671051,0.0590685084018177,6.72155233452811e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0495228983328174,0.00378703408235481,0.042100311531402,0.0569454851342328,7.11296716445079e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMA,Granzyme A,40058,0.0421941118053197,0.00322916432764649,0.0358649497231326,0.0485232738875068,8.03278065743852e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BDNF,Brain-derived neurotrophic factor,37437,0.103109078900524,0.00788816729028498,0.0876482710115654,0.118569886789483,8.23109362247717e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.136509042953323,0.0104509350726297,0.116025210210969,0.156992875695677,9.59213569478936e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMSB10,Thymosin beta-10,39858,0.0964123358311623,0.00738655229214612,0.0819346933385559,0.110889978323769,9.71010770989108e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.072796621821094,0.00557792984697533,0.0618638793210223,0.0837293643211656,1.00474095818801e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0526186457040039,0.0040322240158553,0.0447154866329275,0.0605218047750802,1.10630402629065e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0299075887742911,0.00229322091722833,0.0254128757765235,0.0344023017720586,1.20865424689938e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,39931,0.109910833530357,0.0084318492822099,0.0933844089372253,0.126437258123488,1.21168213168894e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGL1,Fibrinogen-like protein 1,37445,-0.0771396222016385,0.00591968721232228,-0.0887422091377902,-0.0655370352654868,1.38802024188735e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,39913,0.104067343854612,0.00800227182981935,0.0883828910681663,0.119751796641058,1.79935250799766e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGR1,Prostaglandin reductase 1,37437,0.0989415736656256,0.00761099698185701,0.0840240195811858,0.113859127750065,2.07874895353947e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0715318798026128,0.0055177826098034,0.0607170258873982,0.0823467337178275,3.06438189167931e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH9,Protocadherin-9,37382,0.0411909820698507,0.0031771308061254,0.0349638056898449,0.0474181584498565,3.27091603321073e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0472690924365438,0.00364932335934516,0.0401164186522273,0.0544217662208603,3.52969901242813e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAP,Prolyl endopeptidase FAP,40052,0.0337426995377003,0.00260700497218769,0.0286329697922124,0.0388524292831881,3.97362585965982e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,37382,0.122342833378916,0.00946449154250858,0.103792429955599,0.140893236802233,5.35518925818765e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0745517293647742,0.00577242752530222,0.0632377714151819,0.0858656873143666,5.78465334019479e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,37366,0.109025393036248,0.0084388495912672,0.0924852478373641,0.125565538235131,5.86596036181855e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0567754081452075,0.00439667212529969,0.0481579307796201,0.0653928855107949,6.43145922556109e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBN1,Drebrin,37056,0.0645841845039793,0.00501204500419228,0.0547605762957624,0.0744077927121961,9.1407851686433e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,39477,0.0485083750327979,0.00376918306009376,0.0411207762350141,0.0558959738305817,1.03600135966575e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBKS,Ribokinase,39504,0.0608169904969173,0.00473539858180658,0.0515356092765764,0.0700983717172581,1.45645603002485e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0705329781881415,0.00548927335225426,0.0597740024177232,0.0812919539585599,1.45864249555496e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0298262988811107,0.00233023931111808,0.0252590298313192,0.0343935679309021,2.51004310138749e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0947004124641012,0.00739622648551541,0.080203808552491,0.109197016375711,2.56794097063666e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB2,Calretinin,39489,0.0356555947485998,0.00278963631658875,0.0301879075680858,0.0411232819291137,3.19710569762054e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0904745299265418,0.00708367822128941,0.0765905206128145,0.104358539240269,3.83203644674435e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0848320038412731,0.00664198776399403,0.0718137078238448,0.0978502998587014,3.90012698150285e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAP3,Cytosol aminopeptidase,39587,0.0593585876974839,0.00465040619814539,0.0502437915491189,0.0684733838458488,3.97218557353328e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.0920567458777504,0.00723454125666355,0.0778770450146898,0.106236446740811,7.00889879329756e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TST,Thiosulfate sulfurtransferase,39455,0.0928392317598603,0.00731255896456918,0.0785066161893047,0.107171847330416,9.47630899462178e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.146127654294912,0.0115427396970005,0.123503884488791,0.168751424101033,1.48018172255625e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RP2,Protein XRP2,39788,0.0505184575474658,0.0039908002541175,0.0426964890493955,0.0583404260455361,1.50142138541631e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0338827283460995,0.00267977296157475,0.028630373341413,0.039135083350786,1.80394654802241e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSL,Cathepsin L1,39868,0.0288185187976175,0.00228233959509682,0.0243451331912278,0.0332919044040073,2.24172220841715e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTF2,Transcription termination factor 2,37039,0.0593777703146747,0.00470281967351593,0.0501602437545835,0.0685952968747659,2.46379701747879e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,39477,0.054042356368485,0.00428265317255661,0.0456483561502741,0.062436356586696,2.49889147630103e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0732615079087277,0.00580570233432079,0.061882331333459,0.0846406844839964,2.68531238821629e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40LG,CD40 ligand,40058,0.0936231076746026,0.0074334599623813,0.0790535261483353,0.10819268920087,3.33247586855837e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA3,Annexin A3,39985,0.0840413599773848,0.00667586834888887,0.0709566580135626,0.0971260619412069,3.59908751006902e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,37430,0.0579459580154766,0.00460643844352014,0.0489173386661771,0.066974577364776,4.3606523672696e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH7,Protocadherin-7,37382,0.0403824008247723,0.00321140022026214,0.0340880563930585,0.0466767452564861,4.62871427749748e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN4,Cerebellin-4,40030,0.0372383875547597,0.00296373568421413,0.0314294656137001,0.0430473094958194,4.86590084381102e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRD2,Protein ZNRD2,37382,0.0816208259103309,0.0064939495701223,0.0688926847528912,0.0943489670677706,4.9863751296512e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,37124,0.0270286444508611,0.00215056056242044,0.0228135457485171,0.0312437431532052,5.06677330702056e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0448716573977295,0.00357265721762287,0.0378692492511886,0.0518740655442703,5.23267429046362e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOL1,Apolipoprotein L1,37445,0.0737210415484099,0.00586751151439686,0.062220718980192,0.0852213641166277,5.26182860187284e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0781683305511477,0.00622400766496454,0.0659692755278173,0.0903673855744782,5.62095731365105e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0620691186160272,0.00494545461115993,0.0523760275781537,0.0717622096539006,6.31536955394988e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA13,Carbonic anhydrase 13,39657,0.126264680200377,0.0100849322012479,0.106498213085931,0.146031147314823,8.56803831325342e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0770074958180078,0.0061598571350515,0.0649341758333068,0.0890808158027087,1.08522829445165e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGH,Gamma-glutamyl hydrolase,39573,0.0405499836068668,0.00324505255207283,0.034189680604804,0.0469102866089295,1.16070187352224e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,39477,0.0637398757177812,0.0051043074493183,0.0537354331171173,0.0737443183184451,1.29286532216916e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0593143329861404,0.0047481480105283,0.0500079628855049,0.0686207030867759,1.2939780631894e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0519668405637961,0.00416357553779317,0.0438062325097214,0.0601274486178707,1.49977720229069e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0434635894926482,0.00348599284414396,0.036631043518126,0.0502961354671703,1.76816980162899e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,37056,0.102911687693112,0.00826246780541346,0.0867172507945015,0.119106124591722,2.06869592442478e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0780401133858519,0.00627089550919163,0.0657491581878364,0.0903310685838675,2.16859368177616e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILP,Rab-interacting lysosomal protein,39984,0.0705434833829445,0.00567372795244761,0.0594229765961472,0.0816639901697419,2.50099816881658e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD244,Natural killer cell receptor 2B4,40058,0.0317014881713043,0.00255226039282827,0.0266990578013609,0.0367039185412477,2.91173242126121e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0280667363741166,0.00225987757049119,0.0236373763359539,0.0324960964122794,2.97292198627059e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POSTN,Periostin,37437,-0.0441542908087905,0.00355473595764011,-0.0511215732857651,-0.0371870083318159,3.11349386849616e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPT,Dermatopontin,40052,0.0317995331621573,0.00256194804051428,0.0267781150027493,0.0368209513215653,3.24318199801722e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.077881004152354,0.00627778328590913,0.0655765489119721,0.090185459392736,3.559515507781e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,40052,0.037051345780036,0.00298828311608304,0.0311943108725132,0.0429083806875587,3.82651023065567e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMMT,MICOS complex subunit MIC60,37368,0.051914221657956,0.004196005758549,0.0436900503712,0.0601383929447121,5.70865214153122e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0525530713303646,0.00424970877024726,0.0442236421406799,0.0608825005200492,5.76195580468982e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM1,Probable carboxypeptidase X1,39913,0.0802347914232361,0.00649291023436125,0.067508687363888,0.0929608954825841,6.41238149338367e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0772930707308743,0.00625599248501237,0.06503132546025,0.0895548160014985,6.64216720936827e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF23,Fibroblast growth factor 23,40008,0.0689059224741905,0.00558284797967747,0.0579635404340227,0.0798483045143584,7.68351410593441e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0581984966099146,0.00471438015507292,0.0489583115059717,0.0674386817138575,7.98614995021705e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0355783556061822,0.0028844489030577,0.0299248357561891,0.0412318754561753,8.46864306527362e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0403373914544074,0.00327073737533308,0.0339267461987545,0.0467480367100602,8.75473283151804e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.141321381397573,0.0114812518875352,0.118818127698004,0.163824635097142,1.16358402163893e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0903196044411289,0.00734068990041971,0.0759318522363063,0.104707356645952,1.3205059768853e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZD2,PDZ domain-containing protein 2,37021,0.0706004948090604,0.00573959333241233,0.0593508918775323,0.0818500977405886,1.39196555552611e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDT,D-dopachrome decarboxylase,37437,0.0471612642190814,0.00384049774985185,0.0396338886293718,0.0546886398087911,1.76776223714125e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0451296776234987,0.00367514379925641,0.0379263957769561,0.0523329594700412,1.77658872896416e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0434645693479921,0.00354168131115856,0.0365228739781213,0.0504062647178628,1.961134455163e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,39908,-0.0312402625680169,0.0025484099675661,-0.0362351461044465,-0.0262453790315873,2.14983004953327e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA2,Integrin alpha-2,37124,0.0394783520538498,0.00321956256595286,0.0331680094245822,0.0457886946831174,2.22324483207678e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARK7,Parkinson disease protein 7,39858,0.0614992022914996,0.0050186172162167,0.0516627125477149,0.0713356920352844,2.27428938028206e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.081010464444946,0.00661435844833582,0.0680463218862078,0.0939746070036842,2.45292260273347e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.115883742946733,0.00946628519499366,0.0973298239645454,0.134437661928921,2.6455557075461e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB10,Ras-related protein Rab-10,37437,0.0626596577805328,0.00512071029051427,0.0526230656111248,0.0726962499499407,3.00481732057178e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.067444410152524,0.00551412070739328,0.0566367335660332,0.0782520867390149,3.01142229304186e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDCP1,CUB domain-containing protein 1,39749,0.0583693409890103,0.00477224889887174,0.0490157331472217,0.0677229488307989,3.02695695268045e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF2,Fibroblast growth factor 2,39866,0.0778666098417022,0.00636965886534376,0.0653820784656284,0.0903511412177759,3.26345858494782e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASS1,Argininosuccinate synthase,37021,0.0934905000354128,0.00765019213635184,0.0784961234481632,0.108484876622662,3.69165554730005e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARD3,Partitioning defective 3 homolog,37169,0.0863893133697238,0.00707149576858638,0.0725291816632945,0.100249445076153,3.86310135478779e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0715560240096935,0.00586353459752608,0.0600634961985424,0.0830485518208446,4.22438189070561e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL25,C-C motif chemokine 25,40058,0.0581220906066731,0.00476402882273697,0.0487845941141086,0.0674595870992376,4.37563401269473e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3BP,Galectin-3-binding protein,37453,0.0351390297346586,0.00288276087393287,0.0294888184217502,0.040789241047567,5.32861155652996e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UMOD,Uromodulin,40012,-0.0613450814247444,0.00503941762258187,-0.0712223399650049,-0.0514678228844839,6.09229530749629e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0518846312552846,0.00426338096984366,-0.0602408579561782,-0.043528404554391,6.33539477093206e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0627801258615707,0.00515931253955651,0.0526678732840399,0.0728923784391015,6.48387415384231e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,39689,0.0494271749012842,0.00406506197747377,0.0414596534254356,0.0573946963771328,7.27312016246517e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0345987116272067,0.00284520345205229,0.0290221128611842,0.0401753103932292,7.61596726318857e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD72,B-cell differentiation antigen CD72,37124,0.0482522611895626,0.0039747297827425,0.0404617908153873,0.0560427315637378,9.81516861653283e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB2B,Ras-related protein Rab-2B,37368,0.0726986282301752,0.00599923633157168,0.0609401250202947,0.0844571314400557,1.26745780648082e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC3B,Tetranectin,37138,0.0245302536291817,0.00202429714481859,0.0205626312253372,0.0284978760330261,1.27730259076507e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMNL1,Formin-like protein 1,39489,0.0706073283328417,0.00583093474337452,0.0591786962358276,0.0820359604298558,1.33673215533116e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA6,Integrin alpha-6,39866,0.0613696915254181,0.00507009811219731,0.0514322992255114,0.0713070838253249,1.40594137829413e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL24,C-C motif chemokine 24,39908,0.0954244132262579,0.00788455988567399,0.0799706758503369,0.110878150602179,1.43120487655938e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0645685089385565,0.0053341195013374,0.0541136347159352,0.0750233831611778,1.49220882738311e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0617057909715302,0.00510314553553346,0.0517036257218846,0.0717079562211757,1.75226068526654e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTC,Probetacellulin,39477,0.0855377567325977,0.00708210782880304,0.0716568253881437,0.0994186880770516,1.94533946722195e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0782874137717822,0.00648795951834729,0.0655710131158215,0.0910038144277429,2.37861273015873e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCA,Calcitonin,39713,0.0702867658471432,0.00583170150719648,0.0588566308930381,0.0817169008012483,2.63006948994743e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0504415330708683,0.00418425550734731,0.0422403922764676,0.0586426738652691,2.70259260803107e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0819882299075426,0.00680294715903929,0.0686544534758256,0.0953220063392596,2.80927995584732e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPPK1,Epiplakin,37043,0.0859724896714658,0.00713568709100906,0.071986542973088,0.0999584363698436,2.96208009349682e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0822556561902114,0.00683004001044413,0.0688687777697409,0.0956425346106819,3.10994449184073e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FADD,FAS-associated death domain protein,39868,0.0884678612645905,0.00735070619352105,0.0740604771252892,0.102875245403892,3.22523029743191e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DXO,Decapping and exoribonuclease protein,37388,0.0523551562203678,0.00435091350749076,0.0438273657456859,0.0608829466950497,3.51429089810247e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,39720,0.0454246371158901,0.00378243809432003,0.0380110584510229,0.0528382157807574,4.41559302626534e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA2,Carboxypeptidase A2,39933,0.0739592469592003,0.00616439276271764,0.0618770371442738,0.0860414567741269,5.04803529332502e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPLAH,5-oxoprolinase,37043,0.0796019871293295,0.00663540292734998,0.0665965973917235,0.0926073768669354,5.49994252028107e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0444256033458,0.00370939417884301,-0.0516960159363323,-0.0371551907552677,6.52203362699823e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDHB,Succinate dehydrogenase,37382,0.08006287348372,0.0067124063449989,0.0669065570475222,0.0932191899199179,1.23887948911867e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB2,Lysosome membrane protein 2,39486,0.0327607774174097,0.00275264625867983,0.0273655907503972,0.0381559640844221,1.60538031120824e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD84,SLAM family member 5,39866,0.035411910088579,0.00297734154180723,0.0295763206666368,0.0412474995105211,1.74687035247514e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0564275626593129,0.00474753582566458,0.0471223924410103,0.0657327328776155,2.07412228105628e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12A_IL12B,Interleukin-12,39788,0.0836429602004326,0.00704260547452225,0.069839453470369,0.0974464669304962,2.14289584960786e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,39585,0.0601997298627278,0.00507016965507856,0.0502621973387738,0.0701372623866818,2.2397797990591e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0369654940339469,0.00311594163667235,0.0308582484260691,0.0430727396418247,2.51044382955909e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0543398937595461,0.0045902721709904,0.0453429603044049,0.0633368272146872,3.60940907042553e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TF,Serotransferrin,37453,0.0247187682990027,0.0020896002820944,0.0206231517460977,0.0288143848519078,3.95300787790486e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WDR46,WD repeat-containing protein 46,37368,0.0407639624139251,0.0034510545534153,0.0339998954892311,0.0475280293386191,4.86311673509708e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS10,Regulator of G-protein signaling 10,37411,0.0676485985314975,0.00573137292052149,0.0564151076072754,0.0788820894557196,5.38897439434267e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL32,Interleukin-32,39866,-0.0482196834660941,0.00409263313800541,-0.0562412444165847,-0.0401981225156035,6.54214306591742e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0547531633725932,0.00465550405588756,0.0456283754230535,0.0638779513221328,8.8623328250136e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD46,Membrane cofactor protein,39777,0.0318372726969386,0.00271099584582751,0.0265237208391166,0.0371508245547605,1.02771358730304e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEPR,Leptin receptor,39868,-0.0346873598459468,0.00295495651271731,-0.0404790746108727,-0.0288956450810209,1.08856419567233e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0378828459759257,0.00323955985383676,0.0315333086624057,0.0442323832894458,1.8356330663872e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRBP,Acrosin-binding protein,37368,0.042856621954303,0.00367363677827309,0.0356562938688878,0.0500569500397183,2.68654828358086e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFR,Epidermal growth factor receptor,40052,0.017884344322335,0.00153374687371206,0.0148782004498593,0.0208904881948106,2.70370836634115e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARFIP1,Arfaptin-1,37411,0.0771714297336343,0.0066264917854828,0.064183505834088,0.0901593536331806,3.38985092370582e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0448366292791606,0.00385170089814919,0.0372872955187882,0.052385963039533,3.60044701770927e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VGF,Neurosecretory protein VGF,37411,0.0325421232451906,0.00279706638803532,0.0270598731246414,0.0380243733657398,3.87484581278589e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF6,SLAM family member 6,39477,0.0419963285025572,0.00361250961643478,0.034915809654345,0.0490768473507694,4.11927608632647e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMD,Dystrophin,37043,0.0576291569095605,0.00495671771821151,0.0479139901818659,0.067344323637255,4.28694424141914e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCA,Tubulin-specific chaperone A,37124,0.0962577601123843,0.00828139150379479,0.0800262327649465,0.112489287459822,4.43415680414291e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.0981189553578489,0.00845314191006747,0.0815507972141167,0.114687113501581,5.03488547106502e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASSF2,Ras association domain-containing protein 2,39477,0.0611267821673421,0.00527240314018611,0.0507928720125773,0.0714606923221068,5.93705712469311e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ING1,Inhibitor of growth protein 1,39453,0.0499057648553202,0.00430881925206183,0.041460479121279,0.0583510505893614,6.78419494537787e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0998829826106177,0.00863302523868544,0.0829622531427942,0.116803712078441,8.24729146764553e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1B,Meprin A subunit beta,39868,0.127379410089892,0.0110156443443379,0.10578874717499,0.148970073004795,8.36205327347872e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2,Brorin,39684,0.0425684186095798,0.0036859061189857,0.0353440426163678,0.0497927946027917,9.92153033248805e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL26,C-C motif chemokine 26,39866,0.0944647105709025,0.00817995417874821,0.078432000380556,0.110497420761249,9.96443583053866e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADM,Pro-adrenomedullin,40030,0.0290413438394849,0.00251789520801158,0.0241062692317822,0.0339764184471875,1.17232356379927e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3B,Protein FAM3B,39788,0.0395961093250003,0.00343371548155709,0.0328660269811484,0.0463261916688522,1.21040889540973e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL2,C-C motif chemokine 2,39720,0.0569781110067934,0.00494437188843205,0.0472871421054666,0.0666690799081202,1.32471582165742e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD83,CD83 antigen,39866,0.0361280366188505,0.00313663376548761,0.0299802344384948,0.0422758387992063,1.41160109581255e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAL,Integrin alpha-L,37056,0.0470983479471721,0.00409294572792058,0.0390761743204478,0.0551205215738965,1.69637071270734e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.097605611606098,0.00848666916458053,0.0809717400435202,0.114239483168676,1.72565105850506e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0498762868766654,0.00433544892792397,0.0413788069779344,0.0583737667753964,1.75387654860322e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID2,Nidogen-2,39858,0.0797254947121996,0.00695526687167353,0.0660931716437194,0.0933578177806797,2.66952262013913e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GET3,ATPase GET3,37437,0.0614335072936883,0.00535978229305099,0.0509283339993084,0.0719386805880682,2.82296313212321e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,39698,0.030215246085888,0.00264014900713623,0.025040554031901,0.035389938139875,3.29237816945202e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSNAX,Translin-associated protein X,37021,0.0429987543302796,0.00375609036094823,0.035636817222821,0.0503606914377381,3.35381623971056e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0443398683106193,0.00387425064542306,0.0367463370455901,0.0519333995756485,3.46999673985025e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0740902624112857,0.00647757107132226,0.0613942231114941,0.0867863017110774,3.56142131861778e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,39866,0.055335788848313,0.00484524175525621,0.0458391150080108,0.0648324626886152,4.31271001553259e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA2,Apolipoprotein A-II,37445,-0.0519704351673712,0.00455767780370879,-0.0609034836626404,-0.043037386672102,5.53979366978807e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR5,Complement factor H-related protein 5,37267,0.0450765694082218,0.00395322281210673,0.0373282526964926,0.0528248861199509,5.58471045854165e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGRN,Neugrin,37388,0.0232553512013828,0.00204142560180725,0.0192541570218406,0.027256545380925,6.29435892991201e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC79,Protein unc-79 homolog,36962,0.0615313519458247,0.00540787028610224,0.0509319261850643,0.0721307777065851,7.42154739171523e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0345805545092848,0.00304103175340826,0.0286201322726046,0.040540976745965,7.5435223111238e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVR,Poliovirus receptor,40009,0.0404235785499823,0.00356014808170901,0.0334456883098326,0.0474014687901319,9.13860758784835e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOD,Apolipoprotein D,36780,-0.0472032830601364,0.00415840484792415,-0.0553537565620677,-0.039052809558205,1.01041092129144e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0576582414482938,0.00508578612677689,0.0476901006398111,0.0676263822567765,1.1785032732271e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0485634134939547,0.00428730435733793,0.0401602969535724,0.056966530034337,1.24845890508974e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0299718076985454,0.00264656689025266,0.0247845365936502,0.0351590788034407,1.35579051726069e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0214338301610691,0.00189388566971887,-0.0251458460737181,-0.0177218142484201,1.39612705473077e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLNK,B-cell linker protein,37056,0.0423713145313285,0.00374578931998631,0.0350295674641554,0.0497130615985017,1.5701574790561e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0641210830014105,0.00567242056312245,0.0530031386976905,0.0752390273051305,1.63243567208273e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL15,C-C motif chemokine 15,40052,0.0468087694675133,0.00414735647144341,0.0386799507834843,0.0549375881515424,1.97282828285325e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0385380400489893,0.00341629706048647,0.0318420978104359,0.0452339822875428,2.21209408819026e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAP,Prosaposin,37347,0.030198963322763,0.00267789351403084,0.0249502920352625,0.0354476346102634,2.3034490135406e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG4A,Cysteine protease ATG4A,39477,0.0634450955500363,0.00563503168129862,0.052400433454691,0.0744897576453816,2.71032260511889e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0281258021733945,0.00250026003208556,0.0232252925105068,0.0330263118362822,3.1479384978701e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL11,C-X-C motif chemokine 11,40009,0.0836982005043146,0.00744851153698664,0.0690991178918208,0.0982972831168084,3.44744209820637e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML2,Trem-like transcript 2 protein,39858,0.0356247308586648,0.00317194807403025,0.0294077126335655,0.0418417490837641,3.68481527591733e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDK,Midkine,39843,0.0543503326404145,0.00484167142738324,0.0448606566427433,0.0638400086380856,3.92716743203089e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,37445,0.0271989967811374,0.00242487778099735,0.0224462363303826,0.0319517572318923,4.53353853844021e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,37432,0.0206286178118934,0.00184186160337076,0.0170185690692867,0.0242386665545001,5.47126017882855e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN1,Ficolin-1,37430,0.060296684421953,0.00538595145089561,0.0497402195781976,0.0708531492657084,5.76649401445867e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0812725920805945,0.00726473222222211,0.0670337169250391,0.0955114672361498,6.30511581214385e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB6,Heat shock protein beta-6,40030,0.0400227108789881,0.00358645969096923,0.0329932498846884,0.0470521718732878,8.21011548508744e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0320717981284682,0.00287405635049752,0.0264386476814931,0.0377049485754434,8.26102633700767e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD274,Programmed cell death 1 ligand 1,39749,0.035840390501354,0.00321214076665504,0.0295445945987101,0.0421361864039978,8.39400770097363e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0886840548476619,0.007952488937533,0.0730971765300973,0.104270933165227,8.96441926957222e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.071906278627784,0.00645059666488466,0.0592631091646101,0.0845494480909579,9.92925950260118e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0648196911376878,0.00582277059550478,0.0534070607704984,0.0762323215048771,1.11565813758816e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0925680942215603,0.0083333373539021,0.0762347530079122,0.108901435435208,1.52117195692144e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0523218162053173,0.00471815235689598,0.0430742375858012,0.0615693948248334,1.80249442614933e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF22,Kinesin-like protein KIF22,37021,0.128765457090199,0.0116155796031616,0.105998921068003,0.151531993112396,1.96921006255445e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0300571747961146,0.00271150117260177,0.0247426324978152,0.0353717170944141,1.97717146994245e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0642091613243983,0.00579427329707574,-0.0755659369866667,-0.0528523856621298,2.05954040594166e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO1A,Coronin-1A,39520,0.0948105461660711,0.00856151014833019,0.0780299862753439,0.111591106056798,2.13718264439455e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABHD14B,Protein ABHD14B,39687,0.0609124212552013,0.00550535257771961,0.0501219302028708,0.0717029123075317,2.37677508901518e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0924065548038554,0.00838495081559046,0.0759720512052981,0.108841058402413,4.00814411617564e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN4,CCN family member 4,40030,0.0421159558372072,0.00383361396259586,0.0346020724705193,0.049629839203895,5.60643581843922e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.049590370339758,0.00451478776249146,0.0407413863252747,0.0584393543542412,5.77591910819627e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0228100869436742,0.00207710683288884,0.018738957551212,0.0268812163361363,5.89827713346464e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",37388,0.112029985930444,0.0102118862837376,0.0920146888143186,0.13204528304657,6.9399303879156e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM1,Dynamin-1,37382,0.120396729313714,0.0109754705573109,0.0988848070213843,0.141908651606043,7.01179055119485e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",37043,0.091731717421963,0.00836526348687674,0.0753358009876846,0.108127633856241,7.36301984078934e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN9,Septin-9,39788,0.0296990547052219,0.00271026939421872,0.0243869266925533,0.0350111827178906,7.65003811022167e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,37382,0.0502922836142648,0.00459191502845396,0.041292130158495,0.0592924370700345,8.47136610162382e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX9,Sorting nexin-9,39868,0.072456698456427,0.00663420874473377,0.0594536493167488,0.0854597475961051,1.13690946120805e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,40009,0.0477502632197303,0.00437284246761578,0.0391794919832034,0.0563210344562573,1.15911046687976e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,39587,0.0704554760829493,0.00645433171885859,0.0578049859139865,0.0831059662519121,1.21455160948158e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO2,Gamma-enolase,40009,0.0691496539609232,0.00633614984144187,0.0567308002716971,0.0815685076501493,1.24059403085373e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POMC,Pro-opiomelanocortin,37043,0.0741498290061144,0.00679608870394143,0.0608294951463892,0.0874701628658396,1.34496410141462e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0453378188562399,0.00416584646887925,0.0371727597772366,0.0535028779352432,1.81339872153295e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA4,Ephrin-A4,39720,0.0287989296254755,0.00264989961238791,0.0236051263851952,0.0339927328657558,2.04710762047479e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRN1,Secernin-1,39866,0.0584472584634369,0.00538050110085669,0.0479014763057578,0.068993040621116,2.1604668403807e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0242134364023656,0.00223184594627919,0.0198390183476584,0.0285878544570728,2.51072198877665e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG2,Bone marrow proteoglycan,37437,-0.0526678936642075,0.00485514073049759,-0.0621839694959828,-0.0431518178324322,2.64185974562144e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0400993997404775,0.00369639112958387,0.0328544731264931,0.0473443263544619,2.64856831692109e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XCL1,Lymphotactin,40030,0.0568758813974004,0.0052486585305001,0.0465885106776202,0.0671632521171806,2.87527684837799e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS27,Serine protease 27,39818,0.0416485556784804,0.00384426407622069,0.0341137980890879,0.049183313267873,2.9570462199099e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL19,C-C motif chemokine 19,40009,0.119788398306719,0.0110732617111075,0.0980848053529477,0.141491991260489,3.51332420762948e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOE,Apolipoprotein E,37453,0.0750384985595253,0.00694449956186739,0.0614272794182652,0.0886497177007854,4.17937637610012e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.105998607388175,0.00981070458161485,0.08676962640821,0.12522758836814,4.23380736802231e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0692315799121194,0.00640778874753279,0.0566723139669551,0.0817908458572837,4.25918419044282e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP3,Syntaxin-binding protein 3,39477,0.0456974390227324,0.00423206908274865,0.0374025836205451,0.0539922944249198,4.38956384549021e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PER3,Period circadian protein homolog 3,37056,0.121402678479519,0.0112557053831254,0.0993414959285933,0.143463861030445,5.20193082881348e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0494200946073012,0.00458546454856214,0.0404325840921194,0.0584076051224829,5.65508696503364e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.046237258707545,0.00429174604389354,0.0378254364615137,0.0546490809535763,5.94229406071866e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSA,Arylsulfatase A,39858,0.0463729797943411,0.00430646195798763,0.0379323143566853,0.0548136452319968,6.01498182777153e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBN,Nibrin,39587,0.0531065337192954,0.00493263493310138,0.0434385692504167,0.0627744981881741,6.15985089416818e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.037893360555437,0.00352113288634592,0.030991940098199,0.044794781012675,6.75426072417011e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1F,Protein phosphatase 1F,37437,0.0548747001724946,0.005100442247268,0.0448778333678493,0.0648715669771399,6.91262301856677e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0285388767624922,0.00266066530021778,0.0233239727740654,0.033753780750919,9.44127190439547e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0687196698049073,0.00640660701822316,0.0561627200491899,0.0812766195606247,9.84291520306752e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MENT,Protein MENT,37124,-0.0227866835852232,0.00213031686217443,-0.026962104635085,-0.0186112625353613,1.35832636575046e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,37169,0.0777715273422675,0.00727776888714436,0.0635071003234646,0.0920359543610705,1.51364707589663e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.044439155655108,0.0041642185399864,0.0362772873167347,0.0526010239934814,1.70441922161925e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN2,Nectin-2,39846,0.0287605752500794,0.00269885100429146,0.0234708272816682,0.0340503232184907,1.99236386963973e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLB,Beta-klotho,39489,-0.0751267378444625,0.00705131553446179,-0.0889473162920076,-0.0613061593969174,2.0516539668302e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPOCK1,Testican-1,39749,0.0258342768201929,0.00243083195895472,0.0210698461806416,0.0305987074597441,2.7129870871942e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0365957936842964,0.00345388601016454,0.0298261771043739,0.0433654102642189,3.80602440696627e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST2,Bone marrow stromal antigen 2,40009,0.0539729989998239,0.00509641258803534,0.0439840303272746,0.0639619676723731,4.02227337039737e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRG,Histidine-rich glycoprotein,37380,0.0320821468267445,0.00303064099228874,0.0261420904818586,0.0380222031716304,4.38097992597214e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL14,C-C motif chemokine 14,39843,0.0393619230564533,0.00372131812072723,0.032068139539828,0.0466557065730787,4.62495477422856e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM,Paralemmin-1,37299,0.0288149341514644,0.00272454815732694,0.0234748197631035,0.0341550485398252,4.87117750116283e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPA1,Inositol monophosphatase 1,39749,0.0620307720080327,0.0058743082754599,0.0505171277881313,0.0735444162279341,5.58713623324802e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0730958090130323,0.0069271334816854,0.0595186273889289,0.0866729906371357,6.06519126576737e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,37437,0.0278818515443542,0.00264204765860393,0.0227034381334905,0.0330602649552179,6.19180990618012e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.090575448913373,0.00858628440046693,0.0737463314884578,0.107404566338288,6.51247512893708e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7,Complement component C7,37149,-0.0323719592851033,0.00307016339472746,-0.0383894795387691,-0.0263544390314375,6.84789753901713e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0640436946680546,0.0060815071166769,0.0521239407193679,0.0759634486167413,7.56149633248937e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.11143416150742,0.0105848000556611,-0.132180369616515,-0.0906879533983239,7.82741674885e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP6,Bone morphogenetic protein 6,39568,0.0421165068250736,0.00400418882649004,0.0342682967251531,0.0499647169249941,8.68427843966809e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN2,Dynactin subunit 2,39788,0.0954614231574652,0.00907711084976361,0.0776702858919285,0.113252560423002,8.78882871557757e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0702686646940522,0.006695588838148,0.0571453105712821,0.0833920188168223,1.1073146498834e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.0917370388811678,0.00873874145025429,0.0746091056386694,0.108864972123666,1.11004587716514e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGMN,Legumain,39931,0.0360686481724001,0.0034388545045908,0.0293284933434021,0.0428088030013981,1.17994278583558e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0386249331850223,0.00368328542499159,0.0314056937520388,0.0458441726180058,1.24901449692333e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGT,Angiotensinogen,37445,0.0225107940833463,0.00214766309852994,0.0183013744102276,0.026720213756465,1.31524467491927e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPAG1,Sperm-associated antigen 1,37411,0.0582504457830227,0.00558445670044963,0.0473049106501414,0.069195980915904,2.23742366044613e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAEP,Glycodelin,39749,-0.144366850983116,0.0138701413360939,-0.17155232800186,-0.117181373964372,2.73561308155771e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP1,Guanylate-binding protein 1,37376,0.0633915724823251,0.0060898800471995,0.0514554075898141,0.0753277373748361,2.80110330785331e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COLEC12,Collectin-12,39862,0.0247381316070612,0.00237828502487112,0.0200766929583138,0.0293995702558086,2.93263335895481e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,39822,0.0282522302196045,0.00272046780658865,0.0229201133186908,0.0335843471205183,3.48804990325648e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0764263166771356,0.00736552699469702,0.0619898837675294,0.0908627495867417,3.83980595225696e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO2,Roundabout homolog 2,40009,0.0225690448347582,0.00217717897070061,0.018301774052185,0.0268363156173314,4.23567102941153e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP1,Interstitial collagenase,39314,0.091038064489821,0.0087839214052368,0.0738215785355568,0.108254550444085,4.36055516631834e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPH,Hephaestin,37437,0.0261196019343243,0.00252194546259605,0.0211765888276361,0.0310626150410126,4.82486938311815e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.059398094069398,0.00573633109655743,0.0481548851201454,0.0706413030186505,4.96814121692465e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFA,Protransforming growth factor alpha,39866,0.0453371473039127,0.00439032064533364,0.0367321188390587,0.0539421757687666,6.39555959299841e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,37411,0.0893343602789041,0.0086566004939038,0.0723674233108526,0.106301297246956,7.08895918242863e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0542412332371116,0.00525787254417134,0.0439358030505357,0.0645466634236874,7.40122028618627e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACYP1,Acylphosphatase-1,37073,0.0649039900810872,0.00629705300898726,0.0525617661834722,0.0772462139787022,8.13061126412998e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0239196050634394,0.00232267468265595,0.0193671626854337,0.028472047441445,8.57247883621541e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNF,Tumor necrosis factor,39555,0.0373822736461102,0.00364010612107883,0.0302476656487957,0.0445168816434248,1.15675882099273e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,39477,0.0536670003385668,0.00524033541920115,0.0433959429169325,0.063938057760201,1.55069062339993e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA4,Annexin A4,39783,0.0710098303355901,0.00693808330254642,0.0574111870625992,0.0846084736085811,1.6494630738765e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0581461706902898,0.00568066491886967,0.0470120674493053,0.0692802739312744,1.68287690490187e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12B,Interleukin-12 subunit beta,40058,0.0511890482709547,0.00500887884385219,0.0413716457370044,0.061006450804905,1.92066321641203e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0490701941553149,0.00480235703443651,0.0396575743678193,0.0584828139428104,1.9552362759105e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0313212798794925,0.00306600555991811,0.025311908982053,0.037330650776932,2.06764423797419e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFASC,Neurofascin,40058,0.0270668228133467,0.00265067800173283,0.0218714939299503,0.032262151696743,2.092832792351e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0273952317115537,0.00268254460067782,0.0221374442942251,0.0326530191288822,2.15108656160438e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGN,Biglycan,39448,-0.116560754912733,0.0114276262795729,-0.138958902420696,-0.0941626074047704,2.36680201506443e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK4,Serine/threonine-protein kinase 4,39868,0.0851077573661524,0.00835039986413115,0.0687409736324553,0.101474541099849,2.55290076160757e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.071629358364684,0.00703065874450521,0.0578492672254538,0.0854094495039142,2.66152427617448e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSHB,Follitropin subunit beta,37043,0.0638268961772021,0.00626822192800713,0.0515411811983081,0.0761126111560961,2.91545215157533e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0525895544977525,0.005175583436922,0.0424454109613853,0.0627336980341196,3.49614264277387e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,39677,0.035372993206811,0.00348378635402349,0.0285447719529249,0.042201214460697,3.78707719678613e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSB,Cathepsin B,39847,-0.0498085252496227,0.00491643961042648,-0.0594447468860586,-0.0401723036131868,4.75698924938359e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX16,Syntaxin-16,39477,0.0564769530560501,0.00558279923967962,0.0455346665462781,0.0674192395658222,5.54866968365493e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,37169,0.0338884369478005,0.003354566869845,0.0273134858829043,0.0404633880126967,6.58872795941036e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH1,Acid ceramidase,37340,0.0456392007575898,0.0045302280425701,0.0367599537941524,0.0545184477210272,8.70564813247986e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLTA,Clathrin light chain A,39585,0.0448582228312655,0.00445941644699308,0.036117766595159,0.0535986790673719,9.87001792060303e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0464009733629011,0.00463384557987024,0.0373186360263555,0.0554833106994468,1.56570085648049e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XRCC4,DNA repair protein XRCC4,39489,0.0356174961958447,0.00356101967735956,0.0286378976282199,0.0425970947634694,1.75629016832954e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0264114595339155,0.00264257348553249,0.0212320155022718,0.0315909035655592,1.88620162613845e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA4,Laminin subunit alpha-4,39931,0.0321887039158506,0.00322122835768694,0.0258750963347842,0.038502311496917,1.92083381798053e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0331283242790671,0.0033188990106601,0.0266232822181733,0.0396333663399609,2.14768627678568e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0318152341641926,0.00318869388478631,0.0255653941500114,0.0380650741783738,2.23340667333591e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0693778278361827,0.00696150752888179,0.0557332730795744,0.083022382592791,2.51276477812501e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APLP1,Amyloid-like protein 1,39868,-0.0488366187750981,0.00490177710898836,-0.0584441019087153,-0.0392291356414809,2.58610209838313e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0320728333621673,0.00322325712010499,0.0257552494067615,0.0383904173175731,2.93496147545268e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENAH,Protein enabled homolog,39587,0.0457044440395077,0.00459671451778588,0.0366948835846474,0.0547140044943681,3.17286557573174e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0672443272573687,0.00676644501350949,0.0539820950308901,0.0805065594838473,3.43485827718254e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,37388,0.0619081808048186,0.00623861409052922,0.0496804971873813,0.0741358644222558,3.95115164121573e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,39788,0.0322414642583983,0.00325896218019255,0.0258538983852209,0.0386290301315757,5.19265809191611e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0383541743253696,0.00387692232072231,0.0307554065767539,0.0459529420739853,5.34659491614887e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXN,"Frataxin, mitochondrial",40030,0.069433374815969,0.00702989740629163,0.0556547758996374,0.0832119737323006,6.09053787231063e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0457707009050664,0.00463392115680615,0.0366882154377264,0.0548531863724065,6.24248654922006e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOB,Elongin-B,37021,0.037182227397181,0.00376456279026915,0.0298036843282535,0.0445607704661086,6.29908402934283e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLF4,Krueppel-like factor 4,36991,0.0373091383348371,0.0037789463385772,0.0299024035112258,0.0447158731584484,6.55694150339195e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC1,MANSC domain-containing protein 1,39913,-0.0255169282407894,0.00258794443444857,-0.0305892993323086,-0.0204445571492702,7.21190349646388e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR2,Folate receptor beta,40009,-0.0272120458986068,0.00276084758028128,-0.0326233071559581,-0.0218007846412555,7.46033697158578e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG4,Regenerating islet-derived protein 4,39885,0.0442571490132017,0.00450107797263188,0.0354350361868432,0.0530792618395602,9.4538361530425e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0239405299046866,0.00243590854822217,-0.0287149106592021,-0.0191661491501712,1.01364735130814e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML1,Trem-like transcript 1 protein,37445,0.0498742913441445,0.00508096402015731,0.0399156018646362,0.0598329808236529,1.1439149293011e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C5,Complement C5,37453,0.0143059042846687,0.00145838353341778,0.0114474725591698,0.0171643360101675,1.21919912315604e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOTL2,Angiomotin-like protein 2,37333,0.045391980054795,0.00464018301302917,0.0362972213492578,0.0544867387603321,1.59294846117746e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0238993781940732,0.00244369590289099,0.0191097342244068,0.0286890221637395,1.62917520353342e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0216673947430365,0.00222419517910077,0.017307972191999,0.026026817294074,2.31314690370983e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0901100952039254,0.00925555805873893,0.0719692014087971,0.108250988999054,2.45063480936716e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENR,Density-regulated protein,37056,0.0539476064979084,0.0055434572654699,0.0430824302575874,0.0648127827382294,2.62340663341082e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPL,Periplakin,37056,0.0299376184622918,0.00307703335961356,0.0239066330774492,0.0359686038471343,2.68518872184784e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.057137194059908,0.00588202904776947,0.0456084171262798,0.0686659709935361,3.12465873868831e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0778754292688316,0.00802923214738204,0.0621381342599628,0.0936127242777004,3.60550358598992e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0345275822177251,0.00356097224526294,0.0275480766170097,0.0415070878184404,3.61689879142714e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTN,Pleiotrophin,39585,0.0467732441700151,0.00482678119071832,0.0373127530362072,0.056233735303823,3.8214562389861e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX7,Syntaxin-7,37056,0.0458566069777146,0.00473377155323385,0.0365784147333762,0.0551347992220529,4.05249392350151e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX1,Peroxiredoxin-1,39434,-0.0842204559747553,0.00869926097328076,-0.101271007482386,-0.067169904467125,4.17788443201966e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIT2,Slit homolog 2 protein,39489,0.0478698890552599,0.00494534573934255,0.0381770114061485,0.0575627667043713,4.23913165018636e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,37437,0.0231956330086907,0.0023970317240571,0.0184974508295388,0.0278938151878426,4.4580223039706e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FST,Follistatin,39908,0.0476586443501465,0.00492739408017318,0.0380009519530071,0.0573163367472859,4.54748734691434e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0287826781148045,0.00298535771741683,0.0229313769886675,0.0346339792409415,6.29486135436554e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRD1,Natural killer cells antigen CD94,40058,0.0420008474695725,0.00437381422555552,0.0334281715874837,0.0505735233516613,8.89226024169017e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK6,Kallikrein-6,39889,0.0271999614751852,0.00283397849631097,0.0216453636224157,0.0327545593279547,9.34437446020025e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",37403,0.0206988941111978,0.00215951505530616,0.0164662446027977,0.0249315436195979,1.08362212777001e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0332574785419378,0.00347426148021852,0.0264479260407095,0.0400670310431661,1.19029241720078e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR2,Interferon gamma receptor 2,39749,0.0477563106131815,0.00498903982501564,0.0379777925561508,0.0575348286702121,1.19663718475898e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN6,Dynactin subunit 6,39489,0.0651143042601966,0.00680657805736679,0.0517734112677576,0.0784551972526355,1.26889511799443e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSTB,Cystatin-B,39619,0.0388607245383208,0.00406408758952541,0.030895112862851,0.0468263362137906,1.32220598100096e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0310346697661572,0.0032464026740777,0.0246717205249649,0.0373976190073495,1.35300478457481e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSE,Cathepsin E,37124,0.048253497411162,0.00506766111068558,0.0383208816342183,0.0581861131881058,1.99171391792466e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0377849920686671,0.00397012988361421,0.0300035374967832,0.0455664466405509,2.02364753372771e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0349133801180729,0.00367354129377479,0.0277132391822743,0.0421135210538714,2.30655350865687e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,39749,0.0428921321345251,0.00452529134288784,0.034022561102465,0.0517617031665853,2.94100603933824e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD302,CD302 antigen,39788,0.0263489622926617,0.00278201807372646,0.0208962068681579,0.0318017177171656,3.14713048050045e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRIB,Protein scribble homolog,37043,0.0819486562500311,0.00865036227272175,0.0649939461954965,0.0989033663045658,3.16320021433433e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA2,Annexin A2,36879,0.0632734760201393,0.00667985481549015,0.0501809605817786,0.0763659914585,3.20432356407026e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0331285236644736,0.00349831643178251,0.0262718234581799,0.0399852238707673,3.26993452044899e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARCO,Macrophage receptor MARCO,39868,0.0237354424602072,0.00251085633295916,0.0188141640476072,0.0286567208728071,3.73397928003105e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0269165036052605,0.00284842567351449,0.0213335892851721,0.0324994179253489,3.85607050318368e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMM2,Phosphomannomutase 2,37021,0.0545520518123981,0.00577189399507084,0.0432391395820592,0.0658649640427369,3.90366906156744e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBD,Thrombomodulin,39868,0.0245647881533898,0.00260406496742231,0.0194608208172421,0.0296687554895375,4.50959982876867e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0558703061533526,0.00593611771334806,0.0442355154351904,0.0675050968715148,5.66937995911186e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0315660163852566,0.00335652873119589,-0.0381448126984006,-0.0249872200721127,6.08783173437922e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.049553467136085,0.00527100742042032,0.0392222925920612,0.0598846416801089,6.13088625168623e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0346693246006126,0.0036974779596236,0.0274222677997503,0.0419163814014748,7.7045844818828e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMB,RGM domain family member B,40009,0.0228729215622939,0.0024421097688729,0.018086386415303,0.0276594567092848,8.50167614626332e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.0851831558023799,0.0090960117488574,0.0673549727746193,0.10301133883014,8.61328193462686e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0553346904039008,0.00591792566505119,0.0437355561004005,0.0669338247074011,1.00819822233136e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS7_LGALS7B,Galectin-7,39822,0.0363787314765172,0.00389608291390114,0.0287424089652709,0.0440150539877634,1.11613689953088e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,40058,0.0662690385760472,0.00710287420443958,0.0523474051353456,0.0801906720167487,1.19396248902199e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGES2,Prostaglandin E synthase 2,36961,0.0497145645821817,0.00532967614347933,0.0392683993409622,0.0601607298234012,1.25131946668444e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERI1,3'-5' exoribonuclease 1,37169,0.0299164159437535,0.00320810493621661,0.0236285302687689,0.036204301618738,1.27944092436887e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,37411,0.0314328591928468,0.00337939165376565,0.0248092515514661,0.0380564668342275,1.59639092598302e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,39971,-0.0204321757249371,0.00219892787710261,-0.0247420743640582,-0.016122277085816,1.70557118440915e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,37411,0.0612402385533893,0.00660075005585198,0.0483027684439194,0.0741777086628592,1.98923764367329e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0481842772141179,0.0051958081779859,-0.0583680612429703,-0.0380004931852656,2.0230387369501e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0467614633792373,0.0050431054705616,0.0368769766569366,0.0566459501015381,2.10040419955886e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0449199579924047,0.00484763902575028,0.0354185855019341,0.0544213304828752,2.17218013010587e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0745671306893217,0.0080600828379671,0.0587693683269062,0.0903648930517372,2.54335666406611e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX,Glutaredoxin-1,39771,0.0496787228314655,0.00537143603878818,0.0391507081954407,0.0602067374674903,2.55535200807795e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0415275742788522,0.00449707355557844,0.0327133101099185,0.050341838447786,2.925926150357e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA9,Carbonic anhydrase 9,40030,-0.0382149001089659,0.00414610015756802,-0.0463412564177992,-0.0300885438001325,3.42126488815444e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLO1,Lactoylglutathione lyase,39585,0.0511236218502323,0.00554658921484228,0.0402523069891414,0.0619949367113231,3.43045716338028e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCT,Secretin,37039,0.0389145191353726,0.00423216231627976,0.0306194809954643,0.047209557275281,4.3077330552427e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0263799385563109,0.00286964139146275,0.0207554414290439,0.0320044356835779,4.37790252542114e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,39866,0.0437100366232161,0.00475783806055659,0.0343846740245251,0.053035399221907,4.52691235560644e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRDT,Bromodomain testis-specific protein,37021,0.0322291840174378,0.00350766272088476,0.0253541650845036,0.0391042029503719,4.58482995713209e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0590407459468933,0.00644667898782752,0.0464052551307514,0.0716762367630353,6.01692147640699e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.032382101527706,0.00353878250879253,0.0254460878104726,0.0393181152449393,6.32912594654398e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR3,Toll-like receptor 3,40058,0.0532943524933925,0.00583622833337666,0.0418553449599743,0.0647333600268108,7.52753133793511e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSF,Cathepsin F,39913,0.0352353981780137,0.00387559106317349,0.0276392396941937,0.0428315566618338,1.08767425753417e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KITLG,Kit ligand,39868,-0.0322596761348534,0.00354942253404958,-0.0392165443015905,-0.0253028079681162,1.11734573348603e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,40052,0.0278417675693394,0.00306670484411269,0.0218310260748785,0.0338525090638003,1.22268750936409e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMB1,Laminin subunit beta-1,37043,0.0264584791651696,0.00291537093542791,0.0207443521317309,0.0321726061986083,1.29010319902203e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA,Adenosine deaminase,40058,0.0300345430398197,0.00332989776334127,0.0235079434236708,0.0365611426559685,2.09417096760469e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK4,Dickkopf-related protein 4,39718,0.0390742135605411,0.00434574474090251,0.0305565538683721,0.04759187325271,2.71250022805885e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA9,Serpin A9,39715,0.0626063451694888,0.00696391835489904,0.0489570651938867,0.0762556251450909,2.7439244323675e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,39767,0.0400783497391329,0.0044586966668558,0.0313393042720956,0.0488173952061703,2.77543924314062e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,39453,0.0570247642061452,0.00634572054088349,0.0445871519460135,0.0694623764662768,2.84414425432503e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGED1,Melanoma-associated antigen D1,39477,0.041707960872793,0.00464176637074356,0.0326100987861356,0.0508058229594504,2.8687435078118e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XG,Glycoprotein Xg,39985,0.0258790762883694,0.00288032086414132,0.0202336473946524,0.0315245051820864,2.87406873143886e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAST,Gastrin,37388,0.100013327359559,0.0111348043224699,0.0781891108875184,0.121837543831601,3.00492233381215e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0505952892770446,0.00564921570339693,0.0395228264983866,0.0616677520557025,3.79394164195157e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0335370064292104,0.00374668324856233,0.0261935072620283,0.0408805055963926,3.90555297563812e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0567253131571469,0.00634578982713328,0.0442875650959657,0.0691630612183282,4.4270334674539e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0348612997380791,0.00390111117431547,0.0272151218364208,0.0425074776397374,4.55449596536753e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,37021,0.0432390153592535,0.00485176060034244,0.0337295645825823,0.0527484661359247,5.66294607022313e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,39858,-0.022792252976498,0.00256121749260818,-0.02781223926201,-0.0177722666909859,6.22918200310574e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA1,BolA-like protein 1,36991,0.0468798816685377,0.00526747415264598,0.0365556323293516,0.0572041310077238,6.31593819947446e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6A,Ras-related protein Rab-6A,39866,0.0394093033399448,0.0044308044433638,0.0307249266309518,0.0480936800489379,6.49111245567694e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0360945813562288,0.00405783669031463,0.0281412214432121,0.0440479412692455,6.5730522532493e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0354310636542715,0.00399196059110739,0.027606820895701,0.0432553064128419,7.69314253266221e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0446786128853136,0.0050410033875789,0.0347982462456589,0.0545589795249682,8.76829909511098e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NADK,NAD kinase,39868,0.0453124063404516,0.00511388004465602,0.0352892014529258,0.0553356112279774,8.77573463006817e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN2,Matrilin-2,39885,0.0252535643058906,0.00285187216942333,0.0196638948538209,0.0308432337579603,9.2234874275105e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_E,,39866,0.0232033520090623,0.00262210826393187,0.0180640198117559,0.0283426842063688,9.72836002284999e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL5,Insulin-like peptide INSL5,37382,0.0820218111673419,0.00929021146860381,0.0638129966888785,0.100230625645805,1.18626503137522e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0278149059463211,0.00316840285317564,-0.0340249755385454,-0.0216048363540969,1.84782608502653e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPB,Natriuretic peptides B,39585,-0.106479067124052,0.0121381202666406,-0.130269782846667,-0.0826883514014361,1.92766077523527e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0552130083228139,0.00629407109784723,0.0428766289710333,0.0675493876745944,1.96507565772025e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0399364863845054,0.00455819814147234,0.0310024180272196,0.0488705547417912,2.12279949011146e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0235383566814366,0.00268802218352203,-0.0288068801611398,-0.0182698332017334,2.20734327628274e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0394679636232551,0.00450892420783158,0.0306304721759052,0.0483054550706049,2.31459880338732e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100P,Protein S100-P,39585,0.0441562363033181,0.00505036398530596,0.0342575228921184,0.0540549497145177,2.49231168122983e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR2,Complement factor H-related protein 2,37364,0.0472573556390753,0.00540545155172498,0.0366626705976943,0.0578520406804563,2.54578473298929e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0421188688128128,0.00482091267910041,0.032669879961776,0.0515678576638496,2.687141795216e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0314629204163033,0.0036055747320589,0.0243959939414679,0.0385298468911388,2.88982290933116e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRZB,Secreted frizzled-related protein 3,39695,0.0219755627936758,0.00252701483778972,0.0170226137116079,0.0269285118757437,3.76215957860933e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,39817,0.0329757456197523,0.00379522823971269,0.0255370982699154,0.0404143929695892,4.01544670304508e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0304113099210789,0.00350028677632567,0.0235507478394806,0.0372718720026772,4.11075784413128e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM2,Junctional adhesion molecule B,40009,0.0208646763974901,0.00240340702300815,0.0161539986323941,0.025575354162586,4.28138393174117e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPMT,Thiopurine S-methyltransferase,39477,0.0604462409967396,0.00697760891122575,0.0467701275307372,0.0741223544627421,5.04412741216204e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2orf69,UPF0565 protein C2orf69,37039,0.0485354313557297,0.00560307617521337,0.0375534020523115,0.0595174606591479,5.15775208666979e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,39913,0.0194578934706946,0.00224866242828958,0.015050515111247,0.0238652718301421,5.48051270428539e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0254019691514731,0.00294184618457639,-0.0311679876732428,-0.0196359506297033,6.50978992669972e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX6,Syntaxin-6,39477,0.05625742069557,0.00654000082060951,0.0434390190871754,0.0690758223039647,8.56544488880519e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,37043,0.0663797461003318,0.00771647228114415,0.0512554604292893,0.0815040317713743,8.68593007417869e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIPF,Gastric triacylglycerol lipase,37043,0.0493902851652821,0.00574167902820269,0.0381365942700049,0.0606439760605594,8.70707500332328e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMS,Spermine synthase,36991,0.0528097630812012,0.00615029606995551,0.0407551827840884,0.064864343378314,9.96390631825604e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,36991,0.0630483944423946,0.00735414015247965,0.0486342797435345,0.0774625091412547,1.11834360604167e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,39846,0.0562785036287541,0.00657254408257162,0.0433963172269137,0.0691606900305945,1.20201379289177e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FEN1,Flap endonuclease 1,39477,0.051194583186539,0.00598107419916094,0.0394716777561835,0.0629174886168944,1.23859272420048e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL8,Interleukin-8,39750,0.0540824810590967,0.00633280610592074,0.041670181091492,0.0664947810267013,1.46169673768925e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCOF1,Treacle protein,37437,0.0249310535102184,0.00292088739847068,0.0192061142092159,0.030655992811221,1.54316633126278e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0501286197668979,0.00587425869305513,0.0386150727285098,0.0616421668052859,1.56756382610183e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0538097583093808,0.00631438102697899,0.0414335714965019,0.0661859451222596,1.70951552655177e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,37169,0.060492304298397,0.00709753191566759,0.0465811417436886,0.0744034668531055,1.72067836718619e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0518495296910361,0.0060910296531262,0.0399111115709087,0.0637879478111634,1.88585524694506e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SWAP70,Switch-associated protein 70,37382,0.0292774759056338,0.00344283872613064,0.0225295120024178,0.0360254398088499,2.02442891333067e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0486882236448329,0.00572872870272118,0.0374599153874994,0.0599165319021664,2.08264166207934e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0382724987068134,0.00451583524459065,0.0294214616274157,0.047123535786211,2.54742111519539e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK7,Kallikrein-7,36818,0.0317754236215055,0.00374846627387127,0.0244284297247178,0.0391224175182932,2.56079877735388e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH5,Cadherin-5,40052,-0.0247524504789949,0.00292196457944135,-0.0304795010546999,-0.0190253999032899,2.63568024206063e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0927738725951121,0.010953760768487,0.0713045014888775,0.114243243701347,2.7145699004155e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLU,Clusterin,37453,0.0258668816943535,0.00305590708388604,0.0198773038099368,0.0318564595787701,2.8324764108977e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0238472354522502,0.00282503247477828,0.0183101718016847,0.0293842991028156,3.46053067079166e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0739850654999545,0.0087832289891023,0.056769936681314,0.091200194318595,4.03124848131211e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP6,Gastrotropin,39564,0.0435363407765461,0.00518463653435107,0.033374453169218,0.0536982283838742,4.95972529279776e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0421948818518842,0.00502470015641426,0.0323464695453123,0.0520432941584562,5.01069828131211e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBS,Cystathionine beta-synthase,37043,0.0410500924711156,0.00489059934128275,0.0314645177622014,0.0506356671800298,5.18891939859991e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0520336385281716,0.00620475275629557,0.0398723231258323,0.0641949539305109,5.45022371750475e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,39489,0.0453532604242656,0.00540903892651922,0.0347515441282879,0.0559549767202433,5.51410455525222e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIT,Vitrin,37437,0.0295479950005578,0.0035277492787898,0.0226336064141298,0.0364623835869859,6.01488454992007e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,37124,0.033318868651743,0.0039852471885783,0.0255077841621295,0.0411299531413564,6.86036603499387e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GC,Vitamin D-binding protein,37453,0.020718075269105,0.00248030995953577,0.0158566677484149,0.0255794827897951,7.29358307371418e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD101,Immunoglobulin superfamily member 2,37382,0.0336854300074052,0.00404112699902282,0.0257648210893205,0.0416060389254899,8.44569578973512e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0452160454990012,0.00543456368964445,0.034564300667298,0.0558677903307043,9.50424965379013e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0360484248464154,0.0043346242971682,-0.0445442884688651,-0.0275525612239657,9.78869958936039e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0323800411026474,0.00389351044571078,-0.0400113215762406,-0.0247487606290543,9.79240146339052e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,37339,0.0384037674376936,0.00462598200233521,0.0293368427131166,0.0474706921622706,1.12282987413629e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0332879307796712,0.00401121622555039,0.0254259469775925,0.04114991458175,1.1355507143048e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP12,Macrophage metalloelastase,39900,0.0399326842664455,0.00481507365508614,0.0304951399024767,0.0493702286304143,1.18838920951155e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0308616870462443,0.00372133594041447,0.023567868603032,0.0381555054894567,1.19015151920409e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0518631120215701,0.00626100051690074,0.0395915510084447,0.0641346730346956,1.28874178147931e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR3,Small proline-rich protein 3,37388,0.0520127650318398,0.00628406765038067,0.0396959924370937,0.0643295376265859,1.38153429231435e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0260386892198392,0.003151640732379,-0.032215905055302,-0.0198614733843763,1.56498477849922e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL20,C-C motif chemokine 20,40058,0.0664496871115128,0.00807086539102412,0.0506307909451055,0.08226858327792,1.95912298063968e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB2,Plexin-B2,39984,0.018626824550551,0.00226321333510928,0.0141909264137368,0.0230627226873652,2.00966669564887e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0935023633533153,0.0113743452859717,0.0712086465928107,0.11579608011382,2.21065644175777e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK1D,Casein kinase I isoform delta,37056,0.0507778962046664,0.00620582391960303,0.0386144813222445,0.0629413110870883,3.03840237796839e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPK2,Death-associated protein kinase 2,37056,0.0416240819954856,0.00511069398501322,0.0316071217848597,0.0516410422061115,4.14854220176015e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PZP,Pregnancy zone protein,37453,0.0429393584041715,0.00528071600220401,0.0325891550398517,0.0532895617684914,4.61063848402966e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,36593,-0.0847045981686332,0.0104427422727339,-0.105172373023192,-0.0642368233140748,5.46309585516514e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRK1,Protein BRICK1,39489,0.0345755424408113,0.00426996537539908,0.0262064103050291,0.0429446745765934,6.02654837346361e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB6,Integrin beta-6,39587,0.0230074871907357,0.0028441944162524,0.017432866134881,0.0285821082465904,6.43660321922951e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMD,Osteomodulin,39931,-0.0336978759613549,0.00416961763715115,-0.0418703265301712,-0.0255254253925387,6.83405358143831e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGA,Glycoprotein hormones alpha chain,39858,0.0684583859396914,0.00848341319812131,0.0518308960713736,0.0850858758080091,7.54533109192427e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGA,Fibrinogen alpha chain,37149,0.0238478617293176,0.00295644028850822,0.0180532387638415,0.0296424846947938,7.85668618149345e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS1,Nephrin,37056,0.0264963499064002,0.00328747977835272,0.0200528895408289,0.0329398102719715,8.29763884658911e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP3,Stromelysin-1,39858,-0.0365849108781508,0.00457164467920788,-0.0455453344493983,-0.0276244873069034,1.30148643061824e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPG,Macrophage-capping protein,39739,0.0444995330664364,0.00556535537947748,0.0335914365226606,0.0554076296102123,1.37529601169575e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGF,Hepatoma-derived growth factor,40014,0.0717125293955858,0.0089974753404874,0.0540774777282305,0.0893475810629411,1.68799052177285e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL1,Fc receptor-like protein 1,39868,0.0333935542036708,0.00420706090997641,0.0251477148201171,0.0416393935872246,2.19879947133584e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0371442734159793,0.00468099850809246,0.0279695163401181,0.0463190304918405,2.24128898747083e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF7,SLAM family member 7,39866,-0.0437647365638084,0.00552864067695059,-0.0546008722906316,-0.0329286008369853,2.61245629377435e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0424101104558361,0.00535706870337545,0.0319102557972202,0.052909965114452,2.63203116724095e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP8,Caspase-8,39984,0.0467769201755239,0.00591181048275693,0.0351897716293204,0.0583640687217275,2.68654059645831e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,37388,0.0166431703222971,0.00210303780160783,0.0125212162311458,0.0207651244134485,2.68820015539214e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0221101542749049,0.00279812435005399,0.016625830548799,0.0275944780010107,2.92871848931238e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A13,Protein S100-A13,37056,0.0263540276772595,0.00333642575145037,0.0198146332044168,0.0328934221501022,3.03598990849358e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0418657433895324,0.00530081986144615,0.0314761364610979,0.0522553503179668,3.05440722085102e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVALB,Parvalbumin alpha,39971,0.0862164247049817,0.0109428286323211,0.0647684805856324,0.107664368824331,3.51506921912306e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRN,Progranulin,39787,0.0185920084229284,0.00236894659806755,0.013948873090716,0.0232351437551408,4.48675233073222e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDA,Cytidine deaminase,37422,0.0349408266870219,0.0044517738712871,0.0262153498992991,0.0436663034747446,4.51598821054486e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP9,Caspase-9,37056,0.0477110339562864,0.00607979479019401,0.0357946361675062,0.0596274317450667,4.5707460365874e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0553140713585504,0.00707168979931281,0.0414535593518973,0.0691745833652035,5.53399209997547e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0379847670431162,0.00486774637737505,0.0284439841434611,0.0475255499427713,6.39776008739195e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPL14,60S ribosomal protein L14,37043,0.0302982619440273,0.00388238610613478,0.0226887851760032,0.0379077387120515,6.4463309467283e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0318809845581715,0.00409270374696566,0.0238592852141188,0.0399026839022242,7.21680955917894e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR2,TGF-beta receptor type-2,39913,0.0221911393421329,0.00285725703202104,0.0165909155593717,0.0277913631248942,8.54758164341633e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0298932598690403,0.00385620472186107,0.0223350986141926,0.037451421123888,9.70969672213219e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.024686058688859,0.00318688335397223,-0.0309323500626446,-0.0184397673150735,1.00480087414828e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0349879239264978,0.00451854058578241,0.0261315843783643,0.0438442634746314,1.02875374666583e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPR,Nucleoprotein TPR,37021,0.0349922305853151,0.00451953248328991,0.0261339469180669,0.0438505142525633,1.04626645800734e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ULBP2,UL16-binding protein 2,39749,0.027103321112056,0.00350293241874484,0.0202375735713162,0.0339690686527959,1.07606948482299e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,39788,0.0540681677830029,0.00699292192075766,0.0403620408183179,0.067774294747688,1.12310233891356e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0181669599526375,0.00235079274703795,-0.0227745137368319,-0.0135594061684431,1.17070353891054e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0296566904764912,0.00384671815584471,0.0221171228910355,0.0371962580619468,1.33593429403981e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0317878248780361,0.00412546002216915,-0.0398737265214876,-0.0237019232345845,1.38149532678257e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX5,Sorting nexin-5,37043,0.0225091392552574,0.00292302464005908,0.0167800109607416,0.0282382675497732,1.45024597736927e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRH,Corticoliberin,39455,0.0641548574243839,0.00834241346854255,0.0478037270260405,0.0805059878227272,1.55642835061947e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD59,CD59 glycoprotein,39173,0.0155712641625597,0.00202593768017326,0.0116004263094201,0.0195421020156993,1.61048035543657e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD276,CD276 antigen,39862,-0.025842246007752,0.00337442102119786,-0.0324561112092998,-0.0192283808062042,1.99185434032128e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASET2,Ribonuclease T2,39974,0.0186694409803201,0.00244187380021974,0.0138833683318894,0.0234555136287508,2.19766403639632e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LXN,Latexin,39682,-0.0490224402645518,0.00641285062066183,-0.061591627481049,-0.0364532530480546,2.21924141454603e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN2,Calsyntenin-2,40058,-0.0287036787996042,0.00377577943613011,-0.0361042064944192,-0.0213031511047892,3.0739067712113e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS22,Brain-specific serine protease 4,37056,0.0245538827467742,0.00322953563990737,0.0182239928925558,0.0308837726009927,3.09068687717671e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN3,CCN family member 3,40042,0.0235895187919488,0.00310333870184071,0.017506974936341,0.0296720626475566,3.09112225875379e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN4B,Sodium channel subunit beta-4,37043,0.0302316121645836,0.00397674188847898,0.0224371980631648,0.0380260262660024,3.11018044157999e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,37388,0.0259604391877506,0.00343037280656035,0.0192369084868923,0.0326839698886089,4.04038776846984e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,37043,0.0378560854903214,0.00502037981917228,0.0280161410447437,0.047696029935899,4.98817948056516e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,39866,-0.0378697629761868,0.0050240659956886,-0.0477169323277365,-0.0280225936246372,5.04001095243217e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G15,Phospholipase A2 group XV,39913,0.0191239136144467,0.0025374301439592,0.0141505505322867,0.0240972766966068,5.07583350431207e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0230458310844694,0.00305932367245215,0.0170495566864632,0.0290421054824757,5.22694158182887e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0300607220205749,0.0040146026849645,0.0221921007580445,0.0379293432831054,7.37552513056882e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP2,Retinol-binding protein 2,39788,-0.0547656837942162,0.00732609135465686,-0.0691248228493436,-0.0404065447390887,8.09487417402522e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA14,Carbonic anhydrase 14,40030,-0.0251262833783591,0.00336596829732459,-0.0317235812411153,-0.0185289855156029,8.76681682717426e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APRT,Adenine phosphoribosyltransferase,39738,0.0343202173434236,0.00461610182412595,0.0252726577681367,0.0433677769187105,1.09988911197149e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0313240182975267,0.00421463409058509,0.0230633354799799,0.0395847011150735,1.12195794655666e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK3,Dickkopf-related protein 3,40052,-0.0204515661925417,0.00275403920615818,-0.0258494830366118,-0.0150536493484717,1.1747447054141e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0401895186740212,0.00541130455262392,0.0295833617508784,0.0507956755971641,1.17962952708445e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0225787280937033,0.00304136187106765,0.0166176588264107,0.0285397973609959,1.19491399650044e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAM,Signal transducing adapter molecule 1,37368,0.0258907263565322,0.00349371705581485,0.0190430409271351,0.0327384117859293,1.33140861932875e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0232168247771423,0.00314183823177266,0.0170588218428679,0.0293748277114167,1.5616378413332e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD2,Sushi domain-containing protein 2,39858,-0.0199546573491182,0.00270292554178048,-0.0252523914110079,-0.0146569232872284,1.62843208239064e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFAP1,Actin filament-associated protein 1,37124,0.0601580714434489,0.00815032982501717,0.0441834249864153,0.0761327179004826,1.66382308340571e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0499376567745237,0.00677243899910057,0.0366636763362866,0.0632116372127609,1.7418769089203e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,37169,0.050257908130827,0.00682752449693176,0.0368759601168408,0.0636398561448133,1.93141802077733e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH1,Cadherin-1,39315,0.0283940680499527,0.00386407180735473,0.0208204873075374,0.035967648792368,2.10897929268597e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,39788,0.015826732891018,0.00215429574546831,0.0116043132299002,0.0200491525521359,2.13171106955222e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEK,Angiopoietin-1 receptor,39913,0.0152629120268493,0.00207774564935106,0.0111905305541212,0.0193352934995774,2.14195140234343e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0592432539946042,0.00806915259362041,0.0434277149111082,0.0750587930781002,2.2088469498232e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD93,Complement component C1q receptor,39238,-0.0216462071140838,0.00295095292537386,-0.0274300748478165,-0.015862339380351,2.32215112836056e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST5,Cystatin-D,39559,0.0381860577623347,0.00520589559476387,0.0279825023965975,0.0483896131280719,2.32280895113883e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,37021,0.0843825803320974,0.0115052367357655,0.061832316329997,0.106932844334198,2.35960951658875e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFC1,Cryptic protein,39477,0.0328325204910042,0.00447872563704203,0.0240542182424018,0.0416108227396066,2.40039976730815e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0261582616776548,0.00357082119820006,0.0191594521291827,0.0331570712261269,2.5172810282935e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXN,Thioredoxin,37289,0.0303546838355622,0.00414409731800813,0.0222322530922663,0.0384771145788581,2.52890352370396e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0284416415131341,0.00389085419101798,0.0208155672987388,0.0360677157275293,2.80259465727952e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD248,Endosialin,37437,-0.0278062843899201,0.00380684245864214,-0.0352676956088587,-0.0203448731709815,2.94263705877193e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL1,Chordin-like protein 1,39908,0.021420173695387,0.00294015431359085,0.0156574712407489,0.027182876150025,3.35645101628413e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOF,Apolipoprotein F,37445,-0.0180955843364066,0.00248473705173492,-0.0229656689578071,-0.0132254997150062,3.45219245390199e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0421435745805291,0.0058037973698908,0.0307681317355431,0.0535190174255151,4.04628058447891e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0282795866128941,0.00389746653115169,0.0206405522118368,0.0359186210139514,4.20799764327909e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRSF1,G-rich sequence factor 1,36874,0.05628280593009,0.0077615075444301,0.041070251143007,0.071495360717173,4.3537846903735e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,37124,0.0176194171363168,0.00243400806864215,0.0128487613217782,0.0223900729508554,4.77411522989233e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0165180852680406,0.00228333792374273,-0.0209934275985764,-0.0120427429375049,4.89490540097648e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,37368,0.0201585700972926,0.00278852416586627,0.0146930627321947,0.0256240774623905,5.12258778043549e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.029046855228002,0.00402195068402277,0.0211638318873174,0.0369298785686867,5.39382478420572e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0384814847493149,0.00534552322267766,0.0280042592328666,0.0489587102657631,6.34028569839864e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,37021,0.0252853185903063,0.00351352412488151,0.0183988113055385,0.0321718258750741,6.50921238138704e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CX3CL1,Fractalkine,39749,-0.0228324995019013,0.00318315139692945,-0.029071476239883,-0.0165935227639196,7.66514333732075e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0533248291933689,0.00746179957077936,-0.0679499563520965,-0.0386997020346414,9.29412749876276e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYGD,Gamma-crystallin D,37388,0.0660206287968038,0.00924494235726721,0.0479005417765601,0.0841407158170475,9.71950285641717e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN5,CCN family member 5,39858,0.0263306739129065,0.00369182302305986,0.0190947007877091,0.0335666470381038,1.03035968430297e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0390821363840136,0.00548166855162019,0.028338066022838,0.0498262067451891,1.05067144269627e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0378470468734231,0.00531559610505045,0.0274284785075242,0.048265615239322,1.13375177147493e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX2,Sorting nexin-2,37368,0.0550485057001714,0.00773653201489388,0.0398849029509794,0.0702121084493634,1.17214996990629e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP8,GTPase IMAP family member 8,36962,0.033768477136937,0.00475810140279389,0.0244425983874609,0.043094355886413,1.34008575644574e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECE1,Endothelin-converting enzyme 1,39489,0.0238109052000787,0.003355662824212,0.0172338060646232,0.0303880043355342,1.34189494327348e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17D,Interleukin-17D,39587,0.0230561631672666,0.00324961037058256,0.0166869268409248,0.0294253994936084,1.34817121829684e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1A,Protein phosphatase 1A,39477,0.020699105416695,0.00293018830824927,0.0149559363325264,0.0264422745008635,1.68502305911368e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLC,Galectin-10,39841,-0.0450720065317933,0.00638529642328213,-0.0575871875214262,-0.0325568255421603,1.74956121477888e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0346186724978943,0.00491660124640592,0.0249821340549387,0.0442552109408499,1.98564342297918e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0214464537254141,0.00304999592687241,0.0154684617087442,0.027424445742084,2.12372369776467e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0152948826067147,0.00217594859107391,0.0110300233682099,0.0195597418452196,2.16219106444557e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR4,Complement factor H-related protein 4,37409,0.0485570401674822,0.00690854416961066,0.0350162935950453,0.0620977867399191,2.1867491013693e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGFAC,Hepatocyte growth factor activator,37318,0.0190787836318541,0.00271695115342206,0.0137535593711469,0.0244040078925614,2.28997085363301e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBI3_IL27,Interleukin-27,40011,-0.0207061721623896,0.00295204781923549,-0.0264921858880912,-0.014920158436688,2.40489152404144e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIT,Citron Rho-interacting kinase,37039,0.030489798147596,0.00434749397048543,0.0219687099654445,0.0390108863297474,2.44307827376395e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0229679160966973,0.0032756216756358,-0.0293881345809434,-0.0165476976124511,2.46441565403424e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBP,Lipopolysaccharide-binding protein,39931,-0.0389040040962994,0.00555182929305469,-0.0497855895106866,-0.0280224186819122,2.52391619356062e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI2,Serpin I2,37382,0.0384642774415072,0.00549520568740081,0.0276936742942016,0.0492348805888128,2.68783378765869e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0315290892302311,0.00450765579121905,0.0226940838794418,0.0403640945810205,2.76901101154292e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,39477,0.04026096981078,0.00576784164398708,0.0289560001885653,0.0515659394329947,3.06520032466134e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,39867,-0.0636083522747709,0.0091213501242184,-0.081486198518239,-0.0457305060313029,3.21087853273401e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPB2,Coatomer subunit beta',37021,0.0286403715870185,0.00410643903270981,0.0205917510829073,0.0366889920911297,3.21617422587738e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGCR6,Protein DGCR6,36991,0.0289750891095093,0.00415852968564135,0.0208243709256523,0.0371258072933664,3.37701501331621e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.035754889064495,0.00513367782561619,0.0256928805262873,0.0458168976027027,3.44155495553234e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0243865860389815,0.00351188991492018,0.0175032818057379,0.031269890272225,3.98554579121581e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0657594063360106,0.00947133418710734,0.0471955913292802,0.084323221342741,4.01887123573526e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0538952808940193,0.00776667629952429,0.0386725953469516,0.0691179664410869,4.09548492463659e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0229994849184379,0.00331852483552246,0.0164951762408138,0.0295037935960619,4.35000718726917e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,39587,0.0239126796309841,0.00345262822854322,0.0171455283030394,0.0306798309589288,4.49884484476775e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SBSN,Suprabasin,37420,-0.022556934192181,0.00326028087509376,-0.0289470847073648,-0.0161667836769972,4.76229236771478e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK3,NT-3 growth factor receptor,40009,-0.014122930796833,0.00204527338703095,-0.0181316666354137,-0.0101141949582524,5.20172382783354e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0168273364298765,0.00244967996180264,0.0120259637047433,0.0216287091550097,6.69413740215678e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA1,Ephrin-A1,39826,0.0173185532302506,0.00252833091704811,0.0123630246328363,0.0222740818276649,7.66548762701095e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,37357,0.023789561203165,0.00347334661177372,0.0169818018440886,0.0305973205622415,7.74927612273739e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0290607936621257,0.00424698057924195,0.0207367117268115,0.0373848755974399,8.11564129841783e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAM,Integrin alpha-M,39858,-0.0206834012210352,0.0030259663191253,-0.0266142952065208,-0.0147525072355496,8.47873860647379e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA11,Integrin alpha-11,39866,-0.0222351421611532,0.00325959099063227,-0.0286239405027924,-0.0158463438195139,9.33532949068192e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,39868,0.040959913118442,0.00600557626237324,0.0291889836441904,0.0527308425926935,9.4093282530439e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.018293242875394,0.00268630436753084,0.0130280863150336,0.0235583994357544,1.01957732384989e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.029776286858654,0.00437742921387804,0.0211965255994531,0.038356048117855,1.07450970578997e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0371737671096719,0.00546656960396533,0.0264592906858998,0.0478882435334439,1.08236919768056e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0199665321536245,0.00293657754090827,-0.0257222241338047,-0.0142108401734443,1.08949072476565e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB8,Serpin B8,40058,0.0358934230707041,0.00527928884237422,0.0255460169396506,0.0462408292017576,1.09093192067322e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSG,Basigin,40040,0.0126621722987191,0.00186461098554214,0.00900753476705652,0.0163168098303817,1.1540580401123e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALCAM,CD166 antigen,40052,0.0126347476269011,0.00186129247204899,0.00898661438168512,0.0162828808721172,1.1751715491865e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAX,Apoptosis regulator BAX,39456,0.0596218337708575,0.00878487684955211,0.0424034751457354,0.0768401923959796,1.18720517589111e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL3,Insulin-like 3,37388,0.0472169006894352,0.00695820725109941,0.0335788144772804,0.0608549869015901,1.20262177380127e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MILR1,Allergin-1,39587,-0.0322192547481024,0.00474878524693619,-0.0415268738320973,-0.0229116356641075,1.20449422205014e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA12,Serpin A12,39405,0.0768016479181103,0.0113298470014659,0.0545951477952371,0.0990081480409835,1.25624582156975e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYZL2,Lysozyme-like protein 2,36962,0.0234499376313148,0.0034615278186764,0.016665343106709,0.0302345321559205,1.30216985779846e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHPS,Deoxyhypusine synthase,37368,0.0266064062814619,0.00393318327955083,0.0188973670535423,0.0343154455093816,1.39182393547027e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM3,Myomesin-3,37124,-0.0607187387427893,0.00899909354888465,-0.0783569620986032,-0.0430805153869754,1.56975332387414e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.016148769382384,0.00239564802284471,0.0114532992576084,0.0208442395071596,1.6278948188007e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0503584430441822,0.00747160455437521,0.0357140981176068,0.0650027879707576,1.6500006517516e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPQ,Carboxypeptidase Q,37430,0.0242786955686452,0.00362498760912852,0.0171737198547533,0.0313836712825371,2.20222539409225e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0217351847163913,0.00324615600913009,0.0153727189384963,0.0280976504942863,2.23171907811112e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0243351392563619,0.00363548338488207,0.017209591821993,0.0314606866907307,2.26029656308186e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEL1L,Protein sel-1 homolog 1,37043,0.0201241463408738,0.00300705046105266,0.0142303274372106,0.026017965244537,2.28539237668736e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0333360767645834,0.00499554332097238,-0.0431273416736892,-0.0235448118554775,2.58567652582689e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0142769693435879,0.00214061916431686,0.0100813557815268,0.0184725829056489,2.665181496787e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0302624210849997,0.00454517422386238,0.0213538796062295,0.03917096256377,2.86556128366437e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,37437,0.020301733670611,0.00305007570599363,0.0143235852868635,0.0262798820543585,2.9190455102746e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LF,CMRF35-like molecule 1,40030,0.0381014165288244,0.00572653844940588,0.0268774011679888,0.0493254318896599,2.9542907884679e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,39585,0.0336638318953541,0.00507000715727686,0.0237266178670915,0.0436010459236168,3.24398270675189e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0658097686357204,0.00992114899011516,0.0463643166150947,0.0852552206563461,3.40791789201103e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1B,Interleukin-1 beta,39478,0.0354858289817105,0.00535096107173854,0.0249979452811029,0.045973712682318,3.42794836272732e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,37382,0.0322024080520628,0.00485583757024076,0.0226849664143909,0.0417198496897347,3.44474708957534e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0158570496706036,0.00239444385699168,0.0111639397108999,0.0205501596303073,3.66678649434717e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA,Lymphotoxin-alpha,39866,0.025011916135368,0.0037851945422434,0.0175929348325709,0.032430897438165,4.02306786041944e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDM1,Nuclear protein MDM1,37039,0.0198251172139284,0.00300224285833083,0.0139407212116,0.0257095132162568,4.17140524056243e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX1,Heme oxygenase 1,39691,-0.0300745474082742,0.00457137450022386,-0.039034441428713,-0.0211146533878355,4.88854547499685e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0206684604371912,0.00315321951204587,0.0144881501935813,0.0268487706808012,5.7451357761392e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0741186204175213,0.0113199584102225,0.0519315019334853,0.0963057389015573,6.02684790701724e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0300129899532821,0.0045847025139755,0.0210269730258901,0.0389990068806741,6.07610952132566e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C8B,Complement component C8 beta chain,37453,0.0190610894277058,0.0029115749619888,0.0133544025022078,0.0247677763532038,6.09506944330835e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0238896140398886,0.00364941678075938,0.0167367571496002,0.031042470930177,6.12058520255345e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA4,Carbonic anhydrase 4,40052,-0.0146947541381123,0.00224627939620651,-0.0190974617546771,-0.0102920465215476,6.25965656037863e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH1,Protocadherin-1,40018,0.0130369449613454,0.00199422749780849,0.00912825906564072,0.01694563085705,6.44981768524093e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAA4,Serum amyloid A-4 protein,37453,0.020654512981048,0.00316896260455522,0.0144433462761197,0.0268656796859762,7.38862460726958e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFIC,Nuclear factor 1 C-type,37411,0.0261814721075753,0.00402602778712059,0.018290457644819,0.0340724865703317,8.14661971797677e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO3,R-spondin-3,40030,0.0167804108764255,0.00258479747846067,0.0117142078186426,0.0218466139342084,8.71918860520945e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH1,Neurexophilin-1,39489,0.0233788320311977,0.00360389076782515,0.0163152061262604,0.030442457936135,9.01284924025306e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0375636332049139,0.00579417499590699,0.0262070502129362,0.0489202161968916,9.31214486218742e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0338344870854574,0.00521908593772476,0.0236050786475168,0.0440638955233979,9.32205496618483e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,37124,0.032844458587671,0.00507009780293546,0.0229070668939175,0.0427818502814245,9.61810538855572e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,39617,0.0181578366908134,0.00280575043841312,0.0126585658315236,0.0236571075501031,9.9799933037576e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0189188159630756,0.00292478690796314,-0.0246513983026834,-0.0131862336234679,1.02536095385533e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0149219081836679,0.00230841301626464,0.0103974186717892,0.0194463976955466,1.04843107704994e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0384107125393497,0.00594215866764481,0.0267640815507659,0.0500573435279335,1.0539830094456e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENSA,Alpha-endosulfine,37368,0.0325941795648138,0.00504394459642171,0.0227080481558273,0.0424803109738003,1.06843833510608e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0175738939797368,0.00272135157587409,-0.02290774306845,-0.0122400448910236,1.09319523449629e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSR,Insulin receptor,37056,0.0103158110484307,0.00159848807556445,0.00718277442032433,0.013448847676537,1.13130507806538e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A14,Protein S100-A14,37411,0.0315710237101717,0.00490290199701466,0.021961335796023,0.0411807116243205,1.24112141149047e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,37388,0.147664261367536,0.0229495751712551,0.102683094031876,0.192645428703197,1.28228061859186e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITM2A,Integral membrane protein 2A,39866,-0.0364123176114904,0.00566727377881534,-0.0475201742179684,-0.0253044610050123,1.35579987576716e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0335418799120308,0.00523539262594895,0.0232805103651709,0.0438032494588908,1.5281997329942e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSC2,Desmocollin-2,39673,-0.0204309741403264,0.00319500649640969,-0.0266931868732894,-0.0141687614073634,1.65421225148148e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.00959298309726768,0.00150295351376814,0.00664719421028212,0.0125387719842532,1.78659818854231e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0351988411621533,0.00552333777647089,0.0243730991202703,0.0460245832040362,1.90771659083006e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A12,Protein S100-A12,39615,0.0456226241691,0.00716907045572196,0.031571246075885,0.059674002262315,2.02242527624937e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,37021,0.0279134254544684,0.00439262960596503,0.019303871426777,0.0365229794821599,2.1585022772874e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0213930701292539,0.0033716275959385,0.0147846800412144,0.0280014602172934,2.2967142300939e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MST1,Hepatocyte growth factor-like protein,37271,0.0383900567718797,0.00606017516504634,0.0265121134483889,0.0502680000953705,2.45223918981209e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEPD,Xaa-Pro dipeptidase,37445,0.0156168820989548,0.00246733106300311,0.0107809132154687,0.0204528509824409,2.53744317516045e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0223688289159798,0.00353857575985912,0.0154332204266559,0.0293044374053037,2.66153398985803e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,39364,0.0607728147456729,0.00961948779590405,0.041918618665701,0.0796270108256449,2.72768485957746e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0162766748470987,0.00257890856382882,0.0112220140619942,0.0213313356322032,2.83661308210561e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0153581782058573,0.00243496772723329,0.01058564146048,0.0201307149512345,2.91336546623017e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA7,Thyroxine-binding globulin,37453,0.011189990662564,0.00178132870889637,0.00769858639312706,0.0146813949320008,3.44824176020324e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0244454937725181,0.00389563754438586,0.0168100441855218,0.0320809433595144,3.58635199863892e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCOR1,REST corepressor 1,39585,0.0269336266574661,0.00431414801357039,0.0184778965508681,0.035389356764064,4.40010315437028e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0582582990019182,0.00934376669619306,0.0399445162773798,0.0765720817264566,4.63152079895854e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CILP,Cartilage intermediate layer protein 1,37437,0.032168561682738,0.00516307795159758,0.0220489288976068,0.0422881944678693,4.78678450910032e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD14,Monocyte differentiation antigen CD14,39564,0.0244921861723017,0.00393573787157866,0.0167781399440075,0.0322062324005959,5.0003892901814e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0365213369487868,0.00587955004132584,0.0249974188677882,0.0480452550297855,5.39957790158592e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA12,Carbonic anhydrase 12,39788,-0.0189689084212465,0.0030561991719564,-0.024959058798281,-0.0129787580442119,5.5448364628477e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYT1,Synaptotagmin-1,37388,0.0220303337474628,0.0035553783863584,0.0150617921102003,0.0289988753847253,5.94674407351389e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0193011732282491,0.00311687424817252,0.013192099701831,0.0254102467546673,6.09849256996405e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTL1,Cytokine-like protein 1,37437,0.0136044430109447,0.00219742557344739,0.00929748888698784,0.0179113971349016,6.14734571990118e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE6,Ribonuclease K6,37386,0.0164188066443878,0.00265290504103012,0.0112191127639687,0.0216185005248068,6.22987004911171e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0179808276317224,0.00290851776036207,0.0122801328214127,0.023681522442032,6.48142607989575e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0298913813986302,0.0048467039872272,0.0203918415836649,0.0393909212135955,7.14678621216939e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK4,Kallikrein-4,40030,-0.0355852871576329,0.00577204717847597,-0.0468984996274458,-0.02427207468782,7.21076615691128e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO1,Roundabout homolog 1,39885,0.0139537350870351,0.00226497049582543,0.00951439291521725,0.0183930772588529,7.41683421180201e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0360694700104493,0.00585786854399782,0.0245880476642136,0.0475508923566851,7.60776461190552e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL1,Follistatin-related protein 1,37043,-0.0135378468803841,0.00220134233834058,-0.0178524778635316,-0.00922321589723656,7.98155295907649e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNC,Tenascin,39931,-0.027716150955768,0.00451285927186683,-0.0365613551286269,-0.018870946782909,8.36195655254841e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB2,Lamin-B2,37388,0.0161160077823647,0.00262635359523983,0.0109683547356946,0.0212636608290347,8.68408401762602e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL5,Fc receptor-like protein 5,39858,-0.0328507240535496,0.00536255849910973,-0.0433613387118046,-0.0223401093952945,9.22580390974195e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0412427907222004,0.00674009262633565,0.0280322091745825,0.0544533722698182,9.68175193385327e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0370958564327162,0.00607187635023051,0.0251949787862644,0.048996734079168,1.02288895266999e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY75,Lymphocyte antigen 75,39866,0.022544508567698,0.00370563485864215,0.0152814642447594,0.0298075528906366,1.20004725555733e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300A,CMRF35-like molecule 8,37124,0.0169120006342969,0.0027801061292348,0.0114629926209967,0.0223610086475971,1.21032318676264e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFD,Vascular endothelial growth factor D,40024,-0.0207114068894929,0.00340678599967909,-0.0273887074488639,-0.0140341063301219,1.23300777099081e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0156771732174733,0.00258020413327298,-0.0207343733186883,-0.0106199731162583,1.26585403625713e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,39489,0.0338229013891144,0.0055688872502927,0.0229078823785407,0.0447379203996881,1.28012804238859e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOB,Apolipoprotein B-100,37445,0.0132147073288217,0.00217590561843933,0.00894993231668059,0.0174794823409628,1.28732446078269e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSC,Dipeptidyl peptidase 1,39856,0.024924339124487,0.00410456673767304,0.0168793883186478,0.0329692899303261,1.28906745022777e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0223639575006041,0.0036894335268676,0.0151326677879436,0.0295952472132646,1.38428957240921e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0198177984503676,0.00327339217752133,0.0134019497824258,0.0262336471183094,1.44830637401684e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0187821232936902,0.00311111856014005,0.0126843309158157,0.0248799156715647,1.61003330406316e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LUZP2,Leucine zipper protein 2,37368,0.0253334317390629,0.00419655017165099,0.0171081934026269,0.0335586700754988,1.61391606390187e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD1,Polycystin-1,37437,0.0151778459353633,0.00251606383908933,0.0102463608107482,0.0201093310599784,1.6576508884147e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANPEP,Aminopeptidase N,39891,0.0161412014564086,0.00267803900069679,0.0108922450150428,0.0213901578977743,1.70429662893383e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0230554579864881,0.00383705147763746,0.0155348370903187,0.0305760788826575,1.92030562910655e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA2,Carbonic anhydrase 2,39821,0.0389851594159394,0.00651609852287621,0.026213606311102,0.0517567125207768,2.23885342867954e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0243743502172581,0.00407830848791152,0.0163808655809516,0.0323678348535647,2.33743119917625e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0230006035140005,0.00384943211119741,0.0154557165760536,0.0305454904519474,2.34876682130544e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0204793901237603,0.00343977707062739,0.0137374270653306,0.0272213531821899,2.67730400843537e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA7,Carbonic anhydrase 7,37169,-0.0192225987963242,0.00323289583456646,-0.0255590746320745,-0.0128861229605739,2.81765554294067e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,40052,-0.0144298536754244,0.00242944973387669,-0.0191915751538227,-0.00966813219702609,2.91644619898801e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPE,Carboxypeptidase E,39906,-0.0219539039551592,0.0037021919313264,-0.029210200140559,-0.0146976077697595,3.09201022602146e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0200154627741009,0.00338067723400211,0.0133893353954567,0.026641590152745,3.27597029620362e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0252146229614095,0.00426061802749628,0.0168638116275167,0.0335654342953022,3.336406721583e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST1,Cystatin-SN,35640,0.0572524136810972,0.00969462595839071,0.0382509468026514,0.076253880559543,3.61100625111605e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHCY,Adenosylhomocysteinase,39868,0.0383810939738023,0.00650125211063994,0.025638639836948,0.0511235481106566,3.6274288662106e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL34,Interleukin-34,39456,0.0202244130786418,0.00343381634229225,0.013494133047749,0.0269546931095346,3.9467052695349e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB37,Ras-related protein Rab-37,39587,0.0468268007607149,0.00799857415284176,0.031149595421145,0.0625040061002847,4.88289424830268e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",39862,0.0526107503496509,0.00898696171255536,0.0349963053930424,0.0702251953062594,4.88927041905855e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0303615881116744,0.00518746354592588,0.0201941595616597,0.0405290166616891,4.94290721385036e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0315420780880862,0.0053952120917006,0.020967462388353,0.0421166937878193,5.14516541233019e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0241513822462519,0.00413348022222856,0.0160497610106839,0.0322530034818198,5.23235397008713e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0136725781455605,0.00234334767764145,-0.0182655395937378,-0.0090796166973833,5.493737004976e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,40052,-0.0138256019716654,0.00237492818744076,-0.0184804612190493,-0.00917074272428148,5.94314739822661e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP2,Neuropilin-2,39858,-0.015926423808997,0.00273766417020151,-0.021292245582592,-0.0105606020354021,6.08667442009977e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSH,Pro-cathepsin H,39546,0.0403682954284575,0.00694194587548517,0.0267620815125065,0.0539745093444084,6.17663395732819e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CABP2,Calcium-binding protein 2,37039,0.0367137399307566,0.00631537853470629,0.0243355980027323,0.0490918818587809,6.26390469267101e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS2,Growth arrest-specific protein 2,37169,0.0295477985807714,0.00508521147359355,0.019580784092528,0.0395148130690147,6.36987236838712e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGA4,Pepsin A-4,37445,0.0346497945482999,0.00597394890895246,0.0229408546867531,0.0463587344098467,6.77307700325233e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300E,CMRF35-like molecule 2,39991,0.0213832502651896,0.00368986702470059,0.0141511108967764,0.0286153896336027,6.95427869735353e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICOSLG,ICOS ligand,39788,0.0104643190036982,0.00180887886662,0.00691891642512302,0.0140097215822734,7.38839944582845e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSHB,Thyrotropin subunit beta,39868,0.0415087300941677,0.00718284755030938,0.0274303488955614,0.0555871112927741,7.66030419965944e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",37437,0.027185882783042,0.00471134223325661,0.0179516520058591,0.036420113560225,8.08550785719623e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0155819007902846,0.00270162634923432,-0.0208770884347839,-0.0102867131457853,8.19030868410048e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,37043,0.0133787395327389,0.0023246287207706,0.00882246724002849,0.0179350118254492,8.84569296152556e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAD,Chondroadherin,37124,0.0278843571174827,0.00484577429982639,0.018386639489823,0.0373820747451424,8.88900673793195e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCF2,Neutrophil cytosol factor 2,39843,0.0457970196788786,0.00796213594749151,0.0301912332217952,0.0614028061359619,8.98854654374989e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0198812860343581,0.00345817818924656,-0.0266593152852814,-0.0131032567834348,9.13864738274615e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0188961665962054,0.00329355613626491,0.0124407965691261,0.0253515366232846,9.79076820633558e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS53,Serine protease 53,37388,0.0205095300323964,0.0035819534610069,0.0134889012488228,0.0275301588159699,1.05138303262911e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAN,Aggrecan core protein,39730,0.0154701731439505,0.00270216691789922,0.0101739259848681,0.020766420303033,1.05242520683332e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT2,Angiopoietin-2,40030,-0.0208574821559932,0.00365520837108253,-0.0280216905633149,-0.0136932737486714,1.17524731911871e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN3,Matrilin-3,39720,-0.0171514238584103,0.0030069692002398,-0.0230450834908803,-0.0112577642259403,1.19191219989293e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,37368,0.0326397026914955,0.00573229728100758,0.0214044000207206,0.0438750053622703,1.26680654407116e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB1,Calbindin,39788,0.0228006214443675,0.00402097423638511,0.0149195119410527,0.0306817309476823,1.44917490235961e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.011261664768206,0.00198696781161872,0.00736720785743332,0.0151561216789787,1.47178434834118e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR15L,Protein GPR15L,37382,0.033398181134179,0.00589530728180838,0.0218433788618346,0.0449529834065235,1.49834667251107e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,39868,0.00952924137958698,0.00168619968933589,0.00622428998848864,0.0128341927706853,1.61939883595197e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRL,Prolactin,40009,-0.0410023704060828,0.0072767468254003,-0.0552647941838674,-0.0267399466282982,1.78278537416462e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,39456,0.0276387573658545,0.00491503408549119,0.0180052905582917,0.0372722241734172,1.9054664913934e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0204275999316093,0.00363741955593872,0.0132982576019694,0.0275569422612492,1.99432879237172e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB4,Ephrin type-B receptor 4,40052,-0.0126479675225467,0.00225393280227507,-0.0170656758150058,-0.00823025923008751,2.03853748083856e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0417859962543088,0.00744585940507306,0.0271921118203656,0.056379880688252,2.04060833891789e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.026425550376375,0.00471055553308305,-0.0356582392212178,-0.0171928615315322,2.05834411301187e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL2,Fc receptor-like protein 2,39990,0.0249007871528646,0.00443927506311549,0.0161998080291583,0.033601766276571,2.06599815490976e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA4,Apolipoprotein A-IV,37453,0.0190681109054073,0.0034004896122961,0.0124031512653069,0.0257330705455076,2.09317351078885e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YAP1,Transcriptional coactivator YAP1,37388,0.0136979272867671,0.00244975488034794,0.00889640772128516,0.0184994468522491,2.29408642077553e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP9,Fatty acid-binding protein 9,39866,0.0296310891823934,0.00530504418597865,0.0192332025778752,0.0400289757869115,2.36881542790787e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLMP,CXADR-like membrane protein,40030,0.0109628795711193,0.00196504225358225,0.00711139675409809,0.0148143623881405,2.45849692783676e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,37021,-0.0237869623252151,0.00426459307942038,-0.032145564760879,-0.0154283598895512,2.48410027538185e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0285435492153994,0.00512462403533077,0.0184992861061511,0.0385878123246477,2.59780799068274e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0369394957215911,0.00663359957417055,0.0239376405562168,0.0499413508869654,2.61776950925304e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0127803706254626,0.00230657268325122,0.00825948816629022,0.017301253084635,3.0573294636102e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0138045493827458,0.00249656111295291,-0.0186978091641335,-0.00891128960135806,3.27392095507031e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0255820825450956,0.00463549371402726,0.0164965148656022,0.034667650224589,3.47887640229808e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG4,Desmoglein-4,39725,0.0259090237216394,0.00470974217936212,0.0166779290500896,0.0351401183931891,3.83148242088084e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0251726165148691,0.004581542278272,0.0161927936494559,0.0341524393802822,3.99430717677151e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GM2A,Ganglioside GM2 activator,37178,0.0190411860001904,0.00347150705235719,0.0122370321775703,0.0258453398228105,4.21032935211426e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN8,Tetraspanin-8,37382,0.0514953144526612,0.00941029633708622,0.0330511336319722,0.0699394952733502,4.52316837110648e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1,Programmed cell death protein 1,39998,0.0214894630992779,0.00392780771302408,0.0137909599817507,0.0291879662168051,4.53886677699525e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0445941216389063,0.00818869087510892,0.0285442875236928,0.0606439557541198,5.23294159750291e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0373510923897625,0.00689168187691088,0.0238433959110171,0.0508587888685078,6.07271116538818e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP4,Bone morphogenetic protein 4,39720,-0.0238379502273376,0.00441150573812455,-0.0324845014740617,-0.0151913989806135,6.62644341909669e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF2,Scavenger receptor class F member 2,40009,-0.0145930946970034,0.00270084719024997,-0.0198867551898933,-0.0092994342041134,6.64067625282664e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH15,Cadherin-15,39973,0.0277301683374341,0.0051463178587003,0.0176433853343815,0.0378169513404867,7.21059905482235e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,39788,0.030963031648119,0.00574755598242858,0.019697821922559,0.042228241373679,7.25942790937529e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA6,Carbonic anhydrase 6,39817,-0.0328643064497551,0.00610408028707481,-0.0448283038124217,-0.0209003090870884,7.38829530830691e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0133569542916492,0.00248419546935308,-0.0182259774115812,-0.00848793117171716,7.70880288316207e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OBP2B,Odorant-binding protein 2b,39701,-0.0325062332304422,0.00604669135611181,-0.0443577482884214,-0.0206547181724631,7.72927578234467e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0248888668542442,0.00463105413669591,0.0158120007463202,0.0339657329621682,7.79585356058384e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL9,C-X-C motif chemokine 9,39931,0.0335865961013184,0.00625601923222863,0.0213247984061503,0.0458483937964865,8.04142650184566e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0200907059594793,0.00375738247076935,0.0127262363167714,0.0274551756021872,9.08823270968649e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBP1,Z-DNA-binding protein 1,37056,0.0211534019996509,0.00396115270344129,0.013389542700906,0.0289172612983959,9.43768708521163e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0189450445893758,0.00355312242119798,0.0119809246438277,0.0259091645349238,9.87273546938491e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD1,Leiomodin-1,37411,-0.0180130077991328,0.00338192409173452,-0.0246415790189324,-0.0113844365793331,1.01858021503777e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0207407675765694,0.00389573952310255,0.0131051181112884,0.0283764170418504,1.02934929281257e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0134091537396812,0.00252294308685011,0.00846418528945496,0.0183541221899074,1.08149448254633e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0136280833248183,0.00256746427722663,0.00859585334145406,0.0186603133081825,1.1258683161786e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0217697532743991,0.00410816739889695,-0.0298217613762371,-0.013717745172561,1.17899140337887e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCP1,Plastin-2,37437,0.0238758511999321,0.00450885015255083,0.0150385049009325,0.0327131974989318,1.2065422083183e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0454845163830539,0.00860550042808055,0.028617735544016,0.0623512972220917,1.26990830202663e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0181734098934987,0.00344864279584175,0.0114140700136488,0.0249327497733485,1.38378756667129e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAM,Basal cell adhesion molecule,39858,-0.0118840195712462,0.00226022917731247,-0.0163140687587787,-0.00745397038371378,1.47597910499155e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA1,Apolipoprotein A-I,37453,-0.0137709375573286,0.00262452061836772,-0.0189149979693293,-0.00862687714532785,1.5689437548396e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0138210666098699,0.00263686115282707,0.00865281875032889,0.018989314469411,1.6131407776653e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC1,Glypican-1,40030,0.0145809272182334,0.00278244739959715,0.00912733031502303,0.0200345241214439,1.62307878757263e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0181510800648035,0.00346649952398517,0.0113567409977926,0.0249454191318144,1.66044105291728e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYAL1,Hyaluronidase-1,39747,0.011440157990228,0.00218780653699023,0.00715205717772716,0.0157282588027288,1.72540044818226e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0126355111941127,0.0024181018132588,0.00789603164012547,0.0173749907481,1.75952633441996e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC16,Mucin-16,39788,0.0932202993378664,0.0178534799965348,0.0582274785446583,0.128213120131074,1.79800844266189e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0123663477513779,0.00236854914855064,0.00772399142021864,0.0170087040825372,1.80123583201172e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,39868,0.0138609821217192,0.00265596365088708,0.00865529336598051,0.0190666708774579,1.82320370339356e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,39444,0.0141191861140121,0.00271183757475097,0.0088039844675002,0.019434387760524,1.94880322414007e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX18,Sorting nexin-18,37382,0.0225259901411122,0.00434312940158218,0.0140134565140111,0.0310385237682133,2.17284285419541e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOBR,Apolipoprotein B receptor,37043,-0.0211026893739589,0.00408630964611886,-0.0291118562803519,-0.013093522467566,2.44933685250647e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP7,GTPase IMAP family member 7,37124,-0.0160820893006208,0.00313657253932727,-0.0222297714777023,-0.00993440712353938,2.98096068232479e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN10,Ataxin-10,39489,0.0360139546625016,0.0070260881784391,0.0222428218327609,0.0497850874922422,2.99894244971616e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX2,Neuronal pentraxin-2,37437,-0.0165780448474869,0.00323804944871231,-0.022924621766963,-0.0102314679280108,3.10104722483665e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,37437,0.0164706572098778,0.00322327912759961,0.0101530301197826,0.022788284299973,3.26692892980071e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0140065332602019,0.0027578263962445,-0.0194118729968412,-0.00860119352356271,3.84021238978931e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE3,Eosinophil cationic protein,39791,0.0522906971807575,0.0103191839352591,0.0320650966676497,0.0725162976938653,4.07952240952746e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.0161231195452501,0.00319266569872214,-0.0223807443147455,-0.0098654947757547,4.46545183295755e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPO,Myeloperoxidase,39858,0.021950333505802,0.00435160189261837,0.01342119379627,0.030479473215334,4.60418133957535e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0204119315570221,0.00404955284946327,0.012474807972074,0.0283490551419701,4.70197603892307e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MBL2,Mannose-binding protein C,37257,-0.0519956880583077,0.010321879818506,-0.0722265725025796,-0.0317648036140359,4.77980055397726e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD1,Bromodomain-containing protein 1,37169,-0.0148821993060126,0.00295540343170177,-0.0206747900321481,-0.00908960857987719,4.82613258403699e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTB,Lymphotoxin-beta,37368,0.0165222838523806,0.00328164635093259,0.0100902570045527,0.0229543107002085,4.8462555991689e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN1,Contactin-1,40052,-0.0128407236179708,0.00255674068654223,-0.0178519353635936,-0.00782951187234806,5.15988614855778e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0133254824200151,0.00265524526993377,-0.0185297631490853,-0.00812120169094493,5.27351608704252e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0150833755291081,0.00301034663679333,0.00918309612099317,0.020983654937223,5.49883436291188e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL3,Fc receptor-like protein 3,39587,0.0250015782974746,0.00500513439882174,0.015191514875784,0.0348116417191652,5.94093869619047e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0164434008648356,0.00330100328770151,0.00997343442094059,0.0229133673087305,6.38088185273567e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSM,Oncostatin-M,39785,0.0341198170585634,0.00685602961267544,0.0206819990177195,0.0475576350994072,6.53814177802575e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0324360102129749,0.00652254374409026,0.019651824474558,0.0452201959513918,6.67911282464172e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN2,Prefoldin subunit 2,39489,0.0266470519435891,0.00536049117661409,0.0161404892374254,0.0371536146497527,6.73106331221469e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0174424879042533,0.0035171803978774,0.0105488143244136,0.024336161484093,7.151322714041e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,37411,0.0164355045867552,0.0033142609855493,0.00993955305507858,0.0229314561184318,7.17055882052019e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0141254237543004,0.00284856311734769,0.0085422400442989,0.0197086074643018,7.18222846181405e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0184054127776006,0.00371342339987104,0.0111271029138534,0.0256837226413479,7.26607572755494e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0174450664734192,0.00352048556387789,0.0105449147682185,0.0243452181786198,7.29472069229566e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC2,Mucin-2,37437,0.0429319858818333,0.00866620643601229,0.0259462212672492,0.0599177504964174,7.35959072839044e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN3,Calsyntenin-3,37388,0.0143805851746948,0.00290560418938106,0.00868560096350794,0.0200755693858817,7.5393646758584e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH6,Cadherin-6,39868,-0.0180458416671047,0.00364960563784951,-0.0251990687172898,-0.0108926146169197,7.70729679244641e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR1,Cadherin-related family member 1,39489,0.0202020185798953,0.00410108789863791,0.012163886298565,0.0282401508612256,8.47818475805048e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0132584629331614,0.00269272909275883,0.00798071391135409,0.0185362119549687,8.5718630207412e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0232189792183707,0.00471993939674912,-0.032470060435999,-0.0139678980007425,8.7697297150379e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,37411,0.0131810243483413,0.0026866217854082,0.00791524564894119,0.0184468030477413,9.39507224296265e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.014772209029689,0.00301104617377018,0.00887055852909945,0.0206738595302786,9.40587646905011e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG3,Desmoglein-3,39964,0.0156564699551368,0.00319926445419018,0.00938591162492407,0.0219270282853496,9.98784391167867e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP4,Guanylate-binding protein 4,39489,0.0228686991356245,0.00469479365702112,0.0136669035678631,0.0320704947033859,1.12078522423253e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDS,Iduronate 2-sulfatase,40058,0.00420761252873677,0.000863999392337924,0.00251417371975443,0.0059010513377191,1.12693954339528e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,40038,0.0243695793704146,0.00501724852738072,0.0145357722567484,0.0342033864840808,1.20195093412372e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QL2,Complement C1q-like protein 2,37056,0.0195087657440365,0.0040337233376927,0.0116026680021588,0.0274148634859142,1.33693112943673e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0186244923921693,0.00385288255231493,0.011072842589632,0.0261761421947065,1.3511932786062e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,39866,0.02796323999578,0.00581180340786355,0.0165721053163675,0.0393543746751926,1.51200004522552e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPACAM2,HEPACAM family member 2,37388,-0.019288065035804,0.00402438235498975,-0.027175854451584,-0.0114002756200241,1.6621696649166e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,37043,0.0181946104284522,0.00380189416775698,0.0107428978596486,0.0256463229972559,1.72266645535221e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0164586881408343,0.00344061022618087,0.00971509209751982,0.0232022841841488,1.74004498923077e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0177522647319667,0.00372460400051804,0.0104520408909513,0.025052488572982,1.89376541533678e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK8,Kallikrein-8,39315,0.0158574292901374,0.00333872822789485,0.00931352196346349,0.0224013366168113,2.05709070517867e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,37453,0.00800453688372369,0.00169145845476006,0.00468927831239397,0.0113197954550534,2.24194940041386e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI1,Neuroserpin,37088,0.0139888179322418,0.00296259357141497,0.00818213453226842,0.0197955013322151,2.36148935648281e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDN1,Endothelin-1,37043,0.0126965081308758,0.00269854150563933,0.00740736677982268,0.0179856494819289,2.56505300519999e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPF,Centromere protein F,37169,0.0243252670414152,0.00518316376274803,0.014166266066429,0.0344842680164013,2.7173608633087e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18BP,Interleukin-18-binding protein,39931,0.0132911912449144,0.00283392161799262,0.00773670487364882,0.0188456776161799,2.75405470498785e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0187684445780239,0.00400473555972705,0.0109191628809589,0.0266177262750889,2.80535964377842e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCN,Decorin,39585,-0.00973511410863609,0.00208673766008291,-0.0138251199223986,-0.00564510829487359,3.10809303086584e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300C,CMRF35-like molecule 6,40009,0.0148745831344081,0.0031930230875002,0.0086162578829077,0.0211329083859085,3.21118450704503e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0171844487431765,0.00370096733135991,0.00993055277371108,0.0244383447126419,3.45747203610196e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0630822225426229,0.0135858602862411,0.0364539363815902,0.0897105087036555,3.45802168584034e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0288142060213597,0.00620632453526096,0.0166498099322482,0.0409786021104712,3.47144723499575e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0118377372732119,0.00255022686919748,0.00683929260958488,0.016836181936839,3.48037791777524e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN2,Alpha-actinin-2,37021,-0.0263100281509792,0.00567785100986021,-0.0374386161303052,-0.0151814401716532,3.62458101973778e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0207891478326765,0.00449722474888958,-0.0296037083405001,-0.0119745873248529,3.81782162824883e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0233280150708599,0.00505355626740567,0.0134230447867448,0.033232985354975,3.94510035077835e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,39788,-0.0106358656891241,0.00230484848828634,-0.0151533687261653,-0.00611836265208291,3.96997319858387e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY2,Protein canopy homolog 2,39585,0.0266859616361564,0.00578744891031519,0.0153425617719386,0.0380293615003742,4.03880771400001e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR1,Complement receptor type 1,37420,0.0157822745850187,0.00342493155601135,0.00906940873523645,0.022495140434801,4.10156871504688e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0120455830173277,0.00261847615366256,0.00691336975614908,0.0171777962785063,4.25346195782948e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0162722815427896,0.00353798823944713,0.00933782459347324,0.023206738492106,4.27755706291196e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0158108211865116,0.00344344347555062,0.00906167197443239,0.0225599703985908,4.43455041687079e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFAP,Glial fibrillary acidic protein,39453,0.0192576453686268,0.00419712702350469,0.0110312764025577,0.027484014334696,4.50369200762752e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF3,Neurotrophin-3,39866,0.0148129753381365,0.00322930747582091,0.00848353268552756,0.0211424179907455,4.52975161897715e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB2A2,Mammaglobin-A,37021,-0.0138235763445301,0.0030195633908781,-0.0197419205906512,-0.007905232098409,4.73730691152964e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALY,RNA-binding protein Raly,37368,0.0214007936493388,0.00467672259290649,0.012234417367242,0.0305671699314355,4.78118009586378e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0308908859742249,0.00676331460405758,-0.0441469825981777,-0.017634789350272,4.98130340333389e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA2,Adenosine deaminase 2,39782,-0.0180662732773059,0.0039583716677416,-0.0258246817460795,-0.0103078648085324,5.05472314574378e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM2,Myomesin-2,37021,-0.0226037399947158,0.0049524062487208,-0.0323104562422086,-0.012897023747223,5.0595750734101e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0139716848180426,0.00306304521490155,-0.0199752534392497,-0.00796811619683559,5.12761494777484e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAP,Cartilage-associated protein,37039,0.0216368139352436,0.00474521659057598,0.0123361894177147,0.0309374384527725,5.16855180183176e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PREB,Prolactin regulatory element-binding protein,39587,0.0125238819282812,0.00274734721528739,0.00713908138631789,0.0179086824702445,5.18995239174997e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA4,Carboxypeptidase A4,36868,0.0190972164826427,0.00419489631325022,0.0108752197086723,0.0273192132566131,5.34959242981287e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLGN,Calmegin,37039,0.0190254312499943,0.00419241922218596,0.0108082895745098,0.0272425729254788,5.72773652217535e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0169001793011936,0.00373371959612034,0.00958208889279769,0.0242182697095894,6.04495839953176e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0114917486358886,0.00253945611583763,0.00651441464884685,0.0164690826229304,6.07500261888526e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.0113961159752222,0.00252348108765499,-0.016342138907026,-0.00645009304341842,6.35598709035805e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN1,Calsyntenin-1,39489,0.0218261952094255,0.0048363582590079,0.01234693302177,0.0313054573970809,6.44015199792677e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL,Podocalyxin,39788,0.00650935814059555,0.00144333513069962,0.00368042128442429,0.0093382949967668,6.53082594483257e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0265340890154405,0.0058945353633603,0.0149807997032543,0.0380873783276267,6.7968854495041e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPN,Asporin,37437,0.0116575812475305,0.00259213415302382,0.00657699830760383,0.0167381641874572,6.93953900656462e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A11,Protein S100-A11,39703,0.0195967049515354,0.00436119006991146,0.0110487724145089,0.0281446374885619,7.05809316663177e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0210616003610392,0.00468695218966443,0.0118751740692969,0.0302480266527815,7.05881709424474e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,37043,0.0416254912140282,0.00928291970633601,0.0234309685896096,0.0598200138384468,7.38423804578363e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0141200806713152,0.00317548544491622,0.00789612919927936,0.020344032143351,8.78254445162706e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWF,von Willebrand factor,40052,-0.0311745334929418,0.00701344306622843,-0.0449208819027495,-0.0174281850831341,8.84887050280211e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00795677338687736,0.00179032693523232,0.00444773259382202,0.0114658141799327,8.88708109486758e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.022930270520237,0.00516587545735452,0.0128051546238222,0.0330553864166519,9.10709438710431e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0148346283326355,0.0033464806732652,0.00827552621303567,0.0213937304522353,9.35833925995842e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB6,Ephrin type-B receptor 6,39713,0.0128687048498624,0.00290413307654049,0.00717660401984307,0.0185608056798818,9.43519658458441e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTG,Protogenin,40030,0.0105422429457734,0.00238963226919722,0.00585856369814685,0.0152259221934,1.03244537499933e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROS,Uroporphyrinogen-III synthase,37039,0.0290304359366218,0.00658302275190072,0.0161277113428964,0.0419331605303472,1.0424030942134e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2,Ataxin-2,36991,0.0470788539914395,0.0106932250202527,0.0261201329517442,0.0680375750311348,1.07766382595174e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0112989176932942,0.00257046935467952,0.00626079775812238,0.0163370376284661,1.11273746915467e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0167401942323314,0.00381482993397623,-0.0242172609029248,-0.00926312756173797,1.15160924639123e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD209,CD209 antigen,39885,-0.0163645527054687,0.00373058859512651,-0.0236765063519166,-0.00905259905902074,1.15877672019708e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,39826,-0.00946584944501002,0.00215804753589289,-0.0136956226153601,-0.00523607627465996,1.16031952125555e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN8,Septin-8,37357,0.013424129284793,0.00306330085379129,0.00742005961136211,0.019428198958224,1.18350545890083e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0180219505537852,0.00411577972933418,-0.0260888788232802,-0.00995502228429022,1.20122364475027e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0161780111583136,0.00369476430598057,0.0089362731185917,0.0234197491980355,1.20202915424329e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0135772047429572,0.00310404956805218,-0.0196611418963395,-0.0074932675895749,1.22763806212938e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,37021,0.0185366736101609,0.00423842815811389,0.0102293544202576,0.0268439928000641,1.23222151725809e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE1,Ribonuclease pancreatic,37445,0.00940776387946279,0.00215182248677121,0.00519019180539122,0.0136253359535343,1.24029929777475e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRUNE2,Protein prune homolog 2,37169,0.0119592437910316,0.0027380255072936,0.00659271379673617,0.0173257737853271,1.26433103519702e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.00975688205467028,0.00223634116835086,0.0053736533647026,0.014140110744638,1.29159061041304e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF4,Neurotrophin-4,39477,0.016653613525166,0.00381941158633018,0.00916756681595881,0.0241396602343731,1.30741472118462e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS4,Thrombospondin-4,39892,0.018683876673522,0.00428798233690529,0.0102794312931876,0.0270883220538563,1.32516308953019e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0297749065416947,0.00683733124969868,0.0163737372922853,0.0431760757911041,1.34211328112192e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0240860342993761,0.00553277599825474,0.0132417933427968,0.0349302752559554,1.34913115125384e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,37368,0.0249833931133698,0.00574452452388665,0.013724125046552,0.0362426611801877,1.37712110436134e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0140391026644903,0.00324378009461591,-0.0203969116499375,-0.0076812936790431,1.51578293610673e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,39858,-0.0125494481554113,0.00290176262356093,-0.0182369028975907,-0.00686199341323186,1.53617357280477e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0201237354329151,0.0046531803474008,-0.0292439689138207,-0.0110035019520096,1.53812786445158e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPS,Colipase,39836,0.0287410942193386,0.00664642931508134,0.0157140927617792,0.041768095676898,1.53950523033573e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRLB,Fc receptor-like B,39477,0.0240063307460782,0.00555867959180969,0.0131113187461312,0.0349013427460252,1.57911303625773e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,40030,-0.024835808061496,0.00575663979269627,-0.0361188220551806,-0.0135527940678113,1.61067510969036e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTPN,Myotrophin,39585,0.0134367872000994,0.00311591996459824,0.00732958406948685,0.0195439903307119,1.62547927520462e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAT,Catalase,37252,0.0218737726918818,0.00507667225060051,0.0119234950807048,0.0318240503030588,1.65400815666383e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL21,C-C motif chemokine 21,39931,0.0161881407930476,0.00375829645392828,0.00882187974334822,0.0235544018427471,1.6623397013835e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0162237168401831,0.00376795243899523,-0.0236089036206138,-0.00883853005975246,1.67617709574376e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0154215005215592,0.00358340657594363,0.00839802363270967,0.0224449774104087,1.69053619833466e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELENOP,Selenoprotein P,37453,0.00917509097817796,0.00213580958520804,0.00498890419117021,0.0133612777651857,1.75244116119079e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS2,Thrombospondin-2,39858,-0.0147076813240657,0.00346013140338343,-0.0214895388746973,-0.0079258237734342,2.14393894964884e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRELP,Prolargin,39862,0.00902861502442888,0.00212964319059383,0.00485451437086497,0.0132027156779928,2.25278220392185e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAN,Versican core protein,40009,-0.0119953688584997,0.0028387759110453,-0.0175593696441485,-0.00643136807285095,2.39673930682352e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX1,Neuronal pentraxin-1,39858,0.0164483407145584,0.0039230311096666,0.00875919973961189,0.024137481689505,2.7705919517369e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0403388485756145,0.00963537799746087,0.0214535077005912,0.0592241894506379,2.85084742262788e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,39931,0.0104712849418319,0.00250546529783869,0.00556057295806804,0.0153819969255957,2.93854394362484e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.012579828613602,0.00303360089956668,0.00663397085045132,0.0185256863767527,3.388494726282e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0119471040686685,0.00288190373908498,0.00629857274006198,0.0175956353972751,3.40773616179532e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0150855519598486,0.003640994413696,-0.0222219010106928,-0.00794920290900446,3.44563009576144e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROCR,Endothelial protein C receptor,37021,-0.0145488976187309,0.00351366764552822,-0.0214356862039662,-0.00766210903349555,3.48470032007649e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSPN,Persephin,39866,0.0373916519254347,0.00904063970981604,0.0196719980941952,0.0551113057566741,3.55290170239163e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0146075190289155,0.00353277365829715,-0.0215317553991779,-0.00768328265865306,3.57313151612538e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGA,Chromogranin-A,37437,-0.0309164689885935,0.00753148136552739,-0.0456781724650272,-0.0161547655121599,4.06740926294412e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0207991164342899,0.00507051491720075,0.0108609071965764,0.0307373256720033,4.11704068740879e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA1,Carbonic anhydrase 1,39531,0.0233485795152648,0.00569597503388184,0.0121844684488564,0.0345126905816732,4.16783837016692e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,40058,0.00996577214092874,0.00243272122676098,0.00519763853647721,0.0147339057453803,4.21386205457892e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,39489,0.0333655447400792,0.00814992443151149,0.0173916928543167,0.0493393966258418,4.26181684000224e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B2M,Beta-2-microglobulin,37453,0.0120657946134825,0.0029595445559971,0.00626508728372823,0.0178665019432369,4.58980527381449e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0212839426222474,0.00522833893833837,-0.0315314869413906,-0.0110363983031042,4.70614027020057e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SATB1,DNA-binding protein SATB1,37411,0.0117267417710268,0.00288169792414338,0.00607861383970577,0.0173748697023478,4.74043985659018e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.016175456332488,0.00397598992288521,0.00838251608363301,0.023968396581343,4.76297171478264e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHISA5,Protein shisa-5,37437,0.00895476626351754,0.00220270022571841,0.00463747382110946,0.0132720587059256,4.82290271219332e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA1,Annexin A1,37072,0.0170991277366232,0.00420732135789423,0.00885277787515049,0.0253454775980959,4.84896195038029e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0164492936425942,0.00405068245078691,0.00850995603905185,0.0243886312461365,4.91271231046137e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.0074690168763879,0.00184161625759985,-0.0110785847412836,-0.0038594490114922,5.02663490405262e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOSB,Protein fosB,39489,0.0152158755606622,0.00375269413053293,0.00786059506481762,0.0225711560565067,5.04519708423641e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AREG,Amphiregulin,39788,-0.0181928625650614,0.00448893069756578,-0.0269911667322903,-0.00939455839783246,5.08425269937325e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB1A1,Uteroglobin,39903,0.0212862368311509,0.0052525616251494,0.0109912160458581,0.0315812576164437,5.09024546328536e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.00834303400543393,0.00206223573777363,-0.0123850160514703,-0.00430105195939761,5.24328172818874e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST7,Cystatin-F,39882,0.0357484488492559,0.00886370875094426,0.0183755796974051,0.0531213180011066,5.52949128055015e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0722044907949603,0.017927542370977,0.0370665077478453,0.107342473842075,5.66165820913306e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRAL,GDNF family receptor alpha-like,36942,-0.0240323737234352,0.00597451615893314,-0.0357424253949442,-0.0123223220519263,5.79121203790494e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD7,T-cell antigen CD7,37037,0.0165335037030563,0.00411333635040348,0.00847136445626547,0.0245956429498471,5.86494044733151e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECM1,Extracellular matrix protein 1,37106,0.013957767752088,0.00347725773524506,0.00714234259100772,0.0207731929131683,6.00230189979034e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.00981286639777984,0.0024512713874602,0.00500837447835785,0.0146173583172018,6.27792069648817e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLFM4,Olfactomedin-4,36654,0.0473066969620483,0.0118443079229627,0.0240918534330414,0.0705215404910552,6.53189495301237e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,39991,0.00971719607041665,0.00243908636713918,0.00493658679082386,0.0144978053500094,6.80771235051135e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD109,CD109 antigen,39858,-0.0128566584074903,0.00323992813959286,-0.0192069175610923,-0.00650639925388831,7.27358338453279e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN4,Contactin-4,39858,-0.00904094958770597,0.0022917131825598,-0.0135327074255232,-0.00454919174988876,8.0119964649462e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXTL1,Exostosin-like 1,37021,0.0181104982810017,0.00459050094264743,0.0091131164334127,0.0271078801285906,8.01433033534727e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,39866,-0.00919288671392574,0.00234051221697966,-0.0137802906592059,-0.0046054827686456,8.61131815340774e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEFL,Neurofilament light polypeptide,39438,0.0163787096927999,0.00417532922450867,0.0081950644127629,0.0245623549728369,8.79250438359895e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,36962,0.0231546688265131,0.00590421621332137,0.0115824050484032,0.034726932604623,8.83681207234623e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,39477,0.0194185821955177,0.00495207085070542,0.00971252332813507,0.0291246410629003,8.84469057747865e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF16,Fibroblast growth factor 16,37056,0.0181339182130982,0.00464319926365169,0.0090332476563409,0.0272345887698555,9.45073279049115e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLN,Mesothelin,39766,0.0196658152756753,0.00504089428085052,0.00978566248520824,0.0295459680661423,9.60889639571958e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARTN,Artemin,39587,0.016741052015068,0.00430271186931852,0.00830773675120366,0.0251743672789323,0.000100320068268995
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0220063900597685,0.00566172730539606,0.0109094045411922,0.0331033755783448,0.000102038287978013
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLASP1,CLIP-associating protein 1,36962,0.0272718930087547,0.00704071549662245,0.0134720906353747,0.0410716953821347,0.000107825232612642
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0324467426614073,0.00837756987027208,0.0160267057156741,0.0488667796071406,0.000108002213041457
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD3,Bromodomain-containing protein 3,37021,0.0172436533553381,0.00446054960444849,0.00850097613061901,0.0259863305800571,0.000111251589975023
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,37043,0.012397643907475,0.00320725524458051,0.00611142362809719,0.0186838641868528,0.000111393770281515
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.0165035819007889,0.0042756165809035,-0.0248837903993597,-0.00812337340221801,0.000113860930739855
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.024363653025379,0.00632710434219906,-0.0367647775360891,-0.0119625285146688,0.000118333020564845
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBB,Inhibin beta B chain,37124,0.0183253585214757,0.00476011904619383,0.00899552519093581,0.0276551918520156,0.000118784293969112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEO1,Neogenin,37411,0.00798859491695209,0.00207547966467929,0.00392065477418068,0.0120565350597235,0.000119128281543953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0138184051632449,0.00360030332027684,-0.0208749996709875,-0.00676181065550225,0.000124557715440459
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0213121896615615,0.00555381659878694,0.0104267091279391,0.0321976701951839,0.000124835882294829
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0156295554423167,0.00407880517183403,0.00763509730552196,0.0236240135791114,0.000127643663818167
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15,Interleukin-15,39866,0.0119082732375717,0.00311442648071267,0.00580399733537492,0.0180125491397686,0.000132023908348933
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPP1,Osteopontin,40012,-0.0164813184139961,0.0043212707673633,-0.0249510091180282,-0.00801162770996409,0.000137245242052613
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME2,Proteasome activator complex subunit 2,39666,0.0132338593686178,0.00347730358444876,0.00641834434309819,0.0200493743941373,0.000141889929801561
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,37021,-0.0120984118949658,0.0031791003583316,-0.0183294485972957,-0.00586737519263588,0.000142096600521855
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0177232391829417,0.0046664005198579,-0.0268693842018632,-0.00857709416402022,0.00014637642282854
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR1,Folate receptor alpha,39809,0.00998181445565937,0.00262993396909434,0.00482714387623447,0.0151364850350843,0.000147913911999904
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D17,TBC1 domain family member 17,39489,0.0159791551633675,0.00422519990778055,0.00769776334411766,0.0242605469826174,0.000156234599465963
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNU13,NHP2-like protein 1,37021,0.0223796020917538,0.00595241356437979,0.0107128715055695,0.0340463326779382,0.000170817460370479
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMS1,PMS1 protein homolog 1,37039,0.0179577856394238,0.00477868535887675,0.00859156233602533,0.0273240089428222,0.000172089550626993
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,37039,-0.0115539480363843,0.00307967790702835,-0.0175901167341598,-0.00551777933860871,0.000176410585856145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0183594870964888,0.00490010400553705,0.00875528324563618,0.0279636909473414,0.000179882612890576
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD9,COMM domain-containing protein 9,37368,0.0141109045158231,0.00377153779681838,0.00671869043405906,0.0215031185975871,0.000183741244964858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0215123551402971,0.00575790595434688,0.0102268594697772,0.032797850810817,0.000187652588053841
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0158613641532511,0.00425351220587364,0.00752448022973882,0.0241982480767635,0.000192904315703275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0126747249576503,0.00341066325291194,-0.0193596249333577,-0.0059898249819429,0.000202918771163918
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,39868,0.0157281378590393,0.00423505574801782,0.00742742859292442,0.0240288471251543,0.000204865811975543
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI4,Protein-arginine deiminase type-4,39456,0.0250781158694959,0.00675270388433079,0.0118428162562076,0.0383134154827843,0.00020489090814074
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,37411,0.0127040522876749,0.00342705948008685,0.00598701570670468,0.0194210888686451,0.000210578515891321
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MET,Hepatocyte growth factor receptor,39879,-0.00691704383861646,0.00187378101170529,-0.0105896546215588,-0.00324443305567409,0.000223683778803224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPO,Erythropoietin,39866,0.0273293776669126,0.00740620721683414,0.0128132115219176,0.0418455438119075,0.000224941039784868
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0134847652721629,0.00365799220989785,-0.0206544300035627,-0.0063151005407631,0.000228215666035696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO4,Roundabout homolog 4,37043,-0.00631005534514381,0.00171423173380636,-0.00966994954340428,-0.00295016114688335,0.000233264655518469
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0138278221454993,0.00376211171149163,0.00645408319097571,0.0212015611000229,0.000238281231663004
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR2,Complement receptor type 2,39931,0.0158752809611473,0.00435061006215266,0.00734808523932807,0.0244024766829665,0.000264119063747154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0088838759081563,0.00243751561919215,0.0041063452945397,0.0136614065217729,0.000268610314671797
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH3,Cadherin-3,40009,0.0121235711293061,0.00332659693104062,0.00560344114446646,0.0186437011141457,0.000268818698429817
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0215525731969306,0.00592871952658301,0.00993228292482794,0.0331728634690333,0.000278736772500387
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSPN,Claspin,39453,0.012019517931348,0.00330909448657212,0.0055336927376666,0.0185053431250293,0.00028184223806714
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL28,C-C motif chemokine 28,39815,0.0207410343902978,0.00571682951744905,0.00953604853609763,0.0319460202444979,0.000286443551852796
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0125117363059621,0.00345215170724882,0.00574551895975445,0.0192779536521698,0.000290800972649225
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMB,Granzyme B,39866,0.0222830474001609,0.00614870385288551,0.0102315878485053,0.0343345069518165,0.000290953809653954
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL3,Myosin light chain 3,37043,-0.0252566144548886,0.00699931613235283,-0.0389752740743001,-0.011537954835477,0.000309183738280422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP1,Caspase-1,39489,0.0231646681508033,0.0064241591432864,0.0105733162299619,0.0357560200716446,0.0003120802833901
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0167169651968699,0.00463862296834139,0.00762526417892079,0.025808666214819,0.000314495617745837
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0126889090251497,0.00352735507975675,-0.0196025249814729,-0.00577529306882642,0.000322730473690046
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRC1,Macrophage mannose receptor 1,37445,0.00951664551237044,0.00264674594815856,0.00432902345397966,0.0147042675707612,0.000324789250775313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0241726309665669,0.00673344535955882,0.0109750780618317,0.0373701838713022,0.00033175681336064
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0125501635205247,0.00349787171811016,0.00569433495302876,0.0194059920880206,0.000334476137306956
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0088099604509599,0.0024585095940537,-0.0136286392553051,-0.00399128164661465,0.000340264941528022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK11,Kallikrein-11,39779,0.0100082060313125,0.00279501155878897,0.00452998337608614,0.0154864286865389,0.0003436444716085
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK2,Protein AHNAK2,37043,0.0100782516001828,0.00282018676358047,0.00455068554356505,0.0156058176568005,0.000353348257347303
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,39545,0.0257956107186069,0.00722050948106321,0.011643412135723,0.0399478093014907,0.000354585130043801
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0103505170668694,0.00290564464702155,0.00465545355870717,0.0160455805750316,0.000368804842764835
NMR metabolomics,X23508.Triglycerides in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0140998894058378,0.0039615793835849,0.0063351938140114,0.0218645849976642,0.000373352955470266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOC,Brother of CDO,39585,-0.00800757640668566,0.00225025323886413,-0.0124180727548594,-0.00359708005851196,0.000374045501214036
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0186887722759716,0.00525291595707404,0.00839305700010648,0.0289844875518367,0.000375096252760046
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,37056,-0.00996599102317298,0.00280921609391462,-0.0154720545672456,-0.00445992747910032,0.000390098774315196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMP,Cartilage oligomeric matrix protein,39729,0.0113909258484638,0.0032145996006552,0.00509031063117965,0.017691541065748,0.000395991253831753
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFD,Complement factor D,37453,0.00621548690705927,0.00175528926610861,0.00277511994548639,0.00965585386863215,0.000399940509891157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,36991,-0.0213037345105287,0.00602093167997737,-0.0331047606032844,-0.00950270841777306,0.000404135446271094
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0105618124240622,0.00299046289657754,-0.0164231197013542,-0.00470050514677025,0.000413850025776261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,37056,0.0372067824126528,0.0105368493795826,0.016554557628671,0.0578590071966346,0.000415229625963661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1,Integrin beta-1,39862,0.00735610883784749,0.00208505594335183,0.00326939918887791,0.0114428184868171,0.000419861666284981
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0228561463304478,0.006490952927743,0.0101338785920715,0.0355784140688241,0.000430963921870502
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAN,Neurocan core protein,40009,0.0123896380513455,0.0035254072622543,0.00547983981732707,0.0192994362853639,0.000441980090243572
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,37247,-0.0027316829666922,0.00077758228987573,-0.00425574425484863,-0.00120762167853577,0.000444460355896565
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC2,MAM domain-containing protein 2,37437,-0.0111437533876489,0.00317686695311839,-0.0173704126157609,-0.00491709415953685,0.000453321978677155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0170532090603224,0.00486212719878676,0.00752343975070036,0.0265829783699445,0.00045409290456129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPS10,40S ribosomal protein S10,37021,-0.0144533903607144,0.00412777979839847,-0.0225438387655754,-0.00636294195585343,0.000464192825957734
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0127285908894835,0.00363632117956028,0.00560140137754532,0.0198557804014216,0.000466088028276548
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.012241450158589,0.00350232076034535,0.00537690146831209,0.0191059988488658,0.000475193176579546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.00702417656580707,0.00201286789679482,-0.0109693976435249,-0.00307895548808921,0.000485258431155717
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,39587,0.0160424667793524,0.00460563008938615,0.00701543180415554,0.0250695017545493,0.000496750276753668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDHB15,Protocadherin beta-15,37368,-0.0132945884754621,0.00381854106661026,-0.0207789289660183,-0.00581024798490602,0.000500024349815164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP1,Dipeptidase 1,39713,-0.0157791200624002,0.00455068767585291,-0.0246984679070719,-0.00685977221772844,0.000526884501339696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0145644614124753,0.00420598839946704,0.00632072414951993,0.0228081986754307,0.000536282713922541
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC1,Syndecan-1,39868,0.0132008378691281,0.00381344914221604,0.0057264775503847,0.0206751981878716,0.000538269876651316
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0125367892458428,0.00362223608924452,0.00543720651092352,0.019636371980762,0.000539449637069299
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0162811496374208,0.00470719331521772,0.00705505073959407,0.0255072485352475,0.000544072449538239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN1,Tetraspanin-1,39585,0.0133757493533559,0.00387786920757147,0.00577512570651581,0.020976373000196,0.000563614822958958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TK1,"Thymidine kinase, cytosolic",37169,0.0152309981040862,0.00442736913787356,0.006553354593854,0.0239086416143183,0.000583085741911252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0179555515735922,0.00522047598151419,-0.02818768449736,-0.00772341864982438,0.000584396124998236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.01139418938581,0.00331915099073842,-0.0178997253276573,-0.00488865344396275,0.000599086921412589
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL4,Delta-like protein 4,37043,0.0283737240060193,0.00827449392969728,0.0121557159038126,0.044591732108226,0.000607532162535601
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0231316082100105,0.00675517622031417,0.0098914628181947,0.0363717536018262,0.000618258350253975
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNLY,Granulysin,39858,0.0167467931937003,0.00489410533846101,0.00715434673031673,0.0263392396570839,0.000623569269289488
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_DRA,,39799,-0.0115692971583459,0.00340388931113654,-0.0182409202081735,-0.00489767410851831,0.000678363754875937
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00725221143334712,0.00213536610412738,0.00306689386925745,0.0114375289974368,0.000684852592888336
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00968718719443,0.00285832056532595,0.00408487888639114,0.0152894955024689,0.000703228873520146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZU1,Azurocidin,39344,0.0248439412445406,0.00736490284932431,0.0104087316598649,0.0392791508292162,0.000744581393494673
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0193198478269852,0.00573008323076229,0.00808888469469111,0.0305508109592793,0.000749347753068116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERC2,ERC protein 2,37039,0.0242761130019955,0.00720285479826185,0.0101585175974023,0.0383937084065887,0.000752893356055399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCP2,Non-specific lipid-transfer protein,39477,0.0252425848096714,0.00749030601866246,0.010561585013093,0.0399235846062498,0.000753409157900552
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.029120479950177,0.00864200305291302,0.0121821539664675,0.0460588059338865,0.000754807468324519
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0192189048091196,0.00570392098100754,0.00803921968634485,0.0303985899318944,0.000755362373398268
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST6,Cystatin-M,39524,0.015078651137587,0.00450354300583761,0.00625170684614532,0.0239055954290287,0.000815372246609265
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00734346458725357,0.00220653262094811,0.00301866065019527,0.0116682685243119,0.000876528657305542
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,39931,0.00897557169938573,0.00270455496374458,0.00367464397044635,0.0142764994283251,0.000906426992269422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0114931896113929,0.00346979266076931,0.00469239599628501,0.0182939832265007,0.000927625421235027
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMPD3,AMP deaminase 3,37388,0.0225164709896799,0.0068067365527505,0.00917526734628893,0.0358576746330709,0.000942205133101101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN1,Prorelaxin H1,37411,-0.0256336776231229,0.00774920255161316,-0.0408221146242847,-0.0104452406219611,0.000942392434214669
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS4,Galectin-4,39862,0.0167364815498278,0.00506541744666853,0.00680826335435743,0.0266646997452981,0.000955020947394674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKCQ,Protein kinase C theta type,39587,0.0137400681988795,0.0041651243755832,0.00557642442273643,0.0219037119750226,0.000973017525366634
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAG,S-arrestin,36991,-0.0168448520565007,0.00510659980717778,-0.0268537876785691,-0.00683591643443225,0.000974116438942681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFLAM,Pikachurin,37382,0.0097026566144934,0.00294526708581812,0.00392993312628988,0.0154753801026969,0.000989131918766181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0269159122116347,0.00817126634778573,-0.0429315942532948,-0.0109002301699747,0.000990043156478776
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH3,Neurexophilin-3,37056,0.00941055408273891,0.00285735730528048,0.00381013376438917,0.0150109744010886,0.000992275149599823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.0155052583151274,0.00472323850615977,-0.0247628057872006,-0.00624771084305428,0.00103016257924578
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAC1,Cartilage acidic protein 1,40052,0.00947457758640964,0.00288992812771469,0.00381031845608885,0.0151388367167304,0.00104587033643795
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH12,Protocadherin-12,37411,0.00796973532366717,0.00243140241789716,0.00320418658458873,0.0127352840627456,0.00104869989659102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX3,Syntaxin-3,37388,0.0119702096466003,0.00365349162420743,0.00480936606315373,0.0191310532300468,0.0010541349269108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTXR,Neuronal pentraxin receptor,39868,0.0106732806336965,0.00326395662083332,0.00427592565686321,0.0170706356105298,0.00107758034799703
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARCL1,SPARC-like protein 1,39871,-0.00854138786540565,0.00261413433573273,-0.0136650911634418,-0.0034176845673695,0.0010877384640664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0222548696152489,0.00681225648347772,0.00890284690763258,0.0356068923228652,0.00108964092082925
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIF,Leukemia inhibitory factor,39489,0.0161114461626589,0.00493409926171979,0.00644061160968807,0.0257822807156297,0.00109573188083653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,39928,0.0252410190272522,0.00773016935906966,0.0100898870834757,0.0403921509710288,0.00109592240444791
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMOD4,Tropomodulin-4,36962,-0.0127955220533389,0.0039220879098919,-0.020482814356727,-0.00510822974995077,0.00110745645018651
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A14,Zinc transporter ZIP14,39489,0.0101901201411725,0.00313745183892447,0.00404071453688056,0.0163395257454645,0.00116506690332184
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,39489,0.0123306316614659,0.00380472829989521,0.00487336419367133,0.0197878991292606,0.00119414739582473
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,37124,0.00882248965435303,0.0027289947358083,0.00347365997216876,0.0141713193365373,0.00122852163287883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0106859798310272,0.00330730486783258,0.00420366229007531,0.017168297371979,0.00123598195978715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBLN2,Fibulin-2,37437,-0.00939811348185905,0.00290943886348197,-0.0151006136542837,-0.0036956133094344,0.00123991567742306
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0218004804986901,0.00675081264145064,0.00856888772144684,0.0350320732759333,0.00124389466325277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0181129455331436,0.00560907137101149,0.0071191656459611,0.0291067254203261,0.00124427917968971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00870745432807365,0.00270316869324064,0.00340924368932199,0.0140056649668253,0.0012790889105196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00699351028847494,0.00217331259332023,0.00273381760556728,0.0112532029713826,0.0012938536093591
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO6,Unconventional myosin-VI,37411,0.0117548686409531,0.00366628319876765,0.00456895357136851,0.0189407837105377,0.00134808542048064
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0215746562159679,0.00673010290846138,0.00838365451538365,0.0347656579165523,0.00135007677861125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK14,Kallikrein-14,40030,-0.0138329953699075,0.0043337058667776,-0.0223270588687916,-0.00533893187102337,0.00141583487840301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD6,Programmed cell death protein 6,39868,-0.0213183673988886,0.00668868669495712,-0.0344281933210046,-0.00820854147677267,0.0014391966118974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0127075405968356,0.00399273425997663,-0.0205332997463898,-0.00488178144728135,0.00146265007302916
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0104638193679407,0.00329394449901558,0.00400768814987014,0.0169199505860112,0.00149257303793057
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP7,Dipeptidyl peptidase 2,39754,0.0183310387312088,0.00577328907670278,0.00701539214087131,0.0296466853215462,0.00150046662424433
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0152917768622225,0.00481836841949958,0.00584777476000331,0.0247357789644417,0.00150829952045026
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH7B,Myosin-7B,36962,-0.013424350883451,0.00423012778534866,-0.0217154013427344,-0.00513330042416767,0.00150955998570056
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,37388,0.0135419081823947,0.00426846871263378,0.00517570950563245,0.0219081068591569,0.00151447070589878
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY96,Lymphocyte antigen 96,39749,-0.0107544595112361,0.00339356067052133,-0.0174058384254579,-0.00410308059701424,0.00153213067230912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.0091316109135089,0.00288200489396464,-0.0147803405056796,-0.00348288132133822,0.00153583750817567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RA,Interleukin-17 receptor A,39858,0.0134039986947681,0.00423251899420454,0.00510826146612715,0.021699735923409,0.0015435832856503
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHB,Lutropin subunit beta,39477,0.0268941167193524,0.00850074884307075,0.0102326489869337,0.043555584451771,0.00156057082263531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,37056,0.0197360125219544,0.00624220528250516,0.00750129016824426,0.0319707348756645,0.00157203276580385
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0159014922742997,0.00506296518986508,-0.0258249040464352,-0.00597808050216413,0.00168891603119394
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMBS,Porphobilinogen deaminase,40030,0.0129528355014156,0.00412646811061963,0.00486495800460114,0.0210407129982301,0.0016985108419166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,37056,0.00961498456264683,0.00307083645205611,0.00359614511661686,0.0156338240086768,0.00174554691306756
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY6D,Lymphocyte antigen 6D,39761,0.0108637522099266,0.00347404528507303,0.00405462345118352,0.0176728809686698,0.00176846973363989
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL3,Follistatin-related protein 3,39803,0.00898968632030778,0.00287840391090828,0.00334801465492756,0.014631357985688,0.00179247064155449
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0130115375500226,0.00417426155391526,0.00482998490434866,0.0211930901956965,0.00183039812059105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.00920217985479751,0.00295750458842313,-0.0149988888481068,-0.00340547086148817,0.00186558145375917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSB,Lupus La protein,39489,0.0181073646212746,0.00583260143077883,0.00667546581694808,0.0295392634256011,0.00190935551151026
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0127546121773854,0.00411513661772001,-0.0208202799481167,-0.00468894440665421,0.0019429782236366
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM25,Transmembrane protein 25,37411,-0.0133184529012356,0.00429979101106268,-0.0217460432829185,-0.0048908625195528,0.00195582226131922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFB,Vascular endothelial growth factor B,37056,0.00844065185146834,0.00272688548046183,0.00309595630976315,0.0137853473931735,0.00196995503062063
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0359485279648234,0.0116371682855604,0.0131396781251251,0.0587573778045218,0.00201105061827533
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,39788,0.00770636264785031,0.00250030811901619,0.00280575873457859,0.012606966561122,0.00205851607145321
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0104555286350828,0.00340655124361191,0.0037786881976035,0.0171323690725622,0.00214962719215477
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTP1,Glutathione S-transferase P,39393,-0.0204562692801168,0.00666868846339681,-0.0335268986683746,-0.00738563989185905,0.0021622150415584
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH17,Cadherin-17,39868,-0.0195117119541437,0.00637659739165118,-0.03200984284178,-0.00701358106650736,0.00221781618261225
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,37411,-0.0224283358774018,0.00733253086893275,-0.03680009638051,-0.00805657537429363,0.0022270065675644
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,39835,-0.0051102148934487,0.00167208225688008,-0.00838749611693366,-0.00183293366996374,0.00224532904799753
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR4,Proline-rich protein 4,37031,-0.0205163945021498,0.00672295801234891,-0.0336933922063536,-0.00733939679794592,0.00228008832142273
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0149570169020847,0.00490588406400622,0.00534148413663249,0.0245725496675369,0.00230148438131584
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEG1,Protein LEG1 homolog,36703,-0.0204750465735001,0.00672982625919573,-0.0336655060415237,-0.00728458710547644,0.00235147805243432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0168409320999039,0.0055418033701173,-0.0277028667053338,-0.00597899749447398,0.00237917262231618
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNXB,Tenascin-X,39858,-0.00748830966157745,0.00247020324159589,-0.0123299080151054,-0.00264671130804951,0.002437676025022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.012672706223312,0.00418552293411432,0.00446908127244797,0.0208763311741761,0.00246785558295538
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0169756375471266,0.00561176613769589,0.00597657591724271,0.0279746991770106,0.00249107362025985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDK2,Protein sidekick-2,37124,0.0107902454064406,0.00357504870495841,0.00378314994472207,0.017797340868159,0.00254756009393439
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0118040895727702,0.00392571759797251,-0.0194984960647963,-0.00410968308074408,0.00264460372490926
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17C,Interleukin-17C,39587,-0.0191145129227803,0.00638004826093547,-0.0316194075142138,-0.00660961833134679,0.00273988529234496
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RYR1,Ryanodine receptor 1,37021,-0.00975241179828861,0.00325525552855257,-0.0161327126342516,-0.00337211096232557,0.00274148083469898
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN3,Perilipin-3,39868,0.0123198332235255,0.00412247716258653,0.00423977798485595,0.0203998884621951,0.00280818177685236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EP300,Histone acetyltransferase p300,37056,0.00849699007114552,0.00284559600726828,0.00291962189689969,0.0140743582453913,0.00283158255071051
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,37039,-0.0123960050877948,0.00416332402860133,-0.0205561201838534,-0.00423588999173622,0.00291204778949355
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.00970457343025982,0.00326210814782884,0.0033108414605153,0.0160983054000043,0.00293486163015656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0166991531479915,0.00563435233845537,-0.027742483731364,-0.00565582256461896,0.0030429749156728
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0210592648166436,0.00711668761333938,0.00711055709449841,0.0350079725387888,0.00309052110377083
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GKN1,Gastrokine-1,39123,0.00797806380647794,0.00270045289326676,0.00268517613567508,0.0132709514772808,0.00313813851448262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0149005538767272,0.0050444317662174,0.00501346761494114,0.0247876401385133,0.00314292402906517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00753413860538029,0.00258783207214501,-0.0126062894667845,-0.00246198774397606,0.00360337543493028
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,39868,0.0088580275004099,0.00304319523487518,0.00289336484005455,0.0148226901607653,0.00361041601954238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0285917271276931,0.0098258533915967,0.00933305448016353,0.0478503997752226,0.00362107714277394
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH4,Myosin-4,37021,-0.0133366314086511,0.00459547316601869,-0.0223437588140478,-0.00432950400325448,0.00371257041042551
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.016149114024013,0.00561116947841695,0.00515122184631574,0.0271470062017102,0.00400706017200953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAFB2,Scaffold attachment factor B2,37411,0.00757332437988974,0.00263316078392339,0.0024123292433999,0.0127343195163796,0.00403205983332545
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD3,Extracellular superoxide dismutase,37445,-0.016826191580198,0.00585458393977615,-0.0283011761021593,-0.00535120705823676,0.00405911959906029
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0181006148040572,0.00629893835852349,-0.0304465339867632,-0.00575469562135117,0.00406361457696226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0152220967751486,0.00531548890850874,0.00480373851447141,0.0256404550358257,0.00419335583164171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00870141825907636,0.00305090688254214,-0.0146811957488589,-0.00272164076929376,0.00435022706278963
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCLRE1C,Protein artemis,36962,-0.00850950051706686,0.00298406157063561,-0.0143582611955127,-0.00266073983862107,0.00435609047189515
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD55,Complement decay-accelerating factor,39315,0.00694001785886056,0.00243778883509694,0.00216195174207055,0.0117180839756506,0.00442124045283847
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,37043,0.00992154928475825,0.00348527275785806,0.00309041467935645,0.01675268389016,0.00442422584160242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN1,Nectin-1,37056,0.00875171495276532,0.00308537395919652,0.00270438199274014,0.0147990479127905,0.00456780392587657
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00805294968928399,0.00285610159133103,0.00245499057027517,0.0136509088082928,0.00481612080800555
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNG,Interferon gamma,39587,0.0309179558814003,0.0109840233010091,0.00938927021142252,0.0524466415513781,0.00488664925888958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPS,Calcyphosin,37388,0.0235193436937858,0.00836289490174175,0.007128069686372,0.0399106177011997,0.00492525887404567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0108043376241751,0.00384980649706132,0.0032587168899349,0.0183499583584153,0.0050150754940963
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,37388,0.0106170228660292,0.00378316123262082,0.00320202685009237,0.018032018881966,0.00501717417186751
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK15,Kallikrein-15,37351,0.0135630908986998,0.0048427735738907,0.00407125469387401,0.0230549271035256,0.00510665682547201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON1,Spondin-1,39885,0.00856436959916069,0.00305923345699863,0.00256827202344338,0.014560467174878,0.00512406585637829
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100G,Protein S100-G,37411,-0.0120769563012036,0.00431710464857495,-0.0205384814124105,-0.00361543118999665,0.00515777306738125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00818364685472452,0.00292713600696321,-0.0139208334283724,-0.00244646028107662,0.00518368414430019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1,Methionine aminopeptidase 1,39489,0.00817167099845249,0.00292887943061983,0.00243106731443761,0.0139122746824674,0.00527664629675495
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD27,CD27 antigen,39913,-0.0103901650196051,0.00373695697572271,-0.0177146006920216,-0.00306572934718861,0.00543583478377838
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP2,Guanylate-binding protein 2,39587,0.0157969523783885,0.00569441689478354,0.00463589526461279,0.0269580094921643,0.0055417819649635
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGB,Secretogranin-1,39952,0.0104996027087906,0.00378881406730256,0.00307352713687762,0.0179256782807037,0.00559123607900559
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00706024512905269,0.00255381444648942,-0.012065721444172,-0.00205476881393343,0.00570738943416121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCND2,G1/S-specific cyclin-D2,37169,0.00975603883120618,0.00353553454650474,0.00282639112005689,0.0166856865423555,0.0057982509153858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK1,Cyclin-dependent kinase 1,36962,0.00959813960812675,0.00348088001533715,0.00277561477806594,0.0164206644381876,0.00583457165046841
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3D,Protein FAM3D,37382,0.0220320130269692,0.00802174190539286,0.00630939889239919,0.0377546271615392,0.00603077243643168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM19,Probable RNA-binding protein 19,37021,-0.0125309272254834,0.00457246308755018,-0.0214929548770818,-0.00356889957388507,0.00614247458401661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPEP,Aspartyl aminopeptidase,37388,0.0155210837688522,0.00568015485502621,0.00438798025300087,0.0266541872847036,0.00629352353565335
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYMP,Thymidine phosphorylase,39764,0.0176526518461103,0.00650298442194568,0.00490680237909671,0.0303985013131238,0.00664382068004152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME1,Nucleoside diphosphate kinase A,37056,-0.00567900647493921,0.00209936931171746,-0.00979377032590543,-0.00156424262397299,0.00683712305758498
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0762341042778404,0.0282420526522606,0.0208796810794096,0.131588527476271,0.00695560391904063
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX33,Testis-expressed protein 33,37169,-0.0102950110038239,0.00381614347154366,-0.0177746522080494,-0.00281536979959828,0.00698972831189138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0130412980971895,0.00483730877810715,0.00356017289209953,0.0225224233022796,0.00702682840556268
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI3,Elafin,39594,0.0137120199692748,0.00508847617256275,0.00373860667105183,0.0236854332674978,0.00705225420261055
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPJ,Centromere protein J,37169,0.0187867738943508,0.00697919258365607,0.00510755643038489,0.0324659913583167,0.00711508138794656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GL3,Endophilin-A3,37083,0.0213304841399099,0.00793513119034886,0.00577762700682613,0.0368833412729937,0.0071948294203433
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F3,Tissue factor,39931,-0.00697853771648998,0.00260813942209684,-0.0120904909837998,-0.00186658444918018,0.00746541424219959
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L15,Bcl-2-like protein 15,37056,0.0145287873862141,0.0054384964057158,0.00386933443101114,0.0251882403414171,0.00756122060591994
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NINJ1,Ninjurin-1,39477,0.0144155493552793,0.00542233591313745,0.00378777096552989,0.0250433277450287,0.00785577671433821
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0153280821031972,0.00578440005172179,-0.0266655062045719,-0.00399065800182245,0.00806115790265605
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.0115105301327752,0.00435516558560865,0.0029744055849822,0.0200466546805681,0.008227948014664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,37169,0.0131792577541679,0.00498670523541754,0.00340531549274953,0.0229532000155863,0.00823007069723391
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0138901661980599,0.00525676671656281,0.00358690343359678,0.024193428962523,0.00824173399993967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0134535772665494,0.00509986793382907,0.00345783611624439,0.0234493184168544,0.00834884915934575
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.010324562942844,0.00392611330799627,-0.0180197450265167,-0.00262938085917129,0.00855556351004255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAVL4,ELAV-like protein 4,36991,0.0213077006377325,0.00812070994587718,0.00539110914381324,0.0372242921316518,0.00870370978206936
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC1,Hamartin,37056,0.0192302629159659,0.00734858802766323,0.00482703038174593,0.0336334954501858,0.00888425991434197
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF3,Trefoil factor 3,39839,0.0121763647962443,0.00465514375143645,0.00305228304342882,0.0213004465490597,0.00891337641569998
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JCHAIN,Immunoglobulin J chain,39587,-0.0151687690611524,0.00581506148365811,-0.0265662895691222,-0.00377124855318246,0.00910177322466291
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0120688447503282,0.00463757298477861,0.00297920170016212,0.0211584878004943,0.00926731293187763
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP29,Dual specificity phosphatase 29,37039,-0.0166102421036076,0.00638484544405609,-0.0291245391739575,-0.00409594503325766,0.00929179929373591
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0212707766280655,0.00818480742887751,-0.0373129991886655,-0.00522855406746562,0.00936511175767791
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.00733540783611577,0.00283452477357803,-0.0128910763923287,-0.00177973927990283,0.0096672090211811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.0067445899109689,0.00260693230474241,-0.011854177228264,-0.00163500259367379,0.00968535244807727
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2B,Sodium channel subunit beta-2,37039,-0.00716473968679057,0.00276962028250945,-0.0125931954405091,-0.00173628393307205,0.00969488918541423
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0173140674914817,0.00669918767560098,0.00418365964730383,0.0304444753356597,0.00976062673231095
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM1,Myomesin-1,36991,0.011770891988751,0.00455482458058268,0.00284343581080891,0.020698348166693,0.00976925749645099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00985699896236999,0.00381960291406854,-0.0173434206739443,-0.00237057725079565,0.00987262129628884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN2,Contactin-2,40030,0.010956575684937,0.00425500569025218,0.00261676453204277,0.0192963868378313,0.0100332502491909
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.00982701969430558,0.00381796564246344,0.00234380703507724,0.0173102323535339,0.0100670911225358
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0151888133973874,0.00590572418978094,0.0036135939854168,0.0267640328093581,0.0101240946051199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB5,Integrin beta-5,39913,0.00937086545639116,0.00364490280216034,0.00222685596415689,0.0165148749486254,0.0101509002079248
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCC1,Regulator of chromosome condensation,37368,0.0125092544392811,0.00486768132378314,0.00296859904466616,0.022049909833896,0.0101846162540309
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,37169,0.0113676099654674,0.00443367789226779,0.00267760129662255,0.0200576186343123,0.0103605206042984
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BEX3,Protein BEX3,36962,-0.0115252096084052,0.00450060295794108,-0.0203463914059697,-0.00270402781084065,0.0104538099114255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0105720087375302,0.00415581981271081,0.00242660190461704,0.0187174155704434,0.0109733115030281
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00694842705477634,0.00273266648789962,0.00159240073849308,0.0123044533710596,0.0110101481711965
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.00738375545204731,0.00291230663933096,0.00167563443895863,0.013091876465136,0.011244238972659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,36962,0.0103876597896392,0.00410165242827285,0.0023484210302244,0.018426898549054,0.0113350389706084
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0101051634492735,0.00399042748519953,0.00228392557828243,0.0179264013202646,0.0113395291274292
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00884653642678081,0.00351504455077295,-0.0157360237462958,-0.00195704910726583,0.0118556120761424
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.00924766716171457,0.00367701512312182,0.0020407175203958,0.0164546168030333,0.0119132403556998
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIM,Vimentin,39585,0.0283144738373609,0.0112634992105921,0.00623801538460041,0.0503909322901213,0.0119528511542828
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00710843807180321,0.00282981527323151,0.00156200013626944,0.012654876007337,0.0120174573061337
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0172204651183997,0.00689161115900194,-0.0307280229900435,-0.00371290724675591,0.0124750491045251
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00585575826340881,0.00234586944372923,-0.0104536623731181,-0.00125785415369952,0.0125649737372865
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",39788,0.0252062064492702,0.0101385744053388,0.00533460061480609,0.0450778122837344,0.0129228430349625
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00887759801139843,0.00357167518007339,-0.0158780813643423,-0.00187711465845458,0.0129473042831517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC4,MANSC domain-containing protein 4,37021,0.0148883066444663,0.00599209625246865,0.00314379798962775,0.0266328152993049,0.012979948592418
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200,OX-2 membrane glycoprotein,39866,-0.00611998639680011,0.00246890322721174,-0.0109590367221351,-0.00128093607146509,0.0131917096912936
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0169756125237038,0.00686190835051054,-0.0304249528907044,-0.00352627215670311,0.0133775984124585
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0198823905316298,0.00804691461223959,-0.0356543431716194,-0.0041104378916402,0.0134930217857373
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHPK,Sedoheptulokinase,37169,-0.0099239610702597,0.00402489881445463,-0.0178127627465908,-0.00203515939392862,0.0136893011292406
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.0063578959423144,0.00258432475469576,0.00129261942311071,0.0114231724615181,0.013897531956329
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0115401494523739,0.00469262407203722,-0.0207376926335668,-0.00234260627118092,0.013934794382437
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMH,Granzyme H,39585,0.0177934719183614,0.00723617208974444,0.00361057462246228,0.0319763692142605,0.0139446309372245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBN,Ameloblastin,39587,-0.00670214600660197,0.00274086156471016,-0.0120742346734339,-0.00133005733977006,0.0144852720021493
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,39931,0.0061506521945014,0.00251667597903149,0.00121796727559968,0.0110833371134031,0.014537764515865
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH23,Cadherin-23,37388,-0.00630925394998017,0.00258152533434901,-0.0113690436053042,-0.00124946429465611,0.0145380146003463
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.01373207139885,0.00562558016047426,-0.0247582085133795,-0.00270593428432043,0.0146573891124521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0151047766817238,0.00619509796286545,-0.0272471686889401,-0.0029623846745075,0.0147743580652731
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0118992920791852,0.00488309896741446,-0.0214701660553175,-0.00232841810305281,0.0148297197268607
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAP1A,Ras-related protein Rap-1A,37056,-0.0159314001318524,0.00653852579734236,-0.0287469106946435,-0.00311588956906142,0.0148415316064902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,36962,0.00971540785123937,0.00401364974759413,0.00184865434595487,0.0175821613565239,0.0155087690579697
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMA,Repulsive guidance molecule A,40009,-0.00717215282147003,0.00297409216931949,-0.0130013734733362,-0.00134293216960382,0.0158962395846967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL4,Myosin light chain 4,37043,-0.0120133689658668,0.00498985927176493,-0.0217934931385261,-0.00223324479320753,0.0160733193073785
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D1,DCN1-like protein 1,36991,-0.0173325740940288,0.00720560173410794,-0.0314555534928804,-0.00320959469517724,0.0161671659160263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAV,Integrin alpha-V,40030,0.00379817267964944,0.00158810295448057,0.000685490888867516,0.00691085447043137,0.0167845799159592
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG3,Secretogranin-3,39885,-0.00740602030472896,0.00311338569890191,-0.0135082562745767,-0.00130378433488121,0.0173822791926287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,39587,0.0137813994588454,0.00581630762310573,0.00238143651755818,0.0251813624001326,0.0178269860747257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00756780459488145,0.0031953570684811,-0.0138307044491044,-0.0013049047406585,0.0178782196637597
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMR1,Synaptic functional regulator FMR1,39477,0.00809248262243607,0.00342095463345253,0.00138741154086911,0.014797553704003,0.018014840714991
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00684146962054311,0.00289467212624315,0.00116791225310654,0.0125150269879797,0.018116802394929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0166383266793487,0.00705337875456368,0.00281370432040393,0.0304629490382935,0.0183424974235988
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRAXIN,Draxin,39749,0.00950798939376916,0.00404010270034678,0.00158938810108946,0.0174265906864489,0.0186145811483417
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0107460133844302,0.00457412798082648,0.00178072254201025,0.0197113042268501,0.0188228614708692
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.015247778458618,0.00649685873869321,-0.0279816215864567,-0.0025139353307793,0.0189427244401357
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.0073528114901946,0.00314222384242115,0.00119405275904915,0.0135115702213401,0.0192980738298339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.0120416394817951,0.00515961347165652,-0.0221544818862419,-0.00192879707734837,0.0196194139412915
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,37169,0.0154160147390621,0.0066061507665848,0.00246795923655595,0.0283640702415683,0.019632270225699
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00706268250530216,0.00303481604977541,-0.013010921962862,-0.00111444304774236,0.0199658607526668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC4A1,Band 3 anion transport protein,37437,-0.010428216504729,0.00448458650633159,-0.0192180060571389,-0.00163842695231912,0.0200681114967955
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEBP1,Heme-binding protein 1,39585,-0.0120008285140664,0.00516153749820137,-0.0221174420105411,-0.0018842150175917,0.020081991971147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0138583811455269,0.00596076363934745,0.00217528441240591,0.0255414778786479,0.0200881606448214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUK1,Guanylate kinase,37021,-0.00925385122407611,0.00398514935991523,-0.01706474396951,-0.00144295847864227,0.0202435982200999
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD5,Sushi domain-containing protein 5,37064,-0.00756827786640574,0.00325947925296189,-0.013956857202211,-0.00117969853060043,0.0202519182227809
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB116,Beta-defensin 116,36991,-0.0172366693636733,0.00743811353989876,-0.0318153719018748,-0.0026579668254717,0.0205002879104277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0157008412583342,0.00678686979466497,-0.0290031060558776,-0.00239857646079091,0.0207123904084872
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00733794577816775,0.00317742204715922,-0.0135656929905998,-0.00111019856573568,0.0209339959634134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0266642333352233,0.0115629917912186,0.00400076942443485,0.0493276972460117,0.0211237892208183
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0138862749604042,0.0060285333925089,-0.0257022004097216,-0.00207034951108676,0.0212704275322583
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA2,Ephrin type-A receptor 2,39248,0.0064817886776796,0.00282063942115313,0.000953335412219458,0.0120102419431397,0.0215759581025761
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00866034657380734,0.00379151000479747,0.00122898696440431,0.0160917061832104,0.0223785914546015
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G1B,Phospholipase A2,40031,-0.00891350348227297,0.0039228617802707,-0.0166023125716036,-0.00122469439294239,0.0230878589785298
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.013098940666668,0.0057876843765013,0.00175507928872547,0.0244428020446106,0.023634098876594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171B,Protein FAM171B,37368,0.00602610715685681,0.00266387845087607,0.000804905393139699,0.0112473089205739,0.0237036203671089
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA2,GDNF family receptor alpha-2,39788,0.00451134158798845,0.00199898834944782,0.000593324423070717,0.00842935875290619,0.0240332962688857
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB39B,Ras-related protein Rab-39B,37021,0.0192480679684179,0.00853390228125864,0.00252161949715102,0.0359745164396849,0.024119408036984
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,36962,0.0120984653436881,0.00537177773811535,0.00156978097698203,0.0226271497103942,0.0243243860744637
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT1,Diamine acetyltransferase 1,37021,-0.0107284141549211,0.00477783657846061,-0.0200929738487039,-0.00136385446113826,0.0247555058013821
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.00584062665320696,0.00260582241938494,0.000733214711212489,0.0109480385952014,0.0250179161597439
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNLZ,DNL-type zinc finger protein,36991,-0.0192291417528518,0.0086321457386673,-0.0361481474006397,-0.00231013610506386,0.025922734303789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.0108715694091949,0.00488093263848917,0.00130494143775613,0.0204381973806337,0.0259404818328989
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00431900147189708,0.00193935524429632,-0.00812013775071786,-0.0005178651930763,0.0259590810336276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.00839038302496612,0.00377405293373572,-0.0157875267750881,-0.000993239274844113,0.0262179774210861
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L,Seizure 6-like protein,39913,0.0057467070852707,0.00258662087967256,0.000676930161112478,0.0108164840094289,0.0263171764424441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOC,Myocilin,39858,-0.00971692977943867,0.00441369831285311,-0.0183677784726308,-0.00106608108624657,0.0277120999670104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MELTF,Melanotransferrin,37437,0.00613569067750752,0.00279298273033888,0.000661444526043308,0.0116099368289717,0.0280498782707481
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,37039,0.0105018537203346,0.00479896788483397,0.00109587666605997,0.0199078307746091,0.0286611191097055
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.0062324002885257,0.00285062339351252,0.000645178437241161,0.0118196221398102,0.0288059864562142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLVRB,Flavin reductase,39858,0.0135185475964532,0.00619445901128632,0.00137740793433205,0.0256596872585744,0.0290973723900079
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.0110510132514386,0.005066911951937,-0.0209821606772351,-0.00111986582564211,0.0292000366599541
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MN1,Transcriptional activator MN1,37039,-0.0123813697897081,0.00568630215664396,-0.0235265220167303,-0.00123621756268594,0.0294682114997224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.00892024858068602,0.00409758428689937,0.000888983378363253,0.0169515137830088,0.0294985746245896
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO1,Alpha-enolase,39830,0.0165175794209498,0.00759426020229151,0.00163282942445843,0.0314023294174412,0.0296441123396069
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00697230071600037,0.00321800273997073,-0.013279586086343,-0.000665015345657738,0.0302790790681182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6,Interleukin-6,39788,0.0146992539460513,0.00680005071084168,0.00137115455280166,0.028027353339301,0.0306608703588794
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXDNL,Peroxidasin-like protein,37368,0.0123391321762783,0.00572016746773053,0.00112760393952641,0.0235506604130301,0.0310132909131141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.0077722712329993,0.00360444078651819,0.000707567291423651,0.0148369751745749,0.0310779214369316
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSAP,Gamma-secretase-activating protein,39477,0.0182291180200221,0.00845425576691572,0.00165877671686728,0.0347994593231769,0.0310827941379608
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR1,Interferon gamma receptor 1,39931,0.00417980475726137,0.00193935761678926,0.00037866382835442,0.00798094568616832,0.0311569079327836
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE,Angiotensin-converting enzyme,37445,-0.00530966094804544,0.00246538901571669,-0.0101418234188502,-0.000477498477240729,0.0312827520856744
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31,Interleukin-31,37056,-0.0118971848631798,0.00552515296076366,-0.0227264846662765,-0.00106788506008299,0.0313149759945785
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPTC,Opticin,39788,-0.00911900908772514,0.00423593599197082,-0.017421443631988,-0.000816574543462321,0.0313514852064869
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB44,Ras-related protein Rab-44,37368,0.00872988272246228,0.00405987227065334,0.000772533071981734,0.0166872323729428,0.0315503660634134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00802906273027784,0.00374350842179598,-0.015366339236998,-0.000691786223557716,0.0319872528451145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00971979255495805,0.0045355996971045,-0.0186095679612829,-0.000830017148633221,0.0321313121051346
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36A,Interleukin-36 alpha,37056,-0.0121110648413388,0.00565914968316479,-0.0232029982203418,-0.00101913146233579,0.0323661293094467
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAGLN3,Transgelin-3,36962,-0.0123043000570055,0.00575099624748776,-0.0235762527020815,-0.00103234741192946,0.0324130046710109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCG22,Protein PBMUCL2,37021,-0.0111212430682098,0.00521193924656099,-0.0213366439914694,-0.000905842144950295,0.0328774780622029
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.00629181825084253,0.00295413501916381,0.000501713613281459,0.0120819228884036,0.0332005767291614
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNN,Tenascin-N,37437,0.00878096287094175,0.00413184258116539,0.000682551411857581,0.0168793743300259,0.0335885194826282
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00841493342906835,0.00395971853792485,-0.016175981763401,-0.000653885094735648,0.0335939901298822
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00661798788391188,0.00311540950843752,-0.0127241905204494,-0.000511785247374333,0.0336657518277148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLNS1A,Methylosome subunit pICln,37039,-0.00685286295482296,0.00323614901741819,-0.0131957150289626,-0.000510010880683306,0.0342277950637126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN15,Tetraspanin-15,37021,-0.0100276586145155,0.00474932858265132,-0.0193363426365121,-0.000718974592518887,0.0347580798693431
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,37039,0.0106822699569635,0.00506211252880403,0.000760529400507647,0.0206040105134194,0.0348565232856704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0138654700258608,0.00657758093640013,0.000973411390516592,0.0267575286612051,0.0350507238464062
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALB,Ras-related protein Ral-B,37056,0.00591036168501913,0.00281296703219686,0.000396946301913283,0.011423777068125,0.0356499622122695
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAP1,Antigen peptide transporter 1,37169,-0.0118630955755785,0.00565402064495109,-0.0229449760396826,-0.000781215111474325,0.0359089481547722
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSND,Barttin,36962,-0.00676564875744004,0.00324268004070872,-0.0131213016372291,-0.000409995877650953,0.0369583129054491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D2,DCN1-like protein 2,36962,-0.0160997231508907,0.00773289871039746,-0.0312562046232697,-0.000943241678511652,0.0373638604432408
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX5,Syntaxin-5,37056,0.00815116146466847,0.00391610605462449,0.000475593597604467,0.0158267293317325,0.037412374311367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,37186,0.0083988231710668,0.00404020947450412,0.000480012601038726,0.0163176337410949,0.0376540074947251
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,39489,0.010781222696837,0.00518704796609256,0.000614608683295633,0.0209478367103785,0.0376806086611996
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPLX2,Complexin-2,36962,-0.00598096225179211,0.00288476621366218,-0.01163510403057,-0.00032682047301424,0.0381646245159194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL11,Interleukin-11,39587,0.0123881220740633,0.00597708685404703,0.000673031840131084,0.0241032123079954,0.0382255877918825
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,37169,-0.00879768995131582,0.00425459648048375,-0.017136699053064,-0.000458680849567671,0.0386773305626423
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPE4,NXPE family member 4,37021,-0.00694336732251083,0.00336142533119638,-0.0135317609716557,-0.000354973673365914,0.0388855928202343
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,39667,-0.007509450759238,0.00365424790247287,-0.0146717766480848,-0.000347124870391169,0.0398961598413125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TUBB3,Tubulin beta-3 chain,36991,-0.00555113497955331,0.00270539487475109,-0.0108537089340654,-0.000248561025041182,0.0402014956670182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPN1,Epsin-1,37169,0.00848177661980335,0.00413954232945613,0.000368273654069336,0.0165952795855374,0.0404851209241425
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0120901325815183,0.00592034173758095,-0.0236940023871769,-0.000486262775859597,0.0411581528460223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,40052,-0.00612036804242597,0.0030070091073249,-0.0120141058927828,-0.000226630192069168,0.0418301777718839
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESPL1,Separin,36962,-0.0105032502517594,0.0051742238523982,-0.0206447290024599,-0.000361771501058924,0.0423850372842287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00841680641006126,0.00417060025728233,-0.0165911829143346,-0.000242429905787897,0.0435980961625673
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPO,Lactoperoxidase,39344,-0.0115932044868234,0.00574566918077227,-0.0228547160811371,-0.000331692892509752,0.0436366878236393
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00900077445807435,0.00446539118762823,0.000248607730323024,0.0177529411858257,0.0438505715830416
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00709457036393349,0.0035433980781197,-0.0140396305970481,-0.000149510130818879,0.0452843519068162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00487056865447831,0.00243691991309067,-0.00964693168413603,-9.42056248205902e-05,0.0456653816099076
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.0055253405563762,0.00276778736394924,-0.0109502037897167,-0.000100477323035695,0.0459216294083175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0123270282666181,0.0062304499570601,0.000115346350780296,0.0245387101824559,0.0478910437311057
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0089134648978059,0.00450663824460383,-0.0177464758572294,-8.04539383823938e-05,0.0479661598948712
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP6,Guanylate-binding protein 6,37021,-0.00876636877779709,0.00444214342166117,-0.017472969884253,-5.97676713411984e-05,0.0484646678291881
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00273357139026857,0.00139124877747337,6.72378642075375e-06,0.00546041899411638,0.0494539849446007
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.00684618055491963,0.00348610367427783,1.34173533350877e-05,0.0136789437565042,0.0495685894246769
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.0124410399882222,0.00634325021373398,-0.0248738104071408,-8.26956930362333e-06,0.0498647083388032
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,37021,-0.00525311782046009,0.00267933674296787,-0.0105046178366771,-1.61780424306427e-06,0.0499463192955452
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELB,Transcription factor RelB,37056,0.00925884808824653,0.004730257455054,-1.24565236592992e-05,0.0185301527001524,0.0503254280627305
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0182748366164581,0.00936839390794033,-0.0366368886760212,8.72154431049259e-05,0.0511150730810794
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0114261914082221,0.00588571139665457,-0.022962185745665,0.000109802929220894,0.0522379130932048
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD7,FERM domain-containing protein 7,37039,0.00623524207455795,0.00323013409867918,-9.58207588532553e-05,0.0125663049079691,0.0535867281027557
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB2,Integrin beta-2,39731,-0.00532528204879161,0.00276091799974857,-0.0107366813282988,8.61172307155805e-05,0.0537724538561377
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00855936053568545,0.00445496287441588,-0.000172366698169675,0.0172910877695406,0.0547143290017795
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,37169,0.00966525592570468,0.00506705550593284,-0.000266172865923698,0.0195966847173331,0.0564812663670083
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT1A1,Sulfotransferase 1A1,40009,-0.0235614927581523,0.0123936912947264,-0.0478531276958162,0.000730142179511468,0.057308324568686
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00852454675304162,0.00449181846053644,-0.000279417429609807,0.017328510935693,0.0577450668168094
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REST,RE1-silencing transcription factor,36962,-0.0064964091400217,0.00343238943586034,-0.013223892434308,0.00023107415426457,0.0584226793534815
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTKN2,Rhotekin-2,37021,-0.00945643510138929,0.00499887616090398,-0.0192542323767611,0.00034136217398251,0.058551268225352
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0103059691506084,0.00545140193246535,-0.000378778637023659,0.0209907169382405,0.0587068657181038
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB1,Lamin-B1,37348,0.0105215319472058,0.00557327997153848,-0.000402096797009647,0.0214451606914212,0.0590671664565427
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP4,Caspase-4,37169,-0.0298447879073536,0.0158453016981973,-0.0609015792358203,0.00121200342111307,0.0596530383578097
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPE,Coatomer subunit epsilon,39489,0.00853544438393674,0.0045468054942272,-0.000376294384748569,0.0174471831526221,0.0605038413469067
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.00887044613320255,0.00475217026566979,-0.0181846998539153,0.000443807587510232,0.0619745460125917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00875253657607813,0.00469538585105039,-0.000450419691980647,0.0179554928441369,0.0623332921360275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,37043,0.0104753264102171,0.00563637526880752,-0.000571969116645607,0.0215226219370799,0.0631172196050306
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNL1,Thioredoxin-like protein 1,36971,0.0174782458283817,0.0094043895529563,-0.000954357695412633,0.0359108493521761,0.0631176034950114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.00933149839420122,0.00502280657751525,-0.000513202497728675,0.0191761992861311,0.0632125982626067
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA10,Ephrin type-A receptor 10,39489,0.0114479522151335,0.00616455928187276,-0.000634583977337112,0.0235304884076041,0.0633215154693841
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX1B,Syntaxin-1B,37039,0.00756719486903897,0.00408383406177307,-0.000437119892036245,0.0155715096301142,0.0639099490898269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00685745224592937,0.00370198831075105,-0.000398444843142682,0.0141133493350014,0.0639944719112912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.0100422157195822,0.00542180985161084,-0.0206689630287395,0.000584531589574987,0.0640211382135201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22,Interleukin-22,37368,-0.0116483830090981,0.00629216338019427,-0.0239810232342788,0.000684257216082722,0.0641550519263082
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP9,Matrix metalloproteinase-9,39843,0.0107514375574044,0.00581992812430329,-0.000655621566230049,0.0221584966810389,0.064715064636728
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTN,Titin,37021,-0.0120954750368183,0.00657941621990207,-0.0249911308278264,0.00080018075418971,0.0660287756263693
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.00740558080862349,0.0040328565814632,-0.000498818091044378,0.0153099797082914,0.0663300288577328
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK12,Kallikrein-12,39477,-0.0242704306989818,0.0132349082052223,-0.0502108507812176,0.00166998938325397,0.066699833552525
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN2,Neuroligin-2,36991,-0.0082785218203973,0.00453048870158617,-0.0171582796755062,0.000601236034711596,0.0676786926810616
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,37382,0.00878767309631292,0.00481193528368894,-0.00064372005971741,0.0182190662523432,0.0678385228722512
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00604580491001704,0.00332533858248298,-0.000471858711649596,0.0125634685316837,0.0690672196886802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.00570332119660838,0.00314879907008571,-0.000468324980759618,0.0118749673739764,0.0701180055302299
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00573210014579008,0.00316869732832359,-0.0119427469093043,0.000478546617724157,0.0704732772162653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC3,Membrane primary amine oxidase,39931,-0.00521482468761731,0.00288393999797586,-0.01086734708365,0.000437697708415384,0.0705895111467383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00441122588319158,0.00245130973817988,-0.00921579297002416,0.000393341203640991,0.0719557573046631
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.0048415206803989,0.00269499096361546,-0.0101237029690852,0.000440661608287397,0.072435608463886
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00671532251099712,0.00374453645419645,-0.00062396893922792,0.0140546139612222,0.0729374485763447
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.00599846682910815,0.00334488684251092,-0.0125544450404296,0.000557511382213252,0.0729399664908517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",37021,0.0109287251250949,0.00610778773907684,-0.00104253884349574,0.0228999890936855,0.0735879055292273
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00693665905879785,0.00387678089579523,-0.0145351496145565,0.000661831496960799,0.0735919438588191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.00676672433934506,0.00379564852537996,-0.000672746770399674,0.0142061954490898,0.0746479617744155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.0106419450437011,0.00600534600161517,-0.0224124232068669,0.00112853311946462,0.0764043875663103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.00998514835581203,0.00563577258446058,-0.00106096590973071,0.0210312626213548,0.076456196605702
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL9,Interleukin-9,37169,-0.00972211540128919,0.00550443469878939,-0.0205108074109164,0.00106657660833802,0.077379651315778
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.00580712094586094,0.00332071855788952,-0.000701487427602519,0.0123157293193244,0.0803526071514957
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF12,Fibroblast growth factor 12,37056,0.00787514106214983,0.00450667574032016,-0.000957943388877676,0.0167082255131773,0.0805844729111963
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00793517832550007,0.00455079884060342,-0.0168547440530828,0.000984387402082631,0.0812366662323313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.0107985846008554,0.00619325244621429,-0.0229373593954354,0.0013401901937246,0.0812513458716284
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00966396036937329,0.00554543096653728,-0.00120508432503978,0.0205330050637864,0.0814114005433665
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSMB,Beta-microseminoprotein,39780,0.0111783590121758,0.00644257102978435,-0.00144908020620156,0.0238057982305531,0.0827464594833879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,37382,0.00487187365569793,0.00281770862983824,-0.000650835258785016,0.0103945825701809,0.0838283982089991
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA4,Ephrin type-A receptor 4,37124,0.0046797332551578,0.00270932816499956,-0.000630549948241328,0.00999001645855694,0.0841429943478972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0143531169642144,0.00831498664495614,-0.00194425685989958,0.0306504907883285,0.0843396193801883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC44A4,Choline transporter-like protein 4,37039,-0.0112306702344681,0.00651544612110233,-0.0240009446318287,0.00153960416289247,0.0847855857374085
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00715356361072131,0.0041550182673366,-0.015297399414701,0.000990272193258431,0.0851530424452609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WIF1,Wnt inhibitory factor 1,40030,-0.00553903631204337,0.00321886205529093,-0.0118480059404136,0.000769933316326848,0.0853052098649559
NMR metabolomics,X23508.Triglycerides in Medium VLDL,H2AP,Huntingtin-interacting protein M,36962,-0.0082797060947267,0.0048179353366982,-0.0177228593546552,0.00116344716520177,0.0857258929012684
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00672257976234995,0.00391328736240641,-0.0143926229926665,0.000947463467966622,0.0858410712144903
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKLR,Pyruvate kinase PKLR,39881,-0.01050086603768,0.00614052910681975,-0.0225363030870467,0.00153457101168674,0.0872683344572143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00797426500648389,0.00469771408405863,-0.00123325459827103,0.0171817846112388,0.0896306599909724
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00416428794304499,0.00245378981032972,-0.00897371597129126,0.000645140085201266,0.0897036609831985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOP56,Nucleolar protein 56,37021,0.0180078993712523,0.0106152818986971,-0.00279805315019395,0.0388138518926986,0.089831392355064
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD9,Enhancer of filamentation 1,37056,0.00544804612905343,0.00321237718435512,-0.000848213152282604,0.0117443054103895,0.0899180505606146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP8,Neutrophil collagenase,39985,0.0116712581318571,0.00688339806029527,-0.00182020206632162,0.0251627183300359,0.0899873398838785
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1B,Protein phosphatase 1B,37056,0.0103672939709457,0.00613133138611079,-0.00165011554583149,0.0223847034877228,0.090884948111452
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRC,Chymotrypsin-C,39856,0.0100296687157852,0.00593253957250284,-0.00159810884632041,0.0216574462778907,0.0909289280540289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,40058,0.00927976760036392,0.00549589466299355,-0.00149218593910343,0.0200517211398313,0.0913363014432246
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPT,Microtubule-associated protein tau,39489,0.00853654493217662,0.00506010844794398,-0.00138126762579357,0.0184543574901468,0.0916179126988661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDRG1,Protein NDRG1,39489,0.0111937281744625,0.00665696034088388,-0.00185391409366989,0.0242413704425949,0.092684376721745
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA5,Annexin A5,39415,0.00486287193962492,0.00290685579412925,-0.000834565416868412,0.0105603092961182,0.0943675751504114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.011085763103909,0.006628842050916,-0.00190676731588633,0.0240782935237044,0.0944747737078819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,37021,0.00637264725741986,0.00382190789704196,-0.00111829222078237,0.0138635867356221,0.0954587881675131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTNNA1,Catenin alpha-1,36991,-0.00562897143674922,0.00337606834826248,-0.0122460653993437,0.000988122525845242,0.0954755121024838
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUCL3,Mucin-like protein 3,36962,-0.00720465964896043,0.00432545721462636,-0.0156825557896281,0.00127323649170725,0.0958088111122478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00603608271543573,0.00362773127397791,-0.00107427058156097,0.0131464360124324,0.0961582958428679
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP2,Dipeptidase 2,39788,-0.00464416790692673,0.00279265270686273,-0.0101177672123777,0.000829431398524215,0.0963330808766527
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",37021,0.00893855217620359,0.00542108218697665,-0.00168676891027063,0.0195638732626778,0.0992022051459701
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLHL41,Kelch-like protein 41,37411,0.00809554611866182,0.00491189749498014,-0.00153177297149925,0.0177228652088229,0.099344982498258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB1,Scavenger receptor class B member 1,39489,0.00901409447179344,0.00547649686051985,-0.00171983937482547,0.0197480283184124,0.0997921131182433
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAU,Urokinase-type plasminogen activator,39858,-0.00452244580731762,0.00274825310137435,-0.00990902188601134,0.000864130271376098,0.0998717431969743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,37056,0.00505441231017787,0.00307196957982537,-0.000966648066279845,0.0110754726866356,0.0999250160059835
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1A,Interleukin-1 alpha,39587,0.00842041464493594,0.00512900037713545,-0.00163242609424955,0.0184732553841214,0.10066673981877
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00414107894662667,0.00252388624623472,-0.000805738095993372,0.00908789598924672,0.100872289046512
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00578328395519,0.00352808137295621,-0.0126983234461842,0.00113175553580417,0.101192389365145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.00714525141369669,0.00437832373760734,-0.0014362631120137,0.0157267659394071,0.102707827723366
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,37388,0.00418687906290483,0.00257738204412974,-0.000864789743589466,0.00923854786939913,0.104298896495881
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM132A,Transmembrane protein 132A,37043,0.00977612612323009,0.00602867396724019,-0.0020400748525607,0.0215923270990209,0.104911926875267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENG,Endoglin,40052,-0.00263528632488499,0.00162696071203732,-0.00582412932047814,0.000553556670708168,0.105303257584826
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.00535731621806489,0.00330772856405179,-0.00112583176747662,0.0118404642036064,0.10533007757288
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP73,Tumor protein p73,37039,-0.00537337858877872,0.00332642234559637,-0.0118931663861476,0.00114640920859016,0.106256109655883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG3,Proteoglycan 3,37437,-0.00775720511041542,0.00480346501200529,-0.0171719965339458,0.00165758631311495,0.106351555038979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00871336452437854,0.00540236890687281,-0.0193020075818492,0.00187527853309216,0.106794996373573
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00851890082099656,0.00530261758493315,-0.0189120312874655,0.00187422964547241,0.108177850196788
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0398313595998304,0.0248251370111608,-0.0884886281417056,0.00882590894204467,0.108632919921476
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRTN,Neurturin,39587,0.00763838451525924,0.00476880052296339,-0.001708464509749,0.0169852335402675,0.109232922921486
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.00516544041274715,0.00323151627400861,-0.011499212309804,0.00116833148430973,0.109961014773367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASN,Vasorin,39642,0.00419133127275429,0.0026250800461993,-0.000953825617796345,0.00933648816330492,0.110364004690685
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF1,Formylglycine-generating enzyme,37056,0.0104597535783305,0.00657530229585309,-0.00242783892154152,0.0233473460782026,0.111686672405219
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,39788,-0.00702115019902276,0.00444021779704297,-0.015723977081227,0.00168167668318146,0.113837869988567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPA33,Cell surface A33 antigen,39788,0.019862481838287,0.0126093229458161,-0.00485179113551261,0.0445767548120865,0.115225090801482
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,36991,-0.0129002561100276,0.00819690379577681,-0.0289661875497501,0.00316567532969499,0.115558662991462
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDAN1,Codanin-1,37388,0.00339706095653359,0.00216682785295409,-0.000849921635256427,0.00764404354832361,0.116961089242058
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX9,Transcription factor SOX-9,37039,0.00406279547315503,0.0025965474965545,-0.0010264376200918,0.00915202856640186,0.117679301548622
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0126418973425033,0.0081357283807296,-0.00330413028372674,0.0285879249687333,0.12023847096119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0116808399029653,0.0075347805947544,-0.00308733006275332,0.0264490098686839,0.121100173500821
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH2,Growth hormone variant,39477,0.0244507116121502,0.0157927946877824,-0.00650316597590324,0.0554045892002036,0.121589737648225
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00710848553696725,0.00460713966895155,-0.0161384792881123,0.00192150821417779,0.122872186060422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD160,CD160 antigen,40058,0.00664109428462706,0.00430551794726611,-0.00179772089201452,0.0150799094612686,0.122981099594999
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI2,Protein-arginine deiminase type-2,39587,0.00843325278879503,0.00547483789674478,-0.00229742948882474,0.0191639350664148,0.123491343706872
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJP3,Tight junction protein ZO-3,36991,-0.00640516685567962,0.00417676723714456,-0.014591630640483,0.00178129692912371,0.125171240010349
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17F,Interleukin-17F,39587,-0.0113749314224302,0.00744449541347444,-0.0259661424328401,0.00321627958797971,0.126541239180256
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00764809347141101,0.0050053948269696,-0.00216248038944941,0.0174586673322714,0.126543734311367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00724697461793985,0.0047558401063833,-0.00207447199057142,0.0165684212264511,0.127577574578459
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTN,Neuroplastin,39477,0.0122454645820431,0.00806770939412325,-0.00356724583043843,0.0280581749945247,0.129075838212474
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00713376861673016,0.00469996232320579,-0.0163456947702135,0.00207815753675319,0.129080003441179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00494354383015547,0.00326326537446308,-0.00145245630379216,0.0113395439641031,0.129815538123432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLI2,Zinc finger protein GLI2,37056,-0.00500975624897027,0.00330855714815151,-0.0114945282593472,0.00147501576140669,0.130003745252749
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0123601197244956,0.00817911501711212,-0.0283911851580353,0.00367094570904418,0.130766459107547
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.00384108149256078,0.00254456363405669,-0.00882842621531189,0.00114626323019032,0.131184600077106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH17,Protocadherin-17,39868,-0.00504561486036436,0.0033574989254249,-0.0116263127541972,0.00153508303346844,0.132913004319334
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGM2,Phosphoglucomutase-2,37039,0.00873675045049838,0.00581821889647728,-0.00266695858659709,0.0201404594875939,0.13321938433458
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCP11,T-complex protein 11 homolog,37169,-0.00848915866081769,0.00572397200139586,-0.0197081437835536,0.0027298264619182,0.138074502906136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00939754111991151,0.00633709900764893,-0.0218182551749034,0.00302317293508038,0.138114257576611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3G,Semaphorin-3G,37124,0.00624886992315646,0.00421666539158679,-0.00201579424435364,0.0145135340906666,0.138378450454234
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.00971553519857853,0.0065652561641341,-0.0225834372802814,0.00315236688312431,0.138938888230255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5A,Cytochrome b5,36962,0.0101955643559221,0.00689246686069474,-0.00331367069103961,0.0237047994028838,0.139102097072949
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOH,Beta-2-glycoprotein 1,39858,0.00503926694821822,0.00341111990717458,-0.00164652806984396,0.0117250619662804,0.139613390299446
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTN3,Myeloblastin,39421,-0.0065544043271207,0.00444235954918004,-0.0152614290435136,0.00215262038927218,0.140116374155266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,39477,0.0065812464292066,0.00446563207679157,-0.00217139244130487,0.0153338852997181,0.140567794637495
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA6C,Semaphorin-6C,37056,0.00370625685843206,0.00251771370341017,-0.00122846200025188,0.00864097571711599,0.14102517509927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN1,Cerebellin-1,36991,-0.0135933283090444,0.00924218358421477,-0.0317080081341053,0.00452135151601656,0.141371378402887
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",37388,0.00840359811661912,0.00575517150351547,-0.0028765380302712,0.0196837342635094,0.144263269595361
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR2,Toll-like receptor 2,37169,-0.00318177399893814,0.00218168699429869,-0.00745788050776356,0.00109433250988728,0.14475370519872
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00323711661077108,0.00222111725804367,-0.00111627321499452,0.00759050643653668,0.145018260523624
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,37056,0.00282349893632071,0.0019374933144279,-0.00097398795995797,0.00662098583259939,0.145058816317815
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.0035438566801375,0.0024345206670426,-0.00122780382726599,0.00831551718754099,0.145508092592459
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00724728535157279,0.0049824214129018,-0.00251826061771475,0.0170128313208603,0.145813052649075
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRXN3,Neurexin-3,37039,0.00490299043116362,0.00337144180240202,-0.00170503550154434,0.0115110163638716,0.145894969370206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REN,Renin,39868,-0.00917970900495368,0.00632921782183025,-0.021584975935741,0.00322555792583361,0.146974901334621
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP13,Collagenase 3,39489,-0.00445959005892228,0.00308384517464975,-0.0105039266012358,0.00158474648339122,0.148165429703526
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.0100327840466055,0.00695469953249157,-0.0236639951302889,0.003598427037078,0.149159370757751
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0128402873781817,0.00891576360358284,-0.00463460928484065,0.0303151840412041,0.149840914613536
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0114784066760431,0.00802871186296435,-0.0272146819274532,0.00425786857536706,0.152835662745784
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGF,Beta-nerve growth factor,39749,0.00168581161213864,0.00118124377042582,-0.000629426177895972,0.00400104940217326,0.153556419897218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00744367851725331,0.00522033558961951,-0.0176755362729075,0.00278817923840092,0.153920587976164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0203929062227658,0.0143284940863359,-0.00769094218645242,0.0484767546319841,0.154685673780293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEF,Thyrotroph embryonic factor,37021,0.00580696037413545,0.00408011436830398,-0.00219006378774034,0.0138039845360112,0.154691831599245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00593213515314152,0.00418019752781464,-0.00226105200137517,0.0141253223076582,0.155892108113955
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,37021,0.00631207962884403,0.00446520184327985,-0.00243971598398447,0.0150638752416725,0.157498407650041
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD33,Myeloid cell surface antigen CD33,39913,0.0106378165659351,0.00753978215591071,-0.00414015645964992,0.02541578959152,0.158295908510073
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.00944867769900805,0.00669956452117513,-0.0225798241605113,0.00368246876249521,0.15846169377974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRNN,Cornulin,39397,0.00872775428058896,0.00621247943580599,-0.00344870541359079,0.0209042139747687,0.160078576429971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00677558192364774,0.00482455979457313,-0.00268055527371559,0.0162317191210111,0.160225210842585
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.00934856065801504,0.00666410879084197,-0.0224102138880653,0.00371309257203521,0.160693467776778
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00712379728017198,0.00508771482725803,-0.00284812378125376,0.0170957183415977,0.161478352024064
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.00400681578078699,0.00286437187977313,-0.00962098466514233,0.00160735310356835,0.161882604553883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00648272976224071,0.0046398128155068,-0.015576762880634,0.00261130335615262,0.162378041387322
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00403087553254199,0.00288602503642148,-0.00968748460392808,0.00162573353884411,0.16253112408531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBX2,Chromobox protein homolog 2,37021,-0.00540682042943823,0.00389137487283699,-0.0130339151801987,0.00222027432132227,0.164723395008835
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.0179665637295192,0.0129313695010528,-0.0433120479515827,0.00737892049254428,0.164740540158463
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00459501112072776,0.0033227735163976,-0.0111076472128671,0.00191762497141153,0.166723907640328
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.00473164898072376,0.00343167343001512,-0.0114577289035534,0.00199443094210588,0.16797051335123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBZ,Hemoglobin subunit zeta,37437,-0.013983739090626,0.0101419695090816,-0.0338619993284259,0.00589452114717397,0.167979399324835
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD177,CD177 antigen,39844,-0.0165333622437653,0.0119924495744097,-0.0400385634096083,0.00697183892207761,0.168022715681436
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00608423006691176,0.00441391784471639,-0.0147355090425559,0.00256704890873236,0.168097199791449
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00778317243230671,0.00565087062949429,-0.0188588788661155,0.0032925340015021,0.16843050550959
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,37368,0.00498809028099142,0.00362255813275802,-0.0021121236592143,0.0120883042211972,0.168549769292447
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0120768687848518,0.00878939447510619,-0.0293040819560599,0.00515034438635636,0.169456682884444
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR1B,Cornifin-B,37169,0.0115160817597367,0.00842601898286438,-0.00499891544667749,0.0280310789661509,0.171733452995366
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL21R,Interleukin-21 receptor,37056,-0.00706987449614875,0.00522834308775626,-0.017317426948151,0.00317767795585352,0.176327850846804
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA10,Annexin A10,39489,0.0101634877820783,0.00753092605065444,-0.00459712727720437,0.0249241028413611,0.177174526754854
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.0061965826207661,0.00459540214387008,-0.0152035708227515,0.00281040558121925,0.177543009016653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36G,Interleukin-36 gamma,37021,0.00873689148852744,0.00648712715667669,-0.00397787773855887,0.0214516607156138,0.178066423470524
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF9,Fibroblast growth factor 9,36931,0.00523274837759376,0.00389638874193336,-0.00240417355659562,0.0128696703117831,0.179303744392911
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC8,Histone deacetylase 8,37056,0.00816023317911334,0.00607741361552772,-0.00375149750732099,0.0200719638655477,0.179387437512533
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00448678109923988,0.00334661800847139,-0.00207259019736405,0.0110461523958438,0.180043171430372
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROK1,Prokineticin-1,39866,0.00827219916374733,0.00621570209248691,-0.00391057693752703,0.0204549752650217,0.183255633361911
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,39822,-0.0060332726579208,0.00454688302896421,-0.0149451633946906,0.00287861807884906,0.184559758045252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASA1,Ras GTPase-activating protein 1,39489,0.00415860986361659,0.00313782126602204,-0.00199151981778661,0.0103087395450198,0.185085195128938
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANK2,Ankyrin-2,37021,-0.00903300438406054,0.00683313706225188,-0.0224259530260742,0.00435994425795314,0.186210757121293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.00256368818864372,0.00194021040602482,-0.00636650058445237,0.00123912420716493,0.186409176597414
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00612497629944967,0.00464407736944744,-0.0152273679435666,0.00297741534466732,0.187232470782145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCA2A,Guanylin,39796,-0.00408306947149385,0.00309720956863666,-0.0101536002260217,0.001987461283034,0.187420232965094
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNG,Uracil-DNA glycosylase,37368,0.00438696409015427,0.00333406243205458,-0.00214779827667272,0.0109217264569813,0.188263031920078
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00634159184088407,0.00482096135709608,-0.0157906761007924,0.00310749241902425,0.188391607302565
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB7,Integrin beta-7,40030,-0.00574412482938504,0.00436952823427731,-0.0143084001685686,0.00282015050979849,0.188667400461857
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_A,,37411,0.00407260440126475,0.00310308260890471,-0.00200943751218849,0.010154646314718,0.189394526662082
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHD,SH2 domain-containing adapter protein D,37002,0.0104909180158621,0.00800074405528734,-0.00519054033250106,0.0261723763642253,0.189798656442133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL14,C-X-C motif chemokine 14,39587,0.00776889474958295,0.0059354915612161,-0.0038646687104006,0.0194024582095665,0.190591355638378
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA1,Laminin subunit alpha-1,37021,-0.00678100791398017,0.00521601083190399,-0.017004389144512,0.00344237331655165,0.19361100002875
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00370988787631949,0.00285953793641509,-0.00931458223169308,0.00189480647905409,0.194521396963511
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.00520388477162585,0.00401848067870498,-0.0130801069018876,0.00267233735863591,0.195342782348817
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN4,Alpha-actinin-4,39587,0.00389131214354282,0.00301616595158979,-0.00202037312157317,0.00980299740865881,0.197016902125319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00607146847851851,0.00471105587937943,-0.00316220104506517,0.0153051380021022,0.197500638186564
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD82,CD82 antigen,37169,-0.00520781609446756,0.00405079045167741,-0.0131473653797553,0.00273173319082016,0.198594731287755
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP350,Centrosome-associated protein 350,36962,-0.0044749812412191,0.00348146885375692,-0.0112986601945827,0.00234869771214445,0.198685175056061
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00675690328961665,0.00526348990152055,-0.0170733434965969,0.00355953691736363,0.199258919973026
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,40030,0.00721702257067505,0.00563031009180937,-0.00381838520927132,0.0182524303506214,0.199925515673462
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.00351255449725074,0.00274734042713055,-0.00187223273992514,0.00889734173442661,0.201081280016843
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF2,Trefoil factor 2,39908,0.00695458666016839,0.00548064773352254,-0.0037874828975358,0.0176966562178726,0.20448259161123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00529905233593686,0.00418508913656694,-0.0135018270436081,0.00290372237173435,0.20547319553593
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1,Huntingtin-interacting protein 1,37021,0.00408486681251658,0.00322675505298404,-0.00223957309133214,0.0104093067163653,0.20555824590077
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRND,Prion-like protein doppel,37388,-0.00617214700848178,0.00488326177840097,-0.0157433400941477,0.00339904607718411,0.206273553638823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00567837978984822,0.0044954841759902,-0.00313276919509257,0.014489528774789,0.206564233273606
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNR,Tenascin-R,39749,-0.00509190651938174,0.00403188133114835,-0.0129943939284325,0.00281058088966903,0.206639767171013
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00617190365082809,0.00488716188996389,-0.0157507409551573,0.00340693365350113,0.206654340806129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,37437,0.00353083579293139,0.00280508598958898,-0.00196713274666302,0.00902880433252579,0.208150814606443
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00335932394573843,0.0026718631790352,-0.00187752788517055,0.00859617577664742,0.208668579801159
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGBL1,Integrin beta-like protein 1,37437,0.00431753986903202,0.00343472123641304,-0.00241451375433755,0.0110495934924016,0.208765215257469
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B4,Protein ATP1B4,36962,-0.00505944083292715,0.0040279671455172,-0.0129542564381409,0.00283537477228657,0.209110096013833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00787713937765482,0.00629737024728968,-0.0202199850623426,0.00446570630703296,0.211006921092637
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.007619283172635,0.00612423592621882,-0.0196227855880239,0.00438421924275389,0.213477631853905
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.006469586127852,0.00525776777413329,-0.00383563870944925,0.0167748109651533,0.218538881723913
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH22,Cadherin-22,37169,-0.0034268479885826,0.00278608909864511,-0.00888758262192701,0.00203388664476181,0.218724437666907
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1,DNA topoisomerase 1,37382,0.0134326937302244,0.0109415986848795,-0.00801283969213934,0.0348782271525881,0.219591513126285
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSV,Cathepsin L2,39967,0.00482478484198626,0.00393424221332311,-0.00288632989612703,0.0125358995800996,0.220082348464062
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00863428469382862,0.00704616128028651,-0.0224447608031902,0.00517619141553294,0.220450872730286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDNRB,Endothelin receptor type B,37056,0.00548817702670275,0.00448587951376618,-0.00330414682027896,0.0142805008736845,0.221187705173874
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00726660168538321,0.00595134076309128,-0.0189312295810421,0.0043980262102757,0.222106963286425
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPA,Apolipoprotein(a),37186,-0.0205461944956874,0.0169161853170182,-0.0537019177170431,0.0126095287256683,0.22454481650546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0199589629232106,0.0164856256805415,-0.0123528634106507,0.0522707892570719,0.226032817531942
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RETN,Resistin,39790,0.00473734606693958,0.00391646523233462,-0.00293892578843628,0.0124136179223154,0.226451375911476
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.0100180583411451,0.00831725639292582,-0.0263198808712797,0.00628376418898953,0.228421376483625
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.00744350542000742,0.00618221138957161,-0.0195606397435678,0.00467362890355294,0.228599657277382
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTOA,Otoancorin,36991,-0.00613001492541779,0.00509271329377294,-0.0161117329812127,0.00385170313037717,0.228733633530719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERVV_1,,37021,-0.00556204657392987,0.00462797069621869,-0.0146328691385185,0.00350877599065876,0.229449973388518
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL6,Fc receptor-like protein 6,39866,-0.00751366854983537,0.00633082374670937,-0.0199220830933857,0.00489474599371499,0.235308745259614
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00866150744417181,0.00730178275811342,-0.0229730016500741,0.0056499867617305,0.235557611718914
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,39835,0.00504191604899155,0.0042530973018895,-0.00329415466271188,0.013377986760695,0.235849600767335
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDSN,Corneodesmosin,39992,0.00479306738793288,0.00406375912717367,-0.00317190050132752,0.0127580352771933,0.238229898296902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLGAP5,Disks large-associated protein 5,37411,-0.00594046014582422,0.00504214343446199,-0.0158230612773697,0.00394214098572128,0.238752847711231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.0072134629325502,0.00612648757629534,-0.0192213785820891,0.00479445271698867,0.239048391366132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00583190599349248,0.00496093449680134,-0.0155553376072231,0.00389152562023814,0.239789579504218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,39699,0.00316899212409002,0.00272317132451538,-0.00216842367196013,0.00850640792014017,0.244557533621762
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00858142407248625,0.00742682580473966,-0.023138002649776,0.00597515450480349,0.247921157806762
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00512757585890257,0.00444212203728231,-0.0138341350519759,0.00357898333417077,0.24839507733758
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00402511931416417,0.00348721634750124,-0.0108600633552666,0.00280982472693826,0.248415246220656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1A,Lithostathine-1-alpha,39804,-0.00514096644003676,0.004460773186567,-0.0138840818857081,0.00360214900563456,0.249139822139769
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00605300976042209,0.0052542744112381,-0.00424536808560458,0.0163513876064488,0.249331887264423
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.0036702241711553,0.0032187748313596,-0.00263857449830953,0.00997902284062012,0.254197436403256
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB2,Beta-crystallin B2,37388,0.00619574389830508,0.00545911675880845,-0.00450412494895948,0.0168956127455696,0.256422568622167
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.00237405248005557,0.00209198350674167,-0.00647434015326924,0.0017262351931581,0.256465218542176
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00523245248365593,0.00461505915064397,-0.00381306345160624,0.0142779684189181,0.256907806989676
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00453442394806102,0.00400650139784847,-0.012387166687844,0.00331831879172199,0.257753193361825
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,39913,-0.00444067811856868,0.00392400532306681,-0.0121317285517796,0.00325037231464227,0.257790208818546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00852039319380749,0.00752993216239353,-0.0232790602320988,0.00623827384448383,0.257849731469438
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,39931,0.00324382434109239,0.0028759748532307,-0.00239308637123979,0.00888073505342456,0.259377185051297
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00314191974642013,0.00278644874506885,-0.00231951979391481,0.00860335928675507,0.259518789877985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00347041218006735,0.00309661654320133,-0.00953978060474196,0.00259895624460726,0.26243140027293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20,Interleukin-20,39587,0.00525453949380334,0.0046904174532567,-0.00393867871457978,0.0144477577021865,0.262615326672831
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6,Seizure protein 6 homolog,37039,-0.00334489322281934,0.00298780256579356,-0.00920098625177472,0.00251119980613604,0.262940408018621
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLON5,IgLON family member 5,36962,0.0099239902973771,0.00886975562250609,-0.00746073072273484,0.027308711317489,0.263221559644249
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.0028776247018835,0.00257219416199593,-0.00791912525939552,0.00216387585562852,0.26326658752498
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17A,Interleukin-17A,39558,-0.00454618146234337,0.00406727477604342,-0.0125180400233885,0.00342567709870174,0.26369245404612
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,37056,-0.00996605156083438,0.00895530285607654,-0.0275184451587444,0.00758634203707565,0.265786280506448
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00339713035816185,0.00306324380562926,-0.00260682750087149,0.0094010882171952,0.267450851941077
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF1,Trefoil factor 1,39789,0.00801031378600659,0.00722971439872198,-0.00615992643548849,0.0221805540075017,0.267891076144018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS2,Podocin,37056,-0.0107965221097881,0.00981449840657649,-0.030032938986678,0.00843989476710181,0.271326713864815
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.00685746688781297,0.00623460254640367,-0.0190772878787642,0.00536235410313823,0.271390392612777
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.00763545004324488,0.00698759498103892,-0.0213311362060812,0.0060602361195914,0.2745354174707
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSP90B1,Endoplasmin,39405,0.00707331099713998,0.00647927577381973,-0.00562606951954668,0.0197726915138266,0.274989665475932
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGN,Secretagogin,39587,-0.00449993567851396,0.00414026144864946,-0.0126148481178669,0.00361497676083898,0.27710988612208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHIT1,Chitotriosidase-1,39906,0.0157319286907861,0.0144853973084126,-0.0126594500337025,0.0441233074152748,0.277471264418192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,37056,0.00998154257304363,0.0092008713598698,-0.00805216529230117,0.0280152504383884,0.278009008834306
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00515524218617449,0.00475786687309075,-0.0144806612574324,0.00417017688508338,0.278594567459383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF7,Fibroblast growth factor 7,36962,-0.00828559722242004,0.0076544338588521,-0.0232882875857702,0.00671709314093008,0.279069334160256
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD8,Frizzled-8,36991,0.00442161355657586,0.00409173541217011,-0.00359818785127754,0.0124414149644293,0.27988576382925
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171A2,Protein FAM171A2,37411,0.0162943893503836,0.0151007443047318,-0.0133030694868906,0.0458918481876579,0.280586675342839
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDI2,Protein DDI1 homolog 2,37124,0.00775256985144745,0.00723267403742263,-0.0064234712619009,0.0219286109647958,0.283792740531553
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTH3,Cytohesin-3,36962,0.00743284532703123,0.00695545540133064,-0.00619984725957682,0.0210655379136393,0.285253713578029
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,37388,0.00293857150371652,0.00275989441379934,-0.00247082154733018,0.00834796455476322,0.287012356921449
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00261240032711883,0.00246494126982849,-0.00744368521598268,0.00221888456174502,0.289244875674601
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A3,Protein S100-A3,37368,0.00458977281717909,0.00433858248270999,-0.0039138488489325,0.0130933944832907,0.290121381116661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA11,Serpin A11,40052,-0.00414620925798304,0.00392854071097787,-0.0118461490514997,0.0035537305355336,0.291254982353842
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTO1,Protein LTO1 homolog,39587,0.00408381822618284,0.00387617510843992,-0.0035134849863594,0.0116811214387251,0.292096439575518
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.00887721761946703,0.00844767591480573,-0.0076802271735522,0.0254346624124863,0.293348144649618
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.0049369709041385,0.00472300199317855,-0.00432011300249145,0.0141940548107685,0.295901924237367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.00621613501402415,0.00595882859411413,-0.00546316903043954,0.0178954390584878,0.296880363206376
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTTG1,Securin,37169,0.00418325079480136,0.00401160489693454,-0.00367949480319033,0.0120459963927931,0.297065737528269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JUN,Transcription factor AP-1,39587,0.00518411002955438,0.00498647515291914,-0.00458938127016713,0.0149576013292759,0.298525871150681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,37161,-0.00983980782783736,0.00950465750825265,-0.0284689365440126,0.00878932088833784,0.300565535385774
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,36991,0.0115901055610205,0.0111987645001613,-0.0103594728592958,0.0335396839813367,0.300713646924553
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00759327545682452,0.00737813344967764,-0.0220544170181927,0.00686786610454365,0.303423729465972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF75D,Zinc finger protein 75D,37169,0.00584033162355061,0.00569030810647053,-0.00531267226513162,0.0169933355122328,0.304738343229092
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM2,Isthmin-2,37437,-0.0043759539393774,0.00427807815719736,-0.0127609871274842,0.00400907924872943,0.306383546140507
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO6,Coronin-6,36991,-0.00370729360426278,0.00364348552820068,-0.0108485252395361,0.00343393803101055,0.308928235385544
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00393831349657409,0.00387657981837533,-0.00365978294744155,0.0115364099405897,0.309683883405833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.00455116153027313,0.00450453514460302,-0.00427772735314879,0.0133800504136951,0.312342802431171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00545136809104764,0.00546018041861434,-0.00525058552943647,0.0161533217115317,0.31811062190866
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4C,Semaphorin-4C,39788,0.00269543703754173,0.00272085667493408,-0.00263744204532906,0.00802831612041253,0.321867905108431
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCC,Netrin receptor DCC,37039,0.00214718615518421,0.00217328370199982,-0.00211244990073543,0.00640682221110385,0.323174874797881
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC5D,Netrin receptor UNC5D,37056,0.00252513859242672,0.00255945583442262,-0.00249139484304161,0.00754167202789504,0.323860793663165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACHE,Acetylcholinesterase,37124,0.00307769957741731,0.00314677558642886,-0.00308998057198325,0.00924537972681788,0.328068106418606
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLINT1,Clathrin interactor 1,36962,-0.00458968503574142,0.00470516412506057,-0.0138118067208601,0.0046324366493773,0.329351656537658
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00859500873732919,0.00881204694066027,-0.00867660326636494,0.0258666207410233,0.329394585648672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRP15,RRP15-like protein,36991,0.00847566961678479,0.00869085099476499,-0.00855839833295458,0.0255097375665242,0.329458956753402
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAND5,DAN domain family member 5,37056,-0.00503148298450604,0.005164497860291,-0.0151538987906764,0.00509093282166431,0.329953075058618
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPGN,Epigen,37368,-0.00466407024489561,0.00479731434121392,-0.0140668063536749,0.00473866586388368,0.330955898816851
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR4,Toll-like receptor 4,37056,0.00257527241564518,0.00265179992985874,-0.00262225544687796,0.00777280027816832,0.331495722744044
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN1,Neuroligin-1,37039,-0.00627138908458691,0.00646528577703998,-0.0189433492075853,0.00640057103841144,0.332059522744339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,39931,-0.00253598521643732,0.00261640287945782,-0.00766413486017465,0.00259216442730001,0.332428054449783
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0134207858364187,0.013848150210069,-0.0405631602481539,0.0137215885753166,0.332493608753568
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.00420419454807856,0.00436093929870183,-0.00434324647737703,0.0127516355735341,0.335031814957875
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRV1,Acrosomal protein SP-10,37056,0.00675799853549267,0.00701793228721595,-0.00699714874745059,0.0205131458184359,0.335584494428979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00709247740411153,0.00737191120068523,-0.0215414233574546,0.00735646854923153,0.336019209485211
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSLP,Thymic stromal lymphopoietin,39585,0.00555005728974076,0.00577014321157868,-0.00575942340495344,0.016859537984435,0.336135825917686
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00484085285055326,0.0050364373773314,-0.0147122701101228,0.00503056440901628,0.336486151177112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR1,TGF-beta receptor type-1,37056,0.00200626621929215,0.00209440978150478,-0.00209877695245723,0.00611130939104153,0.338123249925767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEB,Nebulin,37021,-0.00345351024756924,0.00361169946001358,-0.0105324411891959,0.00362542069405738,0.338988312309746
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS1,"Nitric oxide synthase, brain",39489,-0.0049591969012987,0.00518769391956874,-0.0151270769836534,0.00520868318105602,0.339110246614185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00426926326201679,0.00447276945826107,-0.0130358914002085,0.00449736487617491,0.339847127461291
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00396897027266807,0.00416419835990134,-0.0121307990580747,0.00419285851273855,0.340547547807598
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.00891248769997142,0.00938131342282597,-0.00947488660876747,0.0272998620087103,0.342116253275601
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESR1,Estrogen receptor,37056,0.00542496910732287,0.00571749872147823,-0.00578132838677446,0.0166312666014202,0.342721361291147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP7,Retinoid-binding protein 7,37382,0.00549173113530642,0.00579509174205115,-0.00586664867911383,0.0168501109497267,0.343323504010496
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,40030,-0.00508391276465891,0.00538408617765471,-0.0156367216728621,0.00546889614354432,0.345057024797082
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,39477,0.00311528759695497,0.00330671273663258,-0.00336586936684488,0.00959644456075483,0.346150826858926
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00242907256968834,0.00258508804387911,-0.00263769999631471,0.00749584513569138,0.347414910468757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.00443644975888497,0.00472215451776542,-0.0136918726137052,0.00481897309593526,0.347492806338944
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00192798994436653,0.00205495474463059,-0.00209972135510942,0.00595570124384248,0.348150543972733
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXOSC10,Exosome component 10,37021,-0.00548557186018413,0.00586458862891945,-0.0169801655728663,0.006009021852498,0.349613795269271
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00463902046473407,0.00497825853118085,-0.0143964071858485,0.00511836625638039,0.351428003059468
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,37039,0.0069784680419463,0.00750845814423937,-0.00773810992076286,0.0216950460046555,0.35269146503615
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL4,Early placenta insulin-like peptide,37368,-0.00474636467726746,0.00513874096969256,-0.0148182969778649,0.00532556762332996,0.355688457687018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA3,Carbonic anhydrase 3,40017,-0.00530768412470439,0.00578651521225021,-0.0166492539407148,0.00603388569130603,0.359025066871875
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00261509752212431,0.00286052719819368,-0.00822173083058393,0.00299153578633532,0.360627376613453
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00473371683007303,0.00518246152075282,-0.0148913414107486,0.00542390775060251,0.361043246677935
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00473210961985087,0.00519275266756626,-0.0149099048482807,0.00544568560857899,0.362158486003589
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.0037699777156068,0.0041570349577484,-0.0119177662327937,0.00437781080158007,0.36448058527123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00257932563594278,0.00284700278047833,-0.0081594510856803,0.00300079981379474,0.364962877057626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6B,Ras-related protein Rab-6B,39489,0.00407918159909255,0.00452002402942542,-0.00478006549858128,0.0129384286967664,0.366821685896401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00484467477742577,0.00539614756856259,-0.0154211240118084,0.00573177445695691,0.369307312524734
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00336291268237222,0.00375185431627377,-0.00399072177752437,0.0107165471422688,0.370091070548531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD1,Glutamate decarboxylase 1,36962,-0.00222643500794039,0.00249435910943034,-0.00711537886242385,0.00266250884654307,0.372094241013837
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBN2,Fibrillin-2,37039,0.00515513720350533,0.00577584158421306,-0.00616551230155227,0.0164757867085629,0.372122868360757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00342550732889634,0.00386231450688917,-0.00414462910460642,0.0109956437623991,0.375143094079128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCNA,Proliferating cell nuclear antigen,36962,0.00543353948834213,0.00614875784683349,-0.00661802589145151,0.0174851048681358,0.376884741405803
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,39866,0.00369160125672073,0.00419628659409807,-0.00453312046771148,0.0119163229811529,0.37901853608672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0141427620326992,0.0163688035113666,-0.0462256169149777,0.0179400928495793,0.387599329946924
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00359095090360385,0.0041774740307144,-0.0117788000038041,0.00459689819659637,0.390025993935791
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.00297150585242085,0.00347206851836285,-0.00383374844357034,0.00977676014841204,0.392106107814002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00518718330422532,0.00607814716240394,-0.0067259851340864,0.017100351742537,0.393444442447802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK1,Kallikrein-1,39720,-0.0101998538069889,0.0120691479993256,-0.033855383885667,0.0134556762716892,0.398057727003947
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAN,Brevican core protein,39749,0.00269807999886186,0.00319940333207547,-0.00357275053200605,0.00896891052972978,0.399069328658654
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00446992287382835,0.00532384525855068,-0.0149046595805877,0.00596481383293097,0.40114556986451
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00545813074426043,0.00653488068372981,-0.0182664968843709,0.00735023539585,0.403603011985821
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHH,Sonic hedgehog protein,37056,-0.00348733519497195,0.00419767992514748,-0.011714787848261,0.00474011745831711,0.406114748382729
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.00413518864281215,0.00498628765182711,-0.0139083124403933,0.00563793515476898,0.406942871070099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC51B,Organic solute transporter subunit beta,37021,0.0060395218330127,0.00729223957611164,-0.00825326773616612,0.0203323114021915,0.407565350079831
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00368413687714599,0.00445628033188246,-0.0124184463276356,0.00505017257334363,0.408405614130484
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,37021,0.00371020219382404,0.00448860819987957,-0.00508746987793993,0.012507874265588,0.408489077374171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STEAP4,Metalloreductase STEAP4,36991,-0.00596753968114489,0.00722385385754371,-0.0201262932419306,0.00819121387964079,0.408769128660416
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.00212811719000679,0.00257624943252497,-0.00717756607775573,0.00292133169774215,0.408786642774907
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENND2B,DENN domain-containing protein 2B,37021,-0.00407766338734528,0.0049604586939338,-0.0138001624274555,0.00564483565276498,0.411072703797947
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF8,SLAM family member 8,39477,0.0041064946549471,0.00499993855522133,-0.0056933849132867,0.0139063742231809,0.411482806180979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00444626808873575,0.00541490762435282,-0.0150594870324673,0.00616695085499577,0.411594985967634
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00509491648405624,0.00620990685016413,-0.00707650094226546,0.0172663339103779,0.411972280657757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,37382,0.00392113325733706,0.00478115798344172,-0.00544993639020871,0.0132922029048828,0.412160968990415
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00507173385203514,0.00621552855824357,-0.0172541698261925,0.00711070212212226,0.414527551439726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBR1,T-box brain protein 1,37039,-0.00377874447844805,0.0046324107845688,-0.0128582696162029,0.00530078065930679,0.414675736947419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFRC,Transferrin receptor protein 1,39918,-0.00305117648017817,0.00375006991839297,-0.0104013135202284,0.00429896055987205,0.415867926461825
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORN4,MORN repeat-containing protein 4,36962,0.00623472551005859,0.00767085571506132,-0.00880015169146158,0.0212696027115788,0.416358419152825
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABO,Histo-blood group ABO system transferase,37445,0.0111508313203777,0.0137933539252042,-0.0158841423730225,0.0381858050137778,0.418862659151732
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2B,Alpha-amylase 2B,38832,0.00372766563816778,0.00462014630411138,-0.00532782111789053,0.0127831523942261,0.419778122305286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,37056,-0.00429535581470575,0.00533235720659819,-0.0147467759396382,0.00615606431022671,0.420530350756324
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99,CD99 antigen,39858,-0.00147769461815517,0.0018393030206073,-0.00508272853854548,0.00212733930223513,0.421755960049271
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPEP,Glutamyl aminopeptidase,37021,0.00322998640118118,0.0040298765245204,-0.0046685715868788,0.0111285443892412,0.422850917752996
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",39842,0.00502001356686929,0.00627530155782673,-0.0072795774864711,0.0173196046202097,0.423743708507411
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00312885052705767,0.00392231194119641,-0.0108165819318026,0.00455888087768729,0.42505567298927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00440055135039843,0.00553946456923762,-0.0064567992053073,0.0152579019061042,0.426976919402326
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL33,Interleukin-33,39587,0.00297591768489679,0.0037602094001176,-0.00439409273933372,0.0103459281091273,0.428708898576193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNPO1,Transportin-1,37169,-0.00268919607068233,0.00340405432493337,-0.00936114254755173,0.00398275040618708,0.429543017731409
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD70,CD70 antigen,39866,-0.00318786720676384,0.00405517014783524,-0.0111360006965209,0.00476026628299324,0.431806391803316
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL2,Podocalyxin-like protein 2,39913,0.00206624947915644,0.00263958748786308,-0.00310734199705521,0.00723984095536808,0.433760477293811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLNL,Mesothelin-like protein,37039,-0.00272332290007857,0.00348681223867728,-0.00955747488788604,0.00411082908772889,0.434795853877102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR3,Folate receptor gamma,39858,-0.0139870402244937,0.0181677560839341,-0.0495958421490045,0.0216217617000171,0.441380873276539
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.00268095722789818,0.00349662322690861,-0.0041724242968427,0.00953433875263907,0.443255210757593
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXK,Tyrosine-protein kinase TXK,37169,-0.00546295050887619,0.00713257283930446,-0.0194427932739129,0.00851689225616056,0.443739964071002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD2,Bromodomain-containing protein 2,36991,-0.00248149791051713,0.00325421914656932,-0.008859767437793,0.00389677161675874,0.445746775645186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00370452174682974,0.00490658807438444,-0.0133214343726232,0.00591239087896376,0.450256634798061
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD2,Glutamate decarboxylase 2,37056,-0.00336226756455178,0.00448058787960128,-0.0121442198085703,0.00541968467946673,0.453022585210421
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.0035022538326295,0.00466950915551538,-0.0126544917774396,0.00564998411218063,0.453252441265509
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,37437,-0.00167298943365077,0.00223597380175621,-0.00605549808509294,0.00270951921779141,0.454343365119332
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00267567576874815,0.00358980177084194,-0.00436033570210205,0.00971168723959834,0.456070607226983
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD4,Sushi domain-containing protein 4,37368,0.0029891109458169,0.00401321399400502,-0.00487678848243294,0.0108550103740667,0.456395172829024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MKI67,Proliferation marker protein Ki-67,37056,0.00281186913355321,0.00377944395620209,-0.00459584102060289,0.0102195792877093,0.45689567202851
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX101,Testis-expressed protein 101,37039,0.00346551049121949,0.0046730587605682,-0.00569368467949419,0.0126247056619332,0.458346814132936
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,36991,0.00309081973359336,0.00417409825435297,-0.00509041284493845,0.0112720523121252,0.459024435904393
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00362050273980343,0.00489241828139349,-0.0132096425713347,0.0059686370917278,0.459299006895484
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,37382,-0.00563653919639795,0.00762473030396157,-0.0205810105921626,0.00930793219936673,0.459771435093557
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG1,Arginase-1,39754,0.00364091931758924,0.00496812882056483,-0.00609661317071782,0.0133784518058963,0.463657523359079
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53BP1,TP53-binding protein 1,37056,-0.00619858944204868,0.00846053372529922,-0.0227812355436352,0.0103840566595378,0.463786424817101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,39913,0.00201057730411714,0.00274631462324895,-0.00337219935745081,0.00739335396568508,0.464118139725341
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00601618869418162,0.00823217071495394,-0.0221512432954913,0.0101188659071281,0.464905407086425
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00393242422423712,0.00542360735103271,-0.006697846183787,0.0145626946322612,0.468430039653516
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL1,Delta-like protein 1,39913,-0.00197886266685743,0.00272989655235944,-0.00732945990948193,0.00337173457576707,0.468532788643735
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0101520389334753,0.0140075675080413,-0.0173027933822857,0.0376068712492363,0.468615573065133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00339892671068708,0.00469244433115353,-0.012596117599748,0.00579826417837385,0.46886975216808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00172646632956986,0.00238434967720422,-0.00294685903775041,0.00639979169689012,0.469027439343919
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00801132146691944,0.0111444781989918,-0.0298544987369434,0.0138318558031045,0.472239843509955
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00238511486495535,0.00332471018499218,-0.00890154682754002,0.00413131709762932,0.473146029970663
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,37039,0.00250502882558719,0.00349210648799159,-0.00433949989087632,0.0093495575420507,0.473176840798426
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2A,Pancreatic alpha-amylase,39246,0.00323978358804994,0.00451865822659201,-0.00561678653607039,0.0120963537121703,0.473397865422888
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.00211063201267685,0.00294584097221689,-0.00366321629286826,0.00788448031822196,0.473706516355151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD2,Leiomodin-2,36991,-0.00440679639418111,0.00616529811711769,-0.0164907807037318,0.00767718791536956,0.474761250173891
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN1,Transcobalamin-1,37235,0.0023436794437194,0.00328883477497683,-0.00410243671523518,0.00878979560267398,0.476095244412164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2BP,LRP2-binding protein,37039,-0.00544866658153937,0.00766293810156196,-0.0204680252606008,0.00957069209752208,0.477071137065411
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1B,Lithostathine-1-beta,40052,0.00367250394524278,0.00521781258539792,-0.00655440872213714,0.0138994166126227,0.481542692432698
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00213567653761238,0.00304671327727645,-0.00383588148584946,0.00810723456107422,0.483329638038788
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00324685493229502,0.00463208139468737,-0.0123257344658823,0.00583202460129221,0.483346979671376
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHP1,Calcineurin B homologous protein 1,36991,0.00486393487899707,0.00697656433102981,-0.00881013120982136,0.0185380009678155,0.4857012623719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOS,Proto-oncogene c-Fos,36931,-0.00236441082205534,0.00339866089262001,-0.00902578617159057,0.00429696452747989,0.486636016572389
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKIV2L,Helicase SKI2W,37021,0.00267156303512274,0.00387307005422665,-0.0049196542711615,0.010262780341407,0.490345233759979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL25,Interleukin-25,36903,-0.0022589164684795,0.00330166564007978,-0.00873018112303587,0.00421234818607687,0.493876940963445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00383939251070764,0.00562456239269049,-0.00718474977896572,0.014863534800381,0.494862104715248
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,39489,0.00343645560006231,0.00504249266868083,-0.00644683003055212,0.0133197412306767,0.495565660213469
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.00520224620989338,0.00764085920641969,-0.00977383783468921,0.020178330254476,0.495979209988977
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA8,Carbonic anhydrase-related protein,37056,0.00170605200281615,0.00250881305049909,-0.00321122157616208,0.00662332558179437,0.496501467222998
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,37056,-0.00501481578260309,0.0073903722571121,-0.0194999454065428,0.00947031384133661,0.49742818375086
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00207191365438647,0.00306740087415613,-0.00394019205895954,0.00808401936773247,0.499393989004587
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM3,Paralemmin-3,37021,0.00489571703909839,0.00727874393075757,-0.00937062106518646,0.0191620551433832,0.501210648912907
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.00371379840392015,0.00552491488995464,-0.00711503478039095,0.0145426315882312,0.501473550607176
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB118,Beta-defensin 118,36991,0.00374446476910177,0.00558454377285844,-0.00720124102570076,0.0146901705639043,0.502547684208728
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL6B,Myosin light chain 6B,37039,-0.005909533780456,0.00888536128320326,-0.0233248418955344,0.0115057743346224,0.506006811038734
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WNT9A,Protein Wnt-9a,39587,0.00179558140627235,0.00270197817107074,-0.00350029580902629,0.007091458621571,0.506352408426456
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,36942,-0.00302400872358144,0.00456908446766277,-0.0119794142802005,0.00593139683303758,0.50808460341165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBH,Dopamine beta-hydroxylase,37430,-0.00690778156436621,0.010475466958819,-0.0274396968036515,0.013624133674919,0.509634281196799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00396612366018667,0.00601595002342876,-0.015757385706107,0.0078251383857337,0.509735214352017
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,36962,0.0025178040910669,0.00381928894966222,-0.00496800225027105,0.0100036104324048,0.509757277816828
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YY1,Transcriptional repressor protein YY1,37056,-0.00175213002561844,0.00267049704901949,-0.00698630424169663,0.00348204419045976,0.511767149644269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.00160804481057662,0.00246697152557698,-0.00644330900070751,0.00322721937955427,0.514522225087842
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,36991,0.00652830998867815,0.0101085925185266,-0.0132845313476341,0.0263411513249904,0.51840857969386
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3,Interleukin-3,36962,-0.00369385812653201,0.00573482691003079,-0.0149341188701924,0.00754640261712834,0.519515521051066
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,36991,0.00461659968015971,0.00722015726440171,-0.00953490855806764,0.0187681079183871,0.522571099406751
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00219757698136349,0.00344516483313602,-0.00455494609158311,0.0089501000543101,0.523567451014853
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",39585,0.00514646486827442,0.00808512885162528,-0.0107003876809111,0.02099331741746,0.524437252741984
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.00201681733575103,0.00317292328388607,-0.00823574697216772,0.00420211230066566,0.525024294245809
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00242575970216252,0.00382725905580172,-0.00992718745153389,0.00507566804720885,0.526215074850052
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL2,Interferon lambda-2,36991,-0.00377229929818336,0.00595621539338849,-0.0154464814692248,0.00790188287285808,0.526523781315155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD48,CD48 antigen,39908,-0.00175875796681426,0.00278068758460666,-0.00720890563264332,0.00369138969901479,0.527075546108005
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,39885,0.00144636477874604,0.00228922806886568,-0.00304052223623069,0.00593325179372277,0.527517883734865
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THY1,Thy-1 membrane glycoprotein,40009,0.00163510830066511,0.00259449199735115,-0.00345009601414315,0.00672031261547337,0.52855766823576
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00292805890008487,0.00466593016441114,-0.00621716422216096,0.0120732820223307,0.530316084414161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,36991,-0.00363121587141604,0.00579002584136791,-0.0149796665204971,0.00771723477766506,0.530571686903774
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVPL,Envoplakin,37169,-0.00197699029144696,0.00316419045850047,-0.00817880359010787,0.00422482300721395,0.532112192711133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00226381467286648,0.00362389322799481,-0.00483901605400335,0.00936664539973632,0.532182728326065
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBQLN3,Ubiquilin-3,37021,-0.00281172369209701,0.00452076862333584,-0.0116724301938352,0.00604898280964123,0.533980916688994
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKKL1,Dickkopf-like protein 1,39788,0.0050235264420553,0.00808268412229862,-0.01081853443765,0.0208655873217606,0.534268338039491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00263366264526309,0.00426839080525831,-0.0057323833330432,0.0109997086235694,0.537235000744498
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,37368,-0.00264752179130301,0.00443609245290266,-0.0113422629989922,0.0060472194163862,0.550641615691402
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00156639959509497,0.002630300336702,-0.00358898906484095,0.0067217882550309,0.551503460084232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,39866,0.00264383415309538,0.00449128543093932,-0.00615908529154568,0.0114467535977365,0.556098568118101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.0032794739395648,0.00566317982945877,-0.014379306405304,0.00782035852617438,0.562540367517824
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00342431552745983,0.00600632660408888,-0.00834808461655437,0.015196715671474,0.568607329719171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLLT1,Protein ENL,36962,-0.00390481016226645,0.00686501878462068,-0.017360246980123,0.00955062665559008,0.569502862045854
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00186742634625258,0.00329409483395634,-0.00458899952830185,0.00832385222080701,0.57079086267709
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00162575037506502,0.00286922231327399,-0.00724942610908205,0.003997925358952,0.570983732948102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO1,R-spondin-1,39749,-0.00189886114022929,0.00339053030192937,-0.00854430053201086,0.00474657825155228,0.575454306378742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,39585,-0.00172037912674909,0.0030784774403471,-0.00775419490982941,0.00431343665633122,0.57627825910906
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCL2,Phosducin-like protein 2,36962,-0.00283806487268436,0.00510846322218862,-0.0128506527881741,0.00717452304280533,0.578520225192394
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00303372535244837,0.00549307346844579,-0.0138001493506021,0.00773269864570537,0.580762898195593
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELL,L-selectin,37453,-0.00119420825071622,0.0021764606265306,-0.0054600710787162,0.00307165457728375,0.583225307675168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR1,Toll-like receptor 1,37056,-0.0013683551416108,0.00250991079297671,-0.00628778029584515,0.00355107001262354,0.585638398149612
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",39585,-0.00226093285616736,0.0041505954403856,-0.0103960999193231,0.00587423420698843,0.585950433195186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,39794,-0.00134008569578081,0.00249713116607926,-0.00623446278129616,0.00355429138973455,0.591516821295343
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00167060156424964,0.00314943631174326,-0.00450229360676715,0.00784349673526644,0.595812642215614
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00316621888471739,0.00597330554151729,-0.0085414599766565,0.0148738977460913,0.596076635166397
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM25,RNA-binding protein 25,36962,-0.00232555298662313,0.00439280223873986,-0.0109354453745533,0.00628433940130699,0.596536417907052
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00258542068324628,0.00494940195265186,-0.00711540714395137,0.0122862485104439,0.601421082928544
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSTN,Osteocrin,37039,-0.00207488718299107,0.00401914382036736,-0.0099524090709111,0.00580263470492896,0.60568774698154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00324332173549279,0.00630736352667319,-0.0156057542477722,0.00911911077678666,0.607112347461102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00157343811696014,0.00306601860664379,-0.0044359583520617,0.00758283458598197,0.607828360848389
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC9,Histone deacetylase 9,36991,-0.00314782100953373,0.00617426073746787,-0.0152493720549708,0.00895373003590329,0.610179400495182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,37169,0.00409533096035925,0.00805269428667397,-0.0116879498415217,0.0198786117622402,0.611064509420119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC2,Stanniocalcin-2,39831,-0.00128327812247461,0.00254258893903258,-0.00626675244297847,0.00370019619802925,0.613767273287902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB5,Serpin B5,39585,0.00234186037566492,0.00467448181988846,-0.00682012399131647,0.0115038447426463,0.61638641839678
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF20,Fibroblast growth factor 20,37056,-0.00206915021893621,0.00413329404847682,-0.0101704065539508,0.00603210611607836,0.616657057200066
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00350005142577178,0.00702113014612258,-0.0102613636606285,0.017261466512172,0.61813809593705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.00290804479228355,0.00584898373409561,-0.00855596332654384,0.0143720529111109,0.619064744706789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN2,Prorelaxin H2,37095,0.00678628891362238,0.0136652315432029,-0.0199975649110553,0.0335701427383001,0.619472436836395
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP15,Matrix metalloproteinase-15,37437,0.0023368802028952,0.00476265560029065,-0.00699792477367448,0.0116716851794649,0.623669583359794
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNB2,Ephrin-B2,37039,-0.00282825471941066,0.00578886558634321,-0.0141744312686434,0.00851792182982202,0.625155672897411
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX2,Transcription factor SOX-2,37391,0.00108864470087324,0.00228402626193107,-0.00338804677251166,0.00556533617425814,0.633630425026341
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00274349369711349,0.00578210704325112,-0.00858943610765871,0.0140764235018857,0.635165563932797
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00127201123259727,0.00269036895174904,-0.00400111191283085,0.00654513437802539,0.636362230925849
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A16,Protein S100-A16,39456,-0.00281424310515325,0.0059698962544453,-0.014515239763866,0.00888675355355955,0.637357642468787
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00165231162706461,0.00353876404804347,-0.0052836659071006,0.00858828916122981,0.640566468381242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00563385669522001,0.0121988353426618,-0.0182758605763971,0.0295435739668371,0.644205637312974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00183834274920757,0.00398545245512504,-0.00964982956125265,0.0059731440628375,0.644617350861212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00169485216664953,0.00368737561807883,-0.00892210837808403,0.00553240404478498,0.645784787288079
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00211958317395639,0.00471301780938137,-0.0113570980803439,0.0071179317324311,0.652911691677243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,37043,-0.00178302529985811,0.00397069454993295,-0.00956558661772669,0.00599953601801047,0.653405710605206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,37039,0.00174124282992157,0.00389587546227234,-0.0058946730761322,0.00937715873597535,0.654921973300517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASQ2,Calsequestrin-2,37021,0.00209225000890834,0.00469123636713306,-0.00710257327067245,0.0112870732884891,0.655610959086806
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL12,Stromal cell-derived factor 1,39587,0.00167557748018542,0.00382983169321644,-0.00583089263851879,0.00918204759888964,0.661749839861417
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PITHD1,PITH domain-containing protein 1,36931,-0.00329838002448518,0.00760638498117473,-0.0182068945875876,0.0116101345386173,0.664562077013193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00295736240463188,0.00682513737286,-0.0104199068461737,0.0163346316554375,0.664800696290846
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00131141540004257,0.00305781312963008,-0.00468189833403239,0.00730472913411753,0.668021070538671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRN1,Neuritin,37411,-0.00143998217880266,0.00338370466231645,-0.0080720433169429,0.00519207895933757,0.670432488780394
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,37124,-0.00160728429591402,0.00380766140603358,-0.00907030065173984,0.0058557320599118,0.672945371644586
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNW1,Interferon omega-1,37021,-0.0014252697374249,0.00340679732642073,-0.00810259249720954,0.00525205302235974,0.675690322756719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSG1,Tryptase gamma,37056,0.0010704326978094,0.00258741156522104,-0.00400089397002385,0.00614175936564264,0.679094737719828
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00290288620053964,0.00718385294312981,-0.0111774655679948,0.0169832379690741,0.686156899719407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAG,Myelin-associated glycoprotein,37039,-0.00178927063329676,0.00443430030904605,-0.010480499239027,0.00690195797243349,0.686581929021914
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00100276956508376,0.00249348870467285,-0.00388446829607503,0.00589000742624255,0.687576306880897
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGN,Mimecan,39858,0.00152553888305043,0.00379367006026887,-0.00591005443507656,0.00896113220117742,0.687595601107117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00086498730581839,0.00216694986167399,-0.00338223442306263,0.00511220903469941,0.689772390115122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00143718263323816,0.00364394461739618,-0.00857931408333468,0.00570494881685836,0.693289931089211
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA3,GDNF family receptor alpha-3,39709,-0.00104044052519494,0.0026567450467747,-0.00624766081687334,0.00416677976648347,0.695342595923654
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00141373270601385,0.00361179303434302,-0.00566538164129846,0.00849284705332617,0.695492142046531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5L,CD5 antigen-like,37380,-0.00175321623378294,0.00449293241489796,-0.0105593637669829,0.00705293129941706,0.696382630076676
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTF,Ciliary neurotrophic factor,36991,0.00124624234423301,0.00326202439422385,-0.00514732546844574,0.00763981015691175,0.702433660965395
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMCH,Pro-MCH,37021,-0.00301637664490258,0.00797314042934793,-0.0186437318864245,0.0126109785966194,0.705201026378895
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKAP12,A-kinase anchor protein 12,37124,-0.000759177267694994,0.00202942567441886,-0.00473685158955596,0.00321849705416598,0.708347217378642
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00277423072648278,0.00748891379297263,-0.0174525017607091,0.0119040403077436,0.711056897496521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00174343818897024,0.00472404982988039,-0.00751569947759532,0.0110025758555358,0.712092038806354
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GJA8,Gap junction alpha-8 protein,36962,0.00211340906022363,0.00574555529273305,-0.00914787931353315,0.0133746974339804,0.713003155122646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP10,Bone morphogenetic protein 10,37124,0.000999154764922683,0.0027213330590303,-0.00433465803077671,0.00633296756062207,0.713508239768541
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00118530445201481,0.00323104034799149,-0.00751814353407813,0.00514753463004852,0.713737456773879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRAS,GTPase Hras,37161,0.00344413354817892,0.00939432044639336,-0.0149687345267521,0.0218570016231099,0.713909289216596
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAYN,Layilin,39713,-0.00112654514053213,0.00309988683386732,-0.00720232333491208,0.00494923305384781,0.716299800223834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.00113529629884892,0.00318074558291227,-0.00509896504365912,0.00736955764135697,0.721150609760372
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00120516608985526,0.00338193143747971,-0.00542341952760497,0.0078337517073155,0.721580891751919
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRING1,SREBP regulating gene protein,36962,0.00204660092051066,0.00575941810979553,-0.00924185857468858,0.0133350604157099,0.722334202212595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.00183682894678699,0.00522836724363499,-0.0120844287443116,0.00841077085073759,0.72535408961841
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00259212933324411,0.00738922736255347,-0.0118907562973607,0.0170750149638489,0.725745184622811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HK2,Hexokinase-2,39585,-0.000919638814337166,0.00262698506536239,-0.00606852954244745,0.00422925191377312,0.726287952899478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTR,Methionine synthase,37021,0.00214865963544209,0.0061959069105482,-0.00999531790923239,0.0142926371801166,0.728756929224459
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00167770988406451,0.00488740066651817,-0.0112570151904401,0.0079015954223111,0.731399005686259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN5,Contactin-5,39897,-0.00118057199855911,0.00345704521564056,-0.0079563806212146,0.00559523662409637,0.732733626176027
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF5,Fibroblast growth factor 5,39587,-0.00108626167597554,0.0031813138466061,-0.0073216368153235,0.00514911346337241,0.732768913327243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX2,Peroxiredoxin-2,37249,0.00199214201113805,0.00585127659572763,-0.00947636011648809,0.0134606441387642,0.733513374278814
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCLN,Nicalin,39587,-0.00170596339325316,0.00506379450237546,-0.0116310006179091,0.00821907383140274,0.736201094266218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POF1B,Protein POF1B,37056,0.0014571136320561,0.00435160407809942,-0.00707203036101877,0.00998625762513097,0.737747202473982
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSD1,Tryptase delta,37411,0.00117432538000152,0.0035156588046733,-0.00571636587715816,0.0080650166371612,0.738364264092691
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.00133079018856428,0.00398950434771656,-0.00915021871008873,0.00648863833296018,0.738707191276168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.00268300447878257,0.00806686426987827,-0.018494058447744,0.0131280494901788,0.739444769337374
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00145777417199309,0.00439444418512919,-0.00715533643086012,0.0100708847748463,0.740097519697532
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA7A,Semaphorin-7A,40002,0.000856274003228849,0.00258740035700526,-0.00421503069650146,0.00592757870295915,0.740694181771776
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00214311657525847,0.00654679449702056,-0.0106886006389018,0.0149748337894188,0.743405675826804
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHC1,SHC-transforming protein 1,36962,-0.00360624987606682,0.0111171195264326,-0.0253958041478747,0.018183304395741,0.745650182962307
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,39477,-0.00143434837569149,0.00446599746935419,-0.0101877034156257,0.00731900666424273,0.748085189827211
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,-0.00125161994240446,0.0039445668647107,-0.00898297099723743,0.00647973111242852,0.751018361248191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTNL10,Butyrophilin-like protein 10,36962,-0.00119933796212839,0.00379710072597319,-0.00864165538503583,0.00624297946077905,0.752116658502452
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.00191335326546996,0.00610477156872396,-0.0138787055401689,0.010051999009229,0.753967108030911
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAGE2A,G antigen 2A,36962,-0.00181906311550452,0.00586701487062901,-0.0133184122619374,0.00968028603092833,0.756528493249915
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NENF,Neudesin,37368,0.0031372120779995,0.0105547724096329,-0.017550141844881,0.02382456600088,0.766294255074652
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13,Interleukin-13,39587,0.00138436557111638,0.00468281633064983,-0.00779395443695728,0.01056268557919,0.767519078455766
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",36991,0.00184365351667738,0.00626359618025416,-0.0104329949966208,0.0141203020299755,0.768499515937013
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.00154570425259394,0.0053907595751112,-0.0121115930198119,0.00902018451462402,0.774321918445987
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG2,"Arginase-2, mitochondrial",37368,-0.00120744114571109,0.00421630218581186,-0.00947139342990234,0.00705651113848016,0.774595746754215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3A,Uroplakin-3a,36991,-0.00130331945511958,0.00458835491931704,-0.010296495096981,0.00768985618674183,0.776377003134365
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN15,Lipocalin-15,37411,-0.00169232489282993,0.00595859768218202,-0.0133711763499067,0.00998652656424684,0.776404025720719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALMS1,Alstrom syndrome protein 1,37169,0.00120215104807889,0.00430555190994339,-0.00723673069541015,0.00964103279156793,0.780088382659182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,36962,0.00170605811265152,0.00611969287152906,-0.0102885399155454,0.0137006561408485,0.780416792779035
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMCN2,Hemicentin-2,37100,-0.00150824352388998,0.00546612520692027,-0.0122218489294537,0.00920536188167375,0.782609567013383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.00195263664811742,0.00717216917175236,-0.016010088224752,0.0121048149285172,0.785431941016246
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRX,Cone-rod homeobox protein,39585,-0.00280635086048059,0.0103954700517826,-0.0231814721619744,0.0175687704410132,0.787195326708818
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5,Interleukin-5,39587,-0.00371516664260543,0.0138607873314045,-0.0308823098121583,0.0234519765269474,0.788676420190918
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSCA,Prostate stem cell antigen,37382,0.00645136835515353,0.0243948600068158,-0.0413625572582054,0.0542652939685124,0.791432555917485
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF6,Fibroblast growth factor 6,37056,0.00103957286918952,0.00394196329842109,-0.00668667519571581,0.00876582093409485,0.792000131804789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,37039,0.00261427807195441,0.00993896238898195,-0.0168660882104502,0.022094644354359,0.79252902496981
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL2,Chordin-like protein 2,39868,0.00142001059210812,0.00540805795960284,-0.00917978300871344,0.0120198041929297,0.792883007755335
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOPH1,Enolase-phosphatase E1,37368,0.00140727775712331,0.0053642660156819,-0.00910668363361322,0.0119212391478598,0.79306099694551
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00252171042404337,0.00963469951673674,-0.0163623006287606,0.0214057214768474,0.793532063656314
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC1,Sialoadhesin,39931,-0.00103589158146448,0.00401366340881127,-0.00890267186273458,0.00683088869980561,0.796339755506729
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.000735299276257627,0.00295110606617302,-0.0050488686134415,0.00651946716595675,0.803239773216611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,-0.000829567711858515,0.00342398083745264,-0.00754057015326569,0.00588143472954866,0.808565594320432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.000553495790546699,0.00229557550617186,-0.00505282378264355,0.00394583220155015,0.809470275961314
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH4,Cadherin-4,36991,0.00106919597876236,0.00449918861812046,-0.00774921371275374,0.00988760567027845,0.812162514814852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2,T-cell surface antigen CD2,37021,-0.00087629333895862,0.00369245307686941,-0.00811350136962267,0.00636091469170542,0.812412162668831
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2,Interleukin-2,39587,0.000703056670495876,0.00299346474141386,-0.00516413422267529,0.00657024756366705,0.814317461700467
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKZF2,Zinc finger protein Helios,39477,-0.00212190930748665,0.00903661886684142,-0.0198336822864958,0.0155898636715225,0.814357495033719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,0.00140153555711812,0.00619736178996595,-0.0107452935512151,0.0135483646654514,0.821087994644371
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL24,Interleukin-24,39587,-0.00102480105994381,0.00453593979331419,-0.00991524305483962,0.00786564093495199,0.821259454877793
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00145974787960139,0.00653130381329425,-0.0142611033536581,0.0113416075944553,0.823149637394976
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC1A4,Neutral amino acid transporter A,37039,-0.00110020703493519,0.00493321354036875,-0.0107693055740579,0.00856889150418756,0.823523120817838
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP1,Retinol-binding protein 1,37039,-0.00147109817173765,0.00674997210725038,-0.0147010435019484,0.0117588471584731,0.827478167045763
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,-0.00122982509678192,0.00567815380762874,-0.0123590065597342,0.00989935636617041,0.828531529410669
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.000597510485451029,0.00281593350692059,-0.00611674015901539,0.00492171918811333,0.831962156272389
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN4,Prefoldin subunit 4,36962,0.00110198459878436,0.00523339763454644,-0.00915547476492667,0.0113594439624954,0.833227879059595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPB41L5,Band 4.1-like protein 5,37039,-0.00122082242070804,0.00617192120446861,-0.0133177879814665,0.0108761431400504,0.843202516976179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.00210957739172285,0.0111162579585328,-0.0196782882070014,0.0238974429904471,0.849489026943594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAL,Galanin peptides,39931,-0.00117070394283555,0.00618393495776458,-0.0132912164600541,0.010949808574383,0.849849306624422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.000741080072332571,0.00394237537881055,-0.0069859756701361,0.00846813581480125,0.850896678559158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL19,Interleukin-19,39419,0.00120463205626001,0.00658660328394589,-0.0117051103802739,0.014114374492794,0.854885737677866
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.000888547969738767,0.0048712471754662,-0.0104361924336525,0.00865909649417499,0.85526637802693
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUOX2,Dual oxidase 2,39585,-0.00124204947733505,0.00685047634446945,-0.0146689831124952,0.0121848841578251,0.856127784259868
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,37056,-0.00210178539100225,0.011634167805885,-0.0249047542905368,0.0207011835085323,0.856640157584866
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCIN,Adseverin,36991,0.00127968085644322,0.00710643880821506,-0.0126489392076583,0.0152083009205447,0.857097695140989
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,39866,0.000794740805330262,0.00441548974748171,-0.00785961909973388,0.00944910071039441,0.85716326529373
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,39866,0.000705241444046264,0.00393278097047105,-0.007003009258077,0.00841349214616953,0.85768568678764
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,-0.000993667036226586,0.00564554814094223,-0.0120589413924733,0.0100716073200202,0.860289620318524
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR5,Proline-rich protein 5,37056,-0.000792079019910847,0.00457910249586252,-0.00976711991180139,0.00818296187197969,0.862672226753249
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS8,Regulator of G-protein signaling 8,39587,-0.00108890732181652,0.00631927643175045,-0.0134746891280474,0.0112968744844144,0.863191959973073
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,-0.00042597475452647,0.00257471511313104,-0.00547241637626332,0.00462046686721038,0.868595498193033
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00052832397599488,0.00321810855728236,-0.00577916879627854,0.0068358167482683,0.869598030344446
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF15,Growth/differentiation factor 15,40052,0.000665531777507259,0.0040727475737887,-0.00731705346711859,0.00864811702213311,0.870196877369877
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.00182413504446288,0.011397773722551,-0.0205155014517371,0.0241637715406629,0.872849143099967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAX,Integrin alpha-X,37169,0.000806169842234904,0.00508236874712377,-0.00915527290212768,0.0107676125865975,0.873969977837448
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,36962,0.000500303814384589,0.00316352008759891,-0.00570019555730928,0.00670080318607846,0.874342754799262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,37169,-0.00116576070073874,0.00737496274396264,-0.0156206876789055,0.013289166277428,0.874404001734302
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.000921076383901041,0.00588496767415513,-0.010613460257443,0.0124556130252451,0.875630685425504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF830,Zinc finger protein 830,37368,-0.00119153422165446,0.00774702898459526,-0.0163757110314612,0.0139926425881522,0.877765541722223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00130901911278281,0.00875049860871545,-0.0158419581602995,0.0184599963858651,0.881087496686359
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,36962,-0.00122281698498134,0.00834314403093498,-0.0175753792856139,0.0151297453156512,0.883477250153454
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI2B,Protein EVI2B,36962,-0.000573946613021999,0.00396616980989841,-0.00834763944042289,0.00719974621437889,0.884941635288341
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF3,Fibroblast growth factor 3,37056,0.000428424575096647,0.00296063115516417,-0.00537441248902513,0.00623126163921843,0.884944282704306
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN7,Septin-7,37169,0.000707521251722497,0.004933088095569,-0.00896133141559275,0.0103763739190377,0.885957817212518
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSN,Gelsolin,37383,-0.000253406003059096,0.00179297449041093,-0.00376763600426452,0.00326082399814633,0.887609189179206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN7,Tetraspanin-7,36991,0.00123082638222195,0.00905765384289661,-0.0165221751498554,0.0189838279142993,0.891911912380815
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPT1,Translationally-controlled tumor protein,39587,0.000838791022394453,0.00626787853563737,-0.0114462509074548,0.0131238329522437,0.893543657109516
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPN3,Calpain-3,37368,0.00048127524523517,0.00361899363302766,-0.00661195227549903,0.00757450276596938,0.894206486333573
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,37021,-0.000911564017128433,0.00689011828255916,-0.0144161958509444,0.0125930678166875,0.894748872772623
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10,Interleukin-10,39587,-0.000955355058920799,0.00760448879474436,-0.0158601530966197,0.0139494429787781,0.900026094356297
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMI,N-myc-interactor,37311,-0.000862359677680264,0.00693550395595196,-0.0144559474313461,0.0127312280759856,0.901048036506533
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RUVBL1,RuvB-like 1,39477,0.00119391299461271,0.0097598024634961,-0.0179352998338396,0.0203231258230651,0.902639543297382
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAPPA,Pappalysin-1,39587,-0.000527535986110533,0.00455883147912738,-0.0094628456852002,0.00840777371297913,0.907878017375633
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MB,Myoglobin,40052,0.000564247569724512,0.00497946388636283,-0.00919550164754664,0.0103239967869957,0.909782290948162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHDC3L,KH domain-containing protein 3,36962,0.000716662005082471,0.00639454279647824,-0.0118166418760149,0.0132499658861798,0.910766447438059
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN4,Nectin-4,39913,-0.000289992081636689,0.00282528768246931,-0.00582755593927653,0.00524757177600316,0.918248697818553
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.000321776014535796,0.00315631894078862,-0.0058646091094099,0.00650816113848149,0.918800604109946
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.000704805433434356,0.00693921081610226,-0.0128960477661261,0.0143056586329948,0.919100711423969
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.000328841899130658,0.0033522383734253,-0.00624154531278293,0.00689922911104424,0.921857151260647
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",37021,0.00036514373459543,0.00380670795389353,-0.00709600385503589,0.00782629132422675,0.923584671808349
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALLD,Palladin,37056,-0.000367374858539837,0.00391788176076646,-0.00804642310964209,0.00731167339256242,0.925294283163757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,37368,0.000437197390200102,0.00550979545672177,-0.0103620017049746,0.0112363964853748,0.936756117153231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK3,Prostate-specific antigen,37437,-0.000587600676047637,0.00756757119061439,-0.0154200402096518,0.0142448388575566,0.938109843676471
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.000293021673273483,0.00378137039641706,-0.00770450765025093,0.00711846430370396,0.93823422078509
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN2,Transcobalamin-2,40012,0.00020626261762569,0.00280970759920848,-0.00530076427682293,0.00571328951207431,0.941480207699438
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF174,Zinc finger protein 174,37056,0.000257555837572695,0.00367283033554373,-0.00694119162009301,0.0074563032952384,0.944095532308166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL1,Interferon lambda-1,39489,0.000294249551835792,0.00431477961891094,-0.00816271850122966,0.00875121760490124,0.945630697315813
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,37039,-0.000270276157656419,0.00411168856197583,-0.00832918573912905,0.00778863342381621,0.947590905510062
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TG,Thyroglobulin,37368,0.000656705636815443,0.0104459174413286,-0.0198172925481886,0.0211307038218195,0.949873179683297
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,39477,-0.000183789370137822,0.00301464177126532,-0.00609248724181785,0.00572490850154221,0.95138740503867
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN6,Prefoldin subunit 6,37039,-0.000377616249310155,0.00634224128804802,-0.0128084091738843,0.012053176675264,0.952523009416954
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.000206380532871225,0.00392684630610959,-0.00749023822710356,0.00790299929284601,0.958086228792282
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3B,Sodium channel subunit beta-3,36991,-0.000218593885223401,0.00427582040846441,-0.00859920188581364,0.00816201411536684,0.959228077775495
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGN,Cingulin,37039,-0.000185690288847227,0.00373519460551905,-0.00750667171566457,0.00713529113797011,0.960351304081864
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,36991,0.000277526063390529,0.0056999413070581,-0.0108943588984433,0.0114494110252244,0.961167656054752
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZPR1,Zinc finger protein ZPR1,36991,0.000418380572904479,0.00923172827023098,-0.0176758068367482,0.0185125679825572,0.963853052025107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.000146677558954465,0.00346482139111082,-0.00664437236762274,0.00693772748553167,0.966233569014413
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI16,Peptidase inhibitor 16,37445,7.57453533847711e-05,0.00229554799377617,-0.00442352871441653,0.00457501942118607,0.973677757864049
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGR,Progesterone receptor,37056,-0.000320148513832909,0.0101027466751006,-0.0201215319970301,0.0194812349693643,0.97472034324255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.000214711419115352,0.00801673972601381,-0.0159275212821024,0.0154980984438717,0.978633237910534
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMP,Olfactory marker protein,36991,-0.000124513661376619,0.00467320533678806,-0.00928399612148121,0.00903496879872797,0.978743950815032
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,8.75346768049088e-05,0.00402167240154594,-0.00779494323022513,0.00797001258383495,0.982635152551282
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37039,6.73437730729368e-05,0.00344092454315319,-0.00667686833150732,0.00681155587765319,0.984385560751141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,39757,4.75355159424985e-05,0.00257473187390209,-0.0049989389569056,0.0050940099887906,0.985270270845621
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",36991,-0.000146735866685175,0.00795107315264161,-0.0157308392458627,0.0154373675124924,0.985276275862218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,36962,5.2440573455997e-05,0.00309623402465297,-0.00601617811486383,0.00612105926177583,0.986487221329231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KEL,Kell blood group glycoprotein,39489,4.9868663364205e-05,0.00341047175456543,-0.00663465597558403,0.00673439330231244,0.988333759945195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,36962,3.33991993481008e-05,0.00400827743390986,-0.00782282457111522,0.00788962296981142,0.993351785381437
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,3.96526811172431e-05,0.00783144662529321,-0.0153099827044574,0.0153892880666919,0.99596019424053
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,9.38949688169182e-06,0.00340653244062162,-0.00666741408673669,0.00668619308050007,0.997800818483628
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD10,Frizzled-10,37039,-1.53307683126674e-05,0.00575565143139211,-0.0112964075738412,0.0112657460372159,0.99787479541009
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,-3.3900194309597e-06,0.00484310595782382,-0.00949587769676564,0.00948909765790372,0.999441516926473
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4,Interleukin-4,39587,-5.20989604051258e-06,0.00867206139783871,-0.0170024502358044,0.0169920304437234,0.999520664223313
